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Abstract 
Novel approaches for the production of fuels and chemicals in Escherichia coli 
by 
Clementina Dellomonaco 
Volatility of oil prices along with major concerns about climate change, oil supply 
security and depleting reserves have sparked renewed interest in the production of 
biofuels and biochemicals. While the carbohydrate portion of edible crops is currently 
used as the primary feedstock in the biological production of fuels and chemicals, the 
availability of fatty acid (F A)-rich feedstocks and recent progress in the development of 
oil-accumulating organisms have drawn the attention to F As as an attractive alternative. 
However, microbial platforms to enable this were nearly absent. To this end, we 
engineered native and heterologous fermentative pathways in E. coli to enable the 
efficient synthesis of fuels and chemicals from F As. The current de facto strategy for the 
synthesis of non-native products in model organisms is Heterologous Metabolic 
Engineering (HeME), which consists of recruiting foreign genes from native producers. 
However, the relative incompatibility of the heterologous pathways with the host 
metabolism may be considered a drawback. As an alternative approach, the HoME 
(Homologous Metabolic Engineering) strategy that we propose overcomes this limitation 
by harnessing the metabolic potential of the host strain. HoME aims at reconstructing 
heterologous pathways to enable biosynthesis of non-natural products by identifying and 
111 
assembling native functional surrogates. Implementation of both HeME and HoME 
strategies in the context of fuels and chemicals biosynthesis has usually been directed to 
the conversion of feedstocks constituents into a specific product. However, we 
demonstrated a novel metabolic platform based on a functional reversal of the fatty acid 
catabolic pathway ({3-oxidation) as a means of synthesizing a wide array of products with 
various chain lengths and functionalities. 
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Extended abstract 
Novel approaches for the production of fuels and chemicals in Escherichia coli 
by 
Clementina Dellomonaco 
Volatility of oil prices along with major concerns about climate change, oil supply 
security and depleting reserves have sparked renewed interest in the production of 
biofuels and biochemicals. Although several biomass feedstocks are available for the 
production of fuels and chemicals, carbohydrates have been so far the option of choice 
for bioconversions. Presently, the design of microbial platforms to efficiently convert 
these building blocks to valuable products involves either manipulating metabolic 
pathways of native producers, or reconstructing synthetic pathways in organisms that are 
more industrially and genetically tractable but do not possess the metabolic trait sought 
for. 
This research work improves upon existing technologies in that i. It demonstrates 
a novel microbial platform that efficiently utilize fatty acid-rich feedstocks to synthesize 
fuels and chemicals; ii. It establishes a new approach to construct efficient microbial cell 
factories by harnessing E. coli innate metabolic potential; and iii. It demonstrates a novel 
platform to produce biomolecules with different chain lengths and functionalities. 
While the carbohydrate portion of edible crops is currently used as the primary 
feedstock in the biological production of fuels and chemicals, the availability of fatty acid 
XV 
(FA)-rich feedstocks and recent progress in the development of oil-accumulating 
organisms have drawn the attention to F As as an attractive alternative. However, 
microbial platforms to enable this were nearly absent prior to our work. Moreover, F As 
are metabolized only under respiratory conditions, a metabolic mode that does not 
support the synthesis of fermentation products. In this work we engineered several native 
and heterologous fermentative pathways to function in E. coli under aerobic conditions, 
thus creating a respiro-fermentative metabolic mode that enables the efficient synthesis of 
fuels and chemicals from FAs. The yield of ethanol, acetate, and acetone in the 
engineered strains exceeded those reported in the literature for their production from 
sugars, and in the case of ethanol and acetate also surpassed the maximum theoretical 
values that can be achieved from lignocellulosic sugars. Butanol was produced at yields 
and titers between two- and three-fold higher than those reported for its production from 
sugars in previously engineered microorganisms. Moreover, this work demonstrates 
propionate production in E. coli, a compound previously thought to be synthesized only 
by Propionibacteria. Finally, the synthesis of isopropanol and succinate was also 
demonstrated. The work hereby reported represents the first effort towards engineering 
microorganisms for the conversion of FAs to the aforementioned products. 
While several of the metabolic traits sought after in an ideal biocatalyst can be 
found in native microorganisms, these are often distinct from the organisms proved 
effective in industrial processes and the environmental conditions under which these 
capabilities are natively utilized often differ from the ones used in a bioreactor. 
Additionally, the same pathways can be controlled by complex regulatory cascades 
established by evolution. When the synthesis of the product of interest cannot be 
XVI 
efficiently achieved in the native orgamsm, synthetic biology provides the means to 
overcome this hurdle by importing biosynthetic pathways in industrially tractable 
bacteria, thus consolidating in one cell any trait of interest. However, incompatibility of 
the imported pathway with the host metabolism is of significant concern. We propose an 
alternative strategy, Homologous Metabolic Engineering (HoME), as a means of 
synthesizing non-native products in industrial organisms without importing foreign 
pathways. We demonstrated the viability of this new approach by engineering and 
redirecting E. coli functionome toward metabolic modes that are typical of organisms 
genetically and metabolically dissimilar. Proof of concept was provided for the case of 
acetone-butanol-ethanol fermentation, peculiar of Clostridial spp., anaerobic dissimilation 
of glycerol to 1,3-PDO, a metabolic mode characteristic of Klebsiella and Citrobacter 
spp. and the yeast homoethanolic fermentation. 
Harnessing the metabolic potential of model organisms provides the opportunity 
to produce a broad array of platform chemicals, thereby creating a consolidated 
framework for the production of advanced fuels and chemicals. By analogy with the 
petrochemical industry, a successful bio industry will build upon the platform-chemical 
approach, where each chemical intermediate is converted to a large number of chemical 
products. Here we demonstrate that a functional reversal of the fatty acid catabolic 
pathway W-oxidation cycle) can be used as a metabolic platform for the synthesis of 
alcohols and carboxylic acids with various chain lengths and functionalities. The reversal 
of the ~-oxidation cycle was engineered in Escherichia coli and used in combination with 
endogenous dehydrogenases and thioesterases to synthesize n-alcohols, fatty acids and 3-
hydroxy-, 3-keto- and trans-~2-carboxylic acids. The superior nature of the engineered 
XVll 
pathway was demonstrated by producing higher-chain linear n-alcohols (C 2: 4) and 
extracellular long-chain fatty acids (C > 10) at higher efficiency than previously reported. 
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Chapter 1 
Introduction 
Volatility of oil prices along with major concerns about climate change, oil supply 
security and depleting reserves have sparked renewed interest in the production of fuels 
and chemicals from renewable resources. Because of its abundance and renewable nature, 
biomass has the potential to offer diverse supplies of reliable, affordable, and 
environmentally sound bioproducts. Given the complexity of biomass in terms of 
chemical composition, a conventional bioprocess for the biosynthesis of fuels and 
chemicals entails several steps such as the use of different forms of biomass, feedstock 
deconstruction to obtain biomass constituents (e.g., monosaccharides, fatty acids, etc.) 
and their conversion to bioproducts (Figure 1-1 ). A major challenge presented by the 
establishment of a viable bioindustry consists in creating microbial cell factories that can 
perform efficient and economical bioconversions from different biomass building blocks 
to a set of biomolecules with various chain lengths and functionalities. 
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Figure 1-1 General bioprocess scheme for the production of fuels from renewable feedstocks 
The different feedstocks are listed arranged according to their environmental and economical 
sustainability. Feedstock deconstruction releases elementary building blocks such as pentoses, 
hexoses, polyols, fatty acids, etc. that are then microbially converted to biofuels (Dellomonaco et 
al., 2010a). 
Because of its abundance and renewable nature, biomass has the potential to offer 
diverse supplies of reliable, affordable, and environmentally sound biomolecules. Many 
biomass feedstocks can be used for the production of renewable fuels and chemicals 
(Figure 1-1 ). These include agricultural lignocellulosic residues, edible and non-edible 
crops, and waste streams (e.g. bagasse from sugar manufacture, industrial by-products) 
(Figure 1-1 ). 
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Vast supplies of diverse renewable resources are therefore available for 
conversion to generic feedstock constituents (carbohydrates, polyols, fatty acids, etc.) that 
can be converted into valuable fuels. The availability of diverse generic feedstock 
building blocks provides many opportunities to employ microbial means for the 
conversion of a wide variety of carbon sources into valuable products. While a number of 
platforms that convert carbohydrates and polyols to biomolecules have already been 
established, microbial processes that can exploit fatty acid-rich feedstocks for the 
synthesis of fuels and chemicals are nearly absent. Thus, the need for the establishment of 
a novel platform that can utilize these abundant renewable feedstocks for fuel and 
chemical production. 
Many native microorganisms possess biochemical pathways for the dissimilation 
of feedstock constituents and their conversion into a diverse set of products. However, 
these native microorganisms, which are usually derived from environmental isolates, 
often present very stringent requirements in terms of nutrients and environmental 
conditions, and therefore do not represent a viable option as industrial microbial 
platforms (Alper and Stephanopoulos, 2009). In addition, while these microorganisms 
could have the ability to convert biomass constituents to a desired bioproduct, the 
favorable traits can still be limited, due to complex regulatory cascades arisen as 
consequence of evolution. Genetic manipulation would be needed in this scenario in 
order to obtain an integrated and multifunctional microbial platform. However, these 
organisms typically suffer from a lack of genetic and metabolic tractability, needed to 
transform them into versatile metabolic platforms. 
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Metabolic engineering and the most recent synthetic biology are valuable 
technologies for enabling diversification of molecules biosynthesis by engineering native 
or de novo pathways, and thus combining favorable traits in industrial model organisms 
(Jarboe et al., 2010). As such, several engineering efforts have revolved around the 
implementation of these methodologies in the context of fuels and chemicals production 
(Dellomonaco et al., 2010a; Lee et al., 2008a). While there have been several rather 
successful attempts of engineering de novo pathways in model organisms by importing 
heterologous genes, the resulting engineered strains often underperform when compared 
to native organisms. This observation raises therefore the concern as to whether the 
attractive metabolic capabilities that we aim at importing are in reality controlled enabled 
by a multitude of genes and physiological factors in the native organisms (Alper and 
Stephanopoulos, 2009). Hence, compatibility of the imported pathway with the host 
metabolism becomes of concern. The need for novel methodologies that can harness 
native fimctionome and consolidate favorable traits in model organisms becomes 
therefore crucial. 
Metabolic engineering and synthetic biology strategies have been to this point 
tailored for the synthesis and optimization of single products. However, by integrating 
synthetic competences from diverse metabolic and phylogenetic origins within an 
integrated biological system, it is possible to envisage envision the development of a 
single technological platform for synthesizing a wide variety of biorenewable molecules 
for use in the chemical and energy industry. By analogy with the current non-renewable 
petrochemical industry, a successful bio-based chemical industry will therefore build 
upon the platform-chemical approach, where each chemical intermediate is converted to a 
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large number of chemical products. Harnessing the metabolic potential of model 
organisms provides therefore opportunity to produce a broad array of platform 
chemicals, thereby creating a consolidated framework for the production of advanced 
fuels and chemicals. 
The overall goal of this study is the development of novel approaches to engineer 
Escherichia coli for the production of fuels and chemicals. The innovative character of 
the research hereby presented consists in combining the design of novel metabolic 
platforms with the development and implementation of innovative metabolic engineering 
approaches for the efficient conversion of diverse biomass constituents to a set of 
biomolecules with various chain lengths and functionalities. 
The development of oil-accumulating organisms and the abundance of non-edible 
fatty acid-rich feedstocks have recently ignited interest in the use of fatty acids as 
attractive alternative to carbohydrates for the production of fuels and chemicals. 
However, microbial platforms to enable this technology were nearly absent. F As are 
catabolized only under respiratory conditions, a metabolic mode that hinders the 
synthesis of fermentation products. In this work, we established a respiro-fermentative 
metabolic mode in E. coli that enables the synthesis of several fuels and chemicals from 
fatty acids. Yields of ethanol, acetate, and acetone in the engineered strains surpassed 
those reported in the literature for their production from sugars, and in the case of ethanol 
and acetate exceeded the maximum theoretical value attainable from lignocellulosic 
sugars. The strain engineered for butanol production outperformed in yields and titers 
microorganisms previously engineered for the synthesis of butanol from sugars. 
Synthesis of succinate, isopropanol and propionate, a compound previously thought to be 
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synthesized only by Propionibacteria, was also demonstrated. This work represents the 
first effort towards engineering microorganisms for the conversion of FAs to fuels and 
chemicals. 
While native bacteria possess a wide set of metabolic capabilities sought after in 
an ideal microbial platforms, genetical tractability may pose concerns when manipulation 
to improve on yields is required. An attractive alternative is the utilization of model 
organisms that are industrially and genetically amenable. However, model organisms 
may not possess the metabolic trait sought for, as inferred from phylogenetics. Metabolic 
engineering and synthetic biology have provided the means to overcome this limitation 
by importing biosynthetic pathways. However, incompatibility of the imported pathway 
with the host metabolism is a significant concern. The proposed alternative strategy, 
Homologous Metabolic Engineering (HoME), aims at harnessing the native metabolic 
potential of industrially amenable microorganisms. The viability of this new approach has 
been demonstrated by engineering and redirecting E. coli functional differentiation 
toward metabolic modes that are typical of organisms genetically or metabolically 
distinct. Proof of concept has been provided for the case of acetone-butanol-ethanol 
fermentation, peculiar of Clostridial spp., anaerobic dissimilation of glycerol to 1,3-PDO, 
a metabolic mode characteristic of Klebsiella and Citrobacter spp., and the yeast 
homoethanolic fermentation. 
Harnessing the metabolic potential of model organisms provides the opportunity 
to create a consolidated framework for the production of a diverse array of chemicals and 
fuels. In analogy with the current petrochemical industry, a viable bioindustry will build 
upon the platform-chemical approach, where a wide array of products are synthesized 
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from a common substrate. In this regard, we propose the functional reversal of E. coli 
fatty acid catabolic pathway (,8-oxidation) as a metabolic platform for the synthesis of 
alcohols and carboxylic acids with various chain lengths and functionalities. The reversal 
of the ~-oxidation cycle has been engineered in Escherichia coli and used in combination 
with endogenous dehydrogenases and thioesterases to synthesize n-alcohols, fatty acids 
and 3-hydroxy-, 3-keto- and trans-~2-carboxylic acids. The superior nature of the 
engineered pathway is demonstrated by the higher efficiencies attained for higher-chain 
linear n-alcohols and extracellular long-chain fatty acids biosynthesis. 
This work has encompassed the following specific objectives, which are 
presented below in the context of each chapter. 
1. Biological Production ofbiofuels and biochemicals from fatty acid-rich feedstocks 
1. Establish appropriate respiro-fermentative metabolic mode to enable the 
production of reduced chemicals and fuels from fatty acids. Metabolism of free 
fatty acids (F As), the main constituents of fats and oils, requires the presence of 
an external electron acceptor, which in tum could preclude the biosynthesis of 
fermentative reduced products. Genetic manipulations and adjustment of the 
availability and/or rate of consumption of terminal electron acceptors have been 
explored in the context of establishing a respiro-fermentative metabolic mode in 
which a balance between cell growth and synthesis of reduced products ts 
simultaneously achieved. 
u. Engineer the constitutive expression of the /3-oxidation pathway for the 
utilization of different length F As at high flux. Under aerobic conditions, E. coli 
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can use fatty acids of various chain lengths as sole carbon and energy sources. 
However, long-chain fatty acids (LCFAs) of at least 12 carbon atoms are 
required for induction of the catabolic enzymes. The fad regulon is primarily 
responsible for the transport, acylation, and P-oxidation of medium- and long-
chain fatty acids and the expression of these genes is specifically controlled by 
fadR gene product. In addition to enzymes of the fad system, growth of E. coli 
on short chain-fatty acids requires two degradative enzymes encoded by the ato 
operon and regulated by the atoC gene product. Genetic manipulation of the 
local regulator FadR and AtoC has been explored to attain constitutive 
expression of the ~-oxidation pathway for the efficient utilization of F As of 
different chain length. 
iii. Engineer native and synthetic pathways in Escherichia coli for the efficient 
production of fuels and chemicals from fatty acids. Strategies implemented to 
this end include 1. Blocking the synthesis of byproducts that compete for both 
carbon and reducing equivalents; 2. Overexpressing native or heterologous 
pathways; 3. Manipulating global regulators and environmental conditions to 
ensure optimal functioning of the pathways. 
2. Engineering functional differentiation in bacteria by harnessing the pluripotent 
capabilities of native hosts 
1. Establish proper sequence, structure and domain-organization homology 
search criteria and metrics for the identification of functional analogues. 
Functional homology is inferred by implementing both phylogenetics and 
functional inference from secondary and tertiary protein structures. A 
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comparison of sequence, structure, and domain-organization & composition is 
performed between the enzymes mediating the heterologous pathways and those 
encoded in the E. coli genome. A set of functional surrogates is obtained after 
ranking the initial targets by appropriate homology metrics and analyzing them 
in the context of primary literature and information from genomic and metabolic 
databases. 
ii. In vivo assembly and functional characterization of native synthetic pathways. 
The pathway identified in "i. " is assembled and functionally expressed in wild-
type E. coli by direct overexpression, and fermentative pathways that consume 
common intermediates are blocked. Since the genes proposed as surrogates 
might be also subjected to several levels of regulation, expression can be also 
promoted by manipulating the corresponding regulators. 
3. Engineered reversal of the B-oxidation cycle as a metabolic platform for the 
combinatorial synthesis of advanced fuels and chemicals 
1. Establish a native metabolic platform for the combinatorial synthesis of fuels 
and chemicals. The fatty acid biosynthesis pathway has been recently proposed 
as a platform for the production of a diverse set of chemicals. However, the use 
of acyl-ACP intermediates and malonyl-ACP as the 2-C donor during chain 
elongation in the fatty acid biosynthesis pathway limits its A TP efficiency, 
making it an energy-consuming pathway. Conversely, the I)-oxidation pathway 
operates with coenzyme-A (CoA) thioester intermediates and directly uses 
acetyl-CoA for acyl-chain elongation (rather than first requiring ATP-dependent 
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activation to malonyl-CoA), characteristics that enable product synthesis at 
maximum carbon and energy efficiency. 
n. Engineer pathways for the synthesis of carboxylic acids and alcohols from acyl-
CoA intermediates generated in the functional reversal of the f3-oxidation cycle. 
Acyl-CoAs generated by the reversal of the f3-oxidation cycle are converted to 
alcohols by a two-step pathway composed of aldehyde-forming acyl-CoA 
reductases & alcohol dehydrogenases. Carboxylic acids, on the other hand, are 
synthesized from acyl-CoAs via specific thioesterases. 
iii. Improve the efficiency of the engineered reversal of the /3-oxidation cycle during 
the synthesis of carboxylic acids and fuels. Ensuring an adequate supply of 
acetyl-CoA and reducing equivalents is necessary for the optimal functioning of 
the engineered reversal of the f3-oxidation cycle. Fuels and chemicals 
biosynthesis is therefore promoted by blocking the synthesis of byproducts that 
compete for both carbon (AcCoA) and reducing equivalents. Global regulators 
and environmental conditions are manipulated to ensure optimal functioning of 
the surrogate enzymes that compose the native pathways. 
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Chapter 2 
Production of biofuels and biochemicals 
from fatty acid-rich feedstocks 
2.1. Motivation and background 
Concerns about climate change and depletion and cost of petroleum resources 
have ignited interest in the establishment of a bio-based industry (Bevan and Franssen, 
2006; Ragauskas et al., 2006; Stephanopoulos, 2007) and the conceptual model of a 
biorefinery has emerged (Kamm et al., 2006; Kamm and Kamm, 2004; Octave and 
Thomas, 2009). 
Because of its abundance and renewable nature, biomass has the potential to offer 
diverse supplies of reliable, affordable, and environmentally sound biofuels to replace 
fossil fuels (Dellomonaco et al., 2010a). Many biomass feedstocks can be used for the 
production of biofuels. These include agricultural lignocellulosic residues, edible and 
non-edible crops, and waste streams (e.g. bagasse from sugar manufacture, industrial by-
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products) (Dellomonaco et al., 2010a). Given their abundance in nature, starch (i.e. com, 
wheat, barley, etc.) and sugar crops (i.e. cane, beet, etc.) are the primary feedstocks 
currently used in the biological production of fuels and chemicals (Dellomonaco et al., 
201 Oa; Ragauskas et al., 2006; Rude and Schirmer, 2009). Although the use of non-edible 
lignocellulosic sugars has been proposed as an efficient and sustainable avenue to the 
aforementioned processes, availability of fatty acid (F A)-rich feedstocks and recent 
progress in the development of oil-accumulating organisms make F As an attractive 
alternative. 
Edible oil-rich crops such as rapeseed, sunflower, soybean and palm are currently 
available and widely used as feedstocks for chemical conversion to biodiesel (Carlsson, 
2009), while oleaginous algae and non-edible FA-rich crops along with industrial by-
products are receiving greater attention as longer-term alternatives. These non-edible FA-
rich feedstocks are presently generated in large amounts and can be exploited for the 
biological production of fuels and chemicals (Durnin et al., 2009; Hu et al., 2008; 
Rosenberg et al., 2008; Schenk et al., 2008; Service, 2009). However, microbial 
platforms to enable this were almost absent prior to our work (Dellomonaco et al., 
2010b). 
2.1.1. Fatty acid degradation in Escherichia coli 
Escherichia coli can utilize fatty acids of diverse chain lengths as sole carbon and 
energy source (Clark and Cronan, 2005), under respiratory conditions. Once activated 
(Figure 2-1 ), fatty acids can either be catabolized via the B-oxidation pathway or they 
serve as precursors for membrane phospholipid biosynthesis. The respiratory catabolic 
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pathway for fatty acids in E. coli is mediated by enzymes encoded within the fad operon, 
which are responsible for transport and activation of long-chain fatty acids, and their 
degradation into acetyl-CoAs (Figure 2-1 ). Transport of long chain and short chain fatty 
acids in E. coli are governed by distinct mechanisms. Long chain fatty acids are 
transported in the cytoplasm by an outer membrane protein, FadL (Black and Dirusso, 
1994), and activated to coenzyme A thioesters by an acyl-CoA synthase, FadD (Black et 
al., 1992) (Figure 2-1 ). While eukaryotic systems possess multiple acyl-CoA synthases 
with different fatty acid chain-length specificities, Escherichia coli has a single acyl-CoA 
synthase, FadD, characterized by broader substrate specificity (Overath et al., 1969). This 
reaction consumes one ATP per molecule of free fatty acid activated. At each cycle of 
the 13-oxidation enzymes encoded within the fad operon progressively shorten the fatty 
acid chain by two carbons while capturing the energy in the form of NADH and F ADH2. 
At the end of each cycle of four reactions, one acetyl-CoA two-carbon unit is released 
from the end of the fatty acid molecule, which then goes through another round of 13- . 
oxidation, continuing to oxidize and shorten even-chain fatty acids until their complete 
degradation to acetyl-CoA (Figure 2-1 ). Fatty acids with an odd number of carbons in the 
acyl chain are reduced to propionyl-CoA, which is then converted to succinyl-CoA that 
then enters the Krebs cycle. 
Fatty Acids 
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FadD/ AtoO 
AMP+ PPi 
~~~~x1-CoA 
<:, f.!;e FADHz-1 FadE 
~ 2,3-Dehydroxyacyi-CoA 
·~ ! FadB 
-G ·~ trans-3-hydroxyacyi-CoA 
NAo··i 
l/: NADH~ FadB 
3-P-ketoacyi-CoA CoASHi FadA/ AtoB 
Acetyi-CoA 
r- --
TCA Cycle 
Glyoxylate Shunt 
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Figure 2-1 Biochemical pathway and regulation of fatty acids catabolism in Escherichia coli 
FA degradation and biosynthesis pathways are regulated both locally and globally 
based on availability of fatty acids to sustain membrane lipid homeostasis and in order to 
quickly respond to environmental changes. Expression of fad genes is repressed by the 
global cyclic AMP-dependent catabolite repression system, as several other sources are 
preferred E. coli substrates over fatty acids. The second specific regulatory system is 
instead locally exerted by the FadR trascriptional factor, which represses the transcription 
of each of the genes essential for fatty acid transport, activation, and ,8-oxidation, 
(Campbell et al., 2003; Clark and Cronan, 2005; Nunn, 1986a) while activating 
transcription of genes encoding key enzymes in the biosynthesis of unsaturated fatty 
acids (Campbell and Cronan, 2001). 
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Growth of wild-type E. coli strains in the presence of long-chain (2: C 12) fatty 
acids coordinately induces the fatty acid degradative (fad) enzymes (Klein et al. , 
1971)(Figure 2-1). On the contrary, fatty acids of medium (C7 to C 11 ) or short (C4 to C6) 
chain lengths cannot induce synthesis of the fad enzymes in Escherichia coli (Black and 
Dirusso, 1994). Although wild-type E. coli strains can only utilize long-chain fatty acids 
as a sole carbon and energy source, MCF As can serve as growth substrates for fadR 
mutants that constitutively express the fad enzymes (Clark and Cronan, 2005). Growth of 
E. coli on short-chain fatty acids requires instead expression of the atoDAB operon (Pauli 
and Overath, 1972). The atoB gene encodes ~-ketoacyl-CoA thiolase (thiolase II), 
responsible for the thiolytic cleavage of short-chain fatty acyl-CoA and subsequent 
synthesis of acetyl-CoA. The atoC gene product positively regulates transcription of the 
aforementioned three structural genes of the ato operon (Jenkins and Nunn, 
1987a)(Figure 2-1). Campbell and coworkers (Campbell et al., 2003) recently tested the 
ability of E. coli K12 to grow on fatty acids under conditions of anaerobic respiration. An 
anaerobic non-fermentative pathway for FA catabolism was identifi ed in E. coli 
(Campbell et al. , 2003), distinct from the aerobic one because it functions with fatty acids 
(Cs:o and C10:o) that cannot be utilized by wild-type Escherichia coli strains under aerobic 
conditions, and it does not seem to be under the regulation of FadR. 
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2.1.2. Feasibility analysis of the utilization of fatty acid-rich feedstocks 
2.1.2.1. Currently available fatty acid-based feedstocks 
Currently, edible oil-rich feedstocks are available and widely used as feedstocks 
for chemical conversion to biodiesel (Carlsson, 2009). Most seed oils are mainly 
composed of a wide range ofF As, the most abundant being palmitic (C16:o) and oleic acid 
(C18:1) (Azocar et al., 2010; Gui et al., 2008). While an upward trend of global vegetable 
oils supply has been reported over the last 10 years, palm oil is currently the world largest 
edible oil produced (45.86 million metric tons per year; USDA Report February 2011, 
http://www.fas.usda.gov), due to the highest yield per hectare (Gui et al., 2008). Palm oil 
processing and refining generates as by-product palm fatty acid distillate (PF AD), a side 
stream with free FAs content up to 93% (palmitic acid being by far the most abundant 
fatty acid at 58.1% ). Production of PF AD accounts for -5% of palm oil total annual 
production and could already support synthesis of biochemicals such to replace close to 
10% of the petrochemicals produced in US. Other side-streams of the meat and vegetable 
oil industry that contain mixtures of free F As are also available. POME (palm oil mill 
effluent) is a high volume liquid waste of palm oil wet mill processing characterized by 
high concentrations of lipids, carbohydrates, proteins, nitrogenous compounds, and 
minerals (Hwang et al.). At present, about 2.5 t of POME are produced for every ton of 
oil extracted in an oil mill (Ahmad et al., 2005; Wu et al., 2009). Additionally, by-
products of meat rendering, such as inedible animal tallow and yellow grease, are a viable 
alternative. They consist of a mixture of triglycerides, their major fatty acyl residues 
being oleic (45%), stearic (25%), and palmitic (25%). Inedible tallow is one of the least 
expensive animal fats (19 US cents/pound; www.thejacobsen.com, June 2010) and its 
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production in the United States (1.5 million metric tons in 2010; Sources: U.S. Census 
Bureau, M311K series for Fat and Oils: Production, Consumption, and Stocks.) greatly 
exceeds domestic consumption. In summary, the production of biochemicals from FA-
rich industrial byproducts can become a realistic alternative in the foreseeable future. 
2.1.2.2. Prospects for large-scale availability of FA-rich feedstocks 
Lately oleaginous algae and non-edible crops are receiving greater attention as 
longer-term alternatives to edible oil crops. Algae accumulate oils mainly in the form of 
triglycerides (:::: 80%), with a FAs profile rich in C16 and C18, similar to plant seed oils 
(Meng et al., 2009). Algae grow rapidly compared to crops and many are exceedingly 
rich in oil, with the average lipid content up to 80% by weight of dry biomass (Rodolfi et 
al., 2009). Today, approximately 5,000-10,000 tons of algae are commercially produced 
primarily for the production of high-value, low-volume food supplements and 
nutraceuticals (Pienkos and Darzins, 2009). A techno-economic model developed at the 
National Renewable Energy Laboratory (NREL; www.nrel.gov), and based on open-pond 
cultivation of algae, has estimated the cost of production for algal lipids ranging from 
$25/gal for low productivity (lOg m-2 day-1 at 15% triglycerides) to $2.50/gal for high 
productivity (50g m -2 day -I at 50% triglycerides) (Pienkos and Darzins, 2009). Although 
at the present stage of technical development the cost-effective high-scale production of 
algal oils is not viable, recent progress in the optimization of these oil-accumulating 
organisms will make F As available at the scale necessary to support the production of 
biofuels (Hu et al., 2008; Rosenberg et al., 2008; Schenk et al., 2008; Service, 2009). 
Non-edible oil crops like Jatropha curcas L., Ricinus communis, Pongamia pinnata, 
Hevea brasiliensis, Cerbera odollam or Cerbera manghas are characterized by average 
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oil content of dry seeds up to 50%, corresponding to a productivity of 225-1590 kg oil/ha 
(Gui et al., 2008). The oil composition of non-edible oil crops is very similar to the more 
common edible vegetable oils, rich in palmitic, oleic, linoleic and stearic acid (Gui et al., 
2008). Although non-edible oil crops are still at an early stage of development, they 
represent very promising platforms for the production of oils. 
2.1.2.3. Product yield and feedstock cost: comparison of sugar- and fatty acid-
based feedstocks 
Availability of FA-rich feedstocks and recent progress in the development of oil-
accumulating organisms (see Section 2.1.2.1) will undoubtedly make FAs available at the 
scale necessary to support the production of biofuels and are currently available to 
support significant biochemical production. 
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Figure 2-2 Comparison of catabolism of fatty acids and glucose to acetyl-CoA 
in Escherichia coli. 
f3-oxidation of fatty acids is represented on the left. Two A TP are released upon activation of 
every molecule of fatty acids. At each turn of the f3-oxidation cycle the fatty acid chain is 
progressively shortened of 2C, with the release of one molecule of acetyl-CoA. The dashed line 
(without arrowheads) between the two Acyl-CoA names is meant to imply that the two names are 
just different instantiations of the same compound. Abbreviations: n, fatty acid chain length; 
Abbreviations: 2[H] = NADH = FADH2 = H2 • 
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F As are not only abundant but also offer several advantages when used for fuel 
and chemical production. For example, their metabolism to the key intermediate 
metabolite acetyl-CoA is very efficient as it results in 100% carbon recovery (Figure 
2-2). Since many fuels and chemicals can be derived from acetyl-CoA, high yields can be 
realized ifF As are used as the carbon source (Figure 2-2). In contrast, sugar metabolism 
generates one molecule of carbon dioxide (or formate) per molecule of acetyl-CoA, 
limiting the yield of products derived from acetyl-CoA (Figure 2-2 and Table 2-2). The 
product yield advantage of F As over sugars is also supported by the higher reduced 
nature of their carbon atoms. Table 2-2 provides a comparison of maximum theoretical 
yields, on both weight and carbon basis, for the production of biofuels and biochemicals 
from F As and lignocellulosic sugars. Maximum theoretical yields have been calculated 
from stoichiometry based on the pathways shown in Figure 2-4 for the utilization ofF As 
and glucose, the synthesis of products, the TCA cycle, and the oxidative phosphorylation. 
The stoichiometric coefficients were obtained by conducting elemental balances on 
carbon, hydrogen and oxygen, and an ATP balance was included in the analysis. 
As an example, when production of biofuels (e.g. ethanol and butanol) 1s 
considered, utilization ofF As (e.g. palmitic acid!Ct6:o) as substrate returns product yields 
2.7-fold (w/w), or 1.4-fold (C/C), higher than sugars (calculations provided for glucose 
but equally valid for other lignocellulosic sugars). Although the current price of 
feedstocks on a weight basis is comparable (lower than 20 USD cents/pound), data 
reported in Figure 2-3 shows that the price per carbon for glucose derived from com is 
remarkably higher. Regardless of the basis used for calculations (i.e. weight or carbon 
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basis), when maximum theoretical yields and costs of FA and sugar feedstocks are 
accounted for, the advantages of using F As are remarkable (Figure 2-3a). 
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Figure 2-3 Price and cost comparison for the use of sugar- and fatty acid-based feedstocks 
in the production of biofuels and biochemicals 
(a) Prices of raw sugar, palm fatty acid distillate (PFAD) and non-edible tallow are reported in 
US cents per pound and on a per-pound of carbon basis. Prices for complex mixtures of fatty 
acids (PFAD, non-edible tallow) have been calculated by weight averaging carbon content of the 
constituents according to reported composition. Source: The Jacobsen, www.thejacobsen.com; 
United States Department of Agriculture, Economic Research Service, www .ers.usda.gov. 
(b) Feedstock cost per gallon of ethanol produced is reported in USD. Data shown have been 
calculated on weight and carbon basis using maximum theoretical yields shown in Table 2-2 
along with feedstock prices from panel (a). 
2.1.3. Fuels and chemicals currently produced by microbial conversion of 
oils/fats 
Despite the numerous aforementioned advantages, utilization of FA-rich 
feedstocks has only been explored in the context of chemical conversions, such as 
synthesis of surfactants or transesterification to FAMEs for use in biodiesel production 
(Biermann et al. , 2011 ). The microbial conversion ofF A-rich feedstocks has instead been 
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exploited only for the production ofpolyhydroxyalkanoates (Liu et al., 2011; Park et al., 
2005; Park et al., 2002), with no report to date of organisms engineered for the 
conversion ofF As to fuels. 
Polyhydroxyalkanoates (PHAs) form a class of natural polyesters that many 
organisms in the environment accumulate in the form of intracellular granules to store 
carbon and reducing equivalents. Metabolic pathways involved in the synthesis and 
degradation of fatty acids generate intermediates activated by acyl carrier protein (ACP) 
and coenzyme A (CoA), respectively. Such metabolites in de novo fatty acid biosynthesis 
and fatty acid ~-oxidation pathways are possible precursors for PHA biosynthesis as they 
can be easily converted into (R)-3-hydroxyacyl-CoAs (R3HA-CoAs), the most favorable 
substrates for PHA synthase, the key enzyme responsible for polymerization of activated 
(R)-hydroxyacyl-monomers in PHA biosynthesis. However, when production of PHA 
from intermediates of the ~-oxidation pathway is considered, an intrinsic limitation 
resides in having to use inhibited metabolic pathways. This limitation has been overcome 
by manipulating strains to make the ~-oxidation pathway functional. The ~-oxidation 
pathway has been further engineered to support PHA biosynthesis in two ways, one 
involving inhibition of key ~-oxidation pathway enzymes, such as FadA and FadB 
(Langenbach et al., 1997; Liu et al., 2011; Vo et al., 2007), and the other involving 
amplification of enzymes that directly convert ~-oxidation pathway intermediates to 
R3HA-CoAs, such as enoyl-CoAhydratase and 3-ketoacyl-ACP reductase (Li et al., 
2007b; Li et al., 2010; Vo et al., 2008). 
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2.2. Methods 
2.2.1. Strains, plasmids and genetic methods 
Strains, plasmids, and primers used in this study are listed in Table 2-1. Wild-type 
K12 E. coli strain MG1655 (Kang et al., 2004b) was used as the host to implement 
metabolic engineering strategies. Gene knockouts were introduced in MG 1655 and its 
derivatives by P1 phage transduction as described elsewhere (Miller, 1992), using as 
donors single gene knock out mutants from the National BioResource Project (NIG, 
Japan) (Baba et al., 2006). Details of the specific protocol used have been described 
before (Yazdani and Gonzalez, 2008). Strain fadR atoC( c), which exhibits constitutive 
expression ofthefadregulon (due tofadR) and ato operon (due to atoC(c)), was obtained 
as follows. Strain MG 1655 fadR was isolated as an spontaneous mutant able to grow on 
MOPS (morpholino-propanesulfonic acid) minimal medium (Neidhart et al., 1974) plates 
containing 0.2% (w/v) decanoic acid (Cro:o) as the sole carbon source. Strain fadR 
atoC( c) was then obtained by transducing fadR with a phage lysate from strain LS5218, 
which is a FadR AtoC(c) mutant (Jenkins and Nunn, 1987b; Spratt et al., 1981b). 
Successful transduction of the atoC(c) mutation into strainfadR was identified by growth 
on MOPS minimal medium plates containing 0.2% (w/v) hexanoic acid (C6:o). 
Standard recombinant DNA procedures were used for gene cloning, plasmid 
isolation, and electroporation. Manufacturer protocols and standard methods (Miller, 
1992; Sambrook and Russell, 2001) were followed for DNA purification (Qiagen, CA, 
USA), restriction endonuclease digestion (New England Biolabs, MA, USA), and DNA 
amplification (Stratagene, CA, USA and Invitrogen, CA, USA). The strains were kept in 
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32.5% glycerol stocks at -80°C. Plates were prepared using Luria-Bertani (LB) medium 
containing 1.5% agar and appropriate antibiotics were included at the following 
concentrations: I 00 ,uglmL ampicillin, 50 ,ug/mL kanamycin, 34 ,ug/mL chloramphenicol 
and 12.5 ,ug/mL tetracycline. All strains created were confirmed by polymerase chain 
reaction using verification primers listed in Table 2-1 and appropriate phenotypic tests, if 
suitable. 
The overexpression of an aerotolerant mutant of E. coli alcohoVacetaldehyde 
dehydrogenase (i.e. AdhE*) was facilitated by the construction of expression vector 
pTHadhE *. The adhE coding region was PCR amplified using genomic DNA of E. coli 
MG1655 as template and c-adhE primers (Table 2-1). The resulting PCR product was 
cloned into vector pUC19 (New England BioLabs). A QuikChange site-directed 
mutagenesis kit from Stratagene Inc. (La Jolla, CA) was then used to generate a 
Glu568Lys (E568K) mutation in the adhE coding sequence using primers m-adhE (Table 
2-1). The E568K adhE mutant (adhE*), encoding an aerobically active AdhE protein, 
was then subcloned into the vector pTrc His 2A from Invitrogen Corp. (Carlsbad, CA) 
using c-adhE primers (Table 2-1 ). 
The butanol pathway from C. acetobutylicum ATCC824 was re-constructed in E. 
coli using plasmids pZS.crt.bcd.etfAB.hbd and pTH.atoB.adhE2. pZS.crt.bcd.etfAB.hbd 
was constructed by first amplifying the crt-bcd-etfAB-hbd operon from C. acetobutylicum 
ATCC824 genomic DNA with primers c-crt.bcd.etfAB.hbd (Table 2-1) and then ligating 
the resulting PCR product into the Kpnl and Mlul sites of pZSKLM (Yazdani and 
Gonzalez, 2008). The pTrc.atoB.adhE2 plasmid was constructed by using overlap PCR to 
fuse the PCR amplified E. coli atoB gene with the PCR amplified C. acetobutylicum 
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adhE2 gene. The fused atoB-adhE2 genes were then cloned into pTrc-His2A 
(Invitrogen, Carlsbad, CA) using the In-Fusion PCR cloning system from Clontech 
Laboratories, Inc. (Mountain View, CA). Details about primers used along with 
promoters and antibiotic markers are provided in Table 2-1. 
The phosphotransacetylase (PTA)-acetate kinase (ACK) pathway for the synthesis 
of acetate from acetyl-CoA (Clark and Cronan, 2005) (Figure 2-4) was amplified through 
overexpression of the ackApta operon (pZS.ackA.pta). The ackApta operon was PCR 
amplified using genomic DNA from strain MG 1655 and primers c-ackA.pta (Table 2-1 ). 
The resulting PCR product was cloned into pZSKLM (Yazdani and Gonzalez, 2008) via 
In-Fusion PCR cloning (Clontech Laboratories, Inc., Mountain View, CA). 
The production of acetone was evaluated using plasmid pTrc.atoDAB.adc, which 
was constructed as follow. The E. coli atoDA genes were amplified using primers c-
atoDA (Table 2-1) and the PCR product directionally cloned into the Bamm and Kpni 
restriction sites of pTrc His 2A (Invitrogen Corp., Carlsbad, CA). The resulting plasmid 
was named pTrc.atoDA. The C. acetobutylicum ATCC824 adc gene was then cloned 
into pTrc.atoDA within the Kpni and EcoRI restriction sites ( c-adc, Table 2-1 ), yielding 
pTrc.atoDA.adc. Lastly, the E. coli atoB gene was amplified (c-atoB, Table 2-1) and 
subsequently cloned within the Kpni restriction sites of pTrc.atoDA.adc, yielding the 
final vector pTrc.atoDAB.adc. Multiple colonies were screened by restriction analysis to 
assess the directionality of the atoB insertion. 
To facilitate the conversion of acetone to isopropanol, the sadh gene from C. 
acetobutylicum was custom synthesized by GenScript Corp. (Piscataway, NJ), PCR 
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amplified with primers c-sadh (Table 2-1 ), and cloned into pZSKLM (Yazdani and 
Gonzalez, 2008) using the In-Fusion PCR cloning system from Clontech Laboratories, 
Inc. (Mountain View, CA). The same approach was used to clone sadh into 
pZS.ackA.pta, thus generating pZS.ackA.pta.sadh (Table 2-1). 
The production of propionate from F As was tested by cloning the E. coli genes 
scpA, scpB, and scpC into pTrc99a (Invitrogen, Carlsbad, CA). To this effect, the 
scpAargKscpBscpC operon from E. coli MG 1655 was PCR amplified using primers c-
scpAargKscpBscpC (Table 2-1) and cloned into pTrc99a, both digested with EcoRI and 
Hindlll. PCR was used to amplify this construct with the exception of argK (primers c-
scpABC, Table 2-1 ), adding a flanking .Xbal site downstream of scpA and upstream of 
scpB . .Xbal digestion and religation of this PCR product and cloning into pTrc-His2A 
rendered pTrc.scpABC. 
2.2.2. Culture medium and cultivation conditions 
MOPS minimal medium (Neidhart et al., 1974) supplemented with 0.5% palmitic 
acid (w/v) and 0.2% (w/v) Brij58 (Fluka Chemie AG, Buchs, Switzerland) was used. The 
oxygen transfer rate (kLa) was estimated from previous reports on gas-liquid mass 
transfer in shake-flask systems (Maier et al., 2004; Van Suijdam et al., 1978) and further 
confirmed by in-vessel measurements conducted by conventional dynamic gassing-out 
technique (Durnin et al., 2009). 
Unless otherwise stated, all chemicals for culture media were obtained from 
Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich Co. (St. Louis, MO). MOPS 
minimum medium, as designed by Neidhart, supplemented with 0.5% palmitic acid (w/v) 
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and 0.2% (w/v) Brij58 (Fluka Chemie AG, Buchs, Switzerland) was used, unless 
otherwise stated. When required the medium was supplemented with 100 ,ug/mL 
ampicillin, 50 ,ug/mL kanamycin, 34 ,ug/mL chloramphenicol and 12.5 ,ug/mL 
tetracycline. Isopropyl-beta-D-thiogalactopyranoside (IPTG, 0.1 mM) and 
anhydrotetracycline ( 100 ng/ml) were used to induce gene expression from constructed 
plasmids. 
Table 2-1 Strains, plasmids, and primers used in this study 
Strain/plasmid 
Primer 
Strains 
MGI655 
&ldhE 
!J.sdhB 
LS5218 
fadR 
fadR atoC(c) 
fadRatoC( c )&JdhE 
fadR atoC( c )!J.sucA 
fadR atoC(c)!J.sdhB 
fadR atoC(c)!J.sucD 
Plasmids 
pTH.adhE* 
pZS.crt.bcd.etfAB.hb 
d 
pTH.atoB.adhE2 
pTH.atoDAB.adc 
pZS.sadh 
pZS.ackA.pta 
pZS.ackA.pta.sadh 
pTrc.scpABC 
Primers a 
v-adhE 
v-sucA 
v-sdhB 
v-sucD 
m-adhE 
c-adhE 
c-ackA.pta 
c-ackA.pta.sadh 
c-sadh 
c-crt. bed etfAB.hbd 
c-atoB 
c-adhE2 
c-atoB.adhE2 
c-scpABC 
c-scpAargKscpBC 
Description/Genotype/ Sequence 
F- 1- ilvG- rtb-50 rph-1 
MGI655, .1-adhE::FRT-kan-FRT; deletion mutant foradhEin MG1655 
MG1655, !J.sdhB::FRT-kan-FRT; deletion mutant for sdhB in MGI655 
fadR601 atoC(Con)2 
MG 1655 evolved for rapid growth onto agar plates with decanoic acid 
fadR transduced with the atoC(C) gene ofLS5218 
fadR atoC(c), &ldhE::FRT-kan-FRT; deletion mutant for adhE in fadR 
atoC(c) 
fadRatoC(c), !J.sucA::FRT-kan-FRT; deletion mutant for sucA injadR atoC(c) 
fadRatoC(c), !J.sdhB::FRT-kan-FRT; deletion mutant for sdhB infadR atoC(c) 
fadRatoC(c), !J.sucD::FRT-kan-FRT; deletion mutant for sueD infadR atoC(c) 
E. coli adhE mutant (E568K) under control ofPtrc (AmpR, oriR pBR322) 
C. acetobutylicum butyryl-CoA synthesis operon (crt, bed, etfAB, hbd) under 
control ofPLtet0-1 (tetR, oriR SC101 *,cat) 
E. coli atoB gene and C. acetobutylicum adhE2 gene under control of Ptrc 
(AmpR, oriR pBR322) 
E. coli atoD, atoA and atoB genes and C. acetobutylicum adc gene under control 
ofPtrc (AmpR, oriR pBR322) 
C. acetobutylicum sadh gene under control ofPLtet0-1 (tetR, oriR SC101 *,cat) 
E. coli ackApta operon under control ofPLtet0-1 (tetR, oriR SC101 *,cat) 
E. coli ackApta operon and C. acetobuty/icum sadh gene under control of 
PLtetO-l (tetR, oriR SC 10 I*, cat) 
E. coli scpA, scpB and scpC genes under control of PLtet0-1 (AmpR, oriR 
pBR322) 
gtttaacattatcaggag; gtcaactaatccttaac 
cacatcactgtgcgtggtagtatcc; caggtcagggaccagaatatctacg 
cttccgtaccgaaagccgtg; accacgcacagtgatgtgcg 
gacagcggcctgaatattattgcag; catcgcgataagcacaaaaaaggcc 
catccggaaactcacttcgaaaagctggcgctg; cagcgccagcttttcgaagtgagtttccgga 
cattaaagaggagaaaggtaccatggctgttactaatg; gatgcctctagcacgcgtttaagcggattttttcg 
cattaaagaggagaaaggtaccatgtcgagtaagttag; gatgcctctagcacgcgtttactgctgctgtgc 
ctgcacagcagcagtaaacgcgtgaggaatgaaaggctttgcg; 
gatgcctctagcacgcgtttacagaatcaccaccgc 
cattaaagaggagaaaggtaccatgaaaggctttgcgatgctg; 
gatgcctctagcacgcgtttacagaatcaccaccgc 
gatggtaccatggaactaaacaatgtcatccttg; gatcacgcgtttattttgaataatcgtagaaacc 
gagatctgcagctggtaccatgaaaaattgtgtcatc; ctttttgatttgtaactttcatttaattcaaccgttcaatcacc 
ggtgattgaacggttgaattaaatgaaagttacaaatcaaaaag; 
cgggcccaagcttcgaattcttaaaatgattttatatagatatcc 
gagatctgcagctggtaccatgaaaaattgtgtcatc; 
cgggcccaagcttcgaattcttaaaatgattttatatagatatcc 
gctctagaatgtcttatcagtatgttaagg; gctctagattaatcatgatgctggc 
cggaattcatgtctaacgtgcaggagtgg; gacaagcttttaacccagcatcgagccg 
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Source 
(Kang et 
al.,2004b) 
This study 
This study 
(Spratt et 
al., 1981a) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
c-atoDA 
c-adc 
c-atoB 
gggatccatgaaaacaaaattgatgac; gaggtacctcataaatcaccccgttg 
cggtaccatgttaaaggatgaag; cggaattcttaagataatcatatataac 
acggtaccaggaggaaatgaaaaattgtgtcatcgtcagtgc; 
ccttcctcctttaattcaaccgttcaatcaccatcgc 
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This study 
This study 
This study 
• "v" indicates the primer sequences (5' to 3') that were used for verification purposes during the 
creation of disruption mutants by phage transduction. "m" indicates primers used for site-directed 
mutagenesis of adhE. "c" indicates primers used for cloning purposes. The forward follows the reverse 
sequence in each case, separated by a semicolon. Genes or operons deleted or cloned are apparent from 
primer names. 
Prior to use, cultures (stored as glycerol stocks at -80 °C) were streaked onto LB 
plates (with appropriate antibiotics if required) and incubated overnight at 37 °C. A 
single colony was used to inoculate 10 mL of LB broth in 15 ml test tubes (GeneMate, 
Kaysville, UT), which were incubated at 37 °C until an OD550 of -0.5 was reached. An 
appropriate volume of this actively growing pre-culture was centrifuged and the pellet 
washed and used to inoculate 25 mL of medium in 50 ml shake flasks to an initial 00550 
of 0.05. Fifty-milliliter shake flasks (Coming Glass Works, Coming, NY) with four 
baffles and plastic foam-stoppers were used for aerobic cultures. Flasks were incubated 
for 72 hours at 37°C in a C24 Rotary Incubator Shaker (New Brunswick Scientific, NJ). 
Samples were centrifuged to pellet cells while the aqueous supernatant was collected for 
metabolite analysis. 
For ethanol and butanol production by high cell density cultures, 10 ml LB liquid 
medium in a test tube was inoculated with E. coli strains and incubated at 3 7°C in a 
rotator (Glas-Col Inc., Terre Haute, IN) until an ODsso of 0.7 was reached. This 10 ml 
culture was used to inoculate 50 ml of LB medium in a 125-ml conical flask (Coming 
Glass Works, Coming, NY) and incubated at 37°C in a C24 Rotary Incubator Shaker 
until an 00550 of0.7 was reached. Cells were collected by centrifugation at 8,000xg, 4°C 
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for 20 min, and washed twice with MOPS minimal medium. The collected cells were 
resuspended in MOPS minimal medium to a final 00550 of 10. The cell suspension 
(25 ml) was transferred to a 50-ml baffled shake flask, and palmitic acid (C16:o) was 
added to a final concentration of 0.5% (w/v). Additional palmitic acid (0.5% w/v) was 
added to the medium at indicated time intervals. 
For acetate production by high cell density cultures, 12.5 ml LB liquid medium in 
a test tube was inoculated with E. coli strain and incubated at 37°C in a rotator (Glas-Col 
Inc., Terre Haute, IN) until an ODsso of 0.8 was reached. This 12.5 ml culture was used to 
inoculate 250 ml of LB medium in a 500-ml conical flask (Coming Glass Works, 
Coming, NY) and incubated at 37°C in a C24 Rotary Incubator Shaker until an 00550 of 
0.8 was reached. Cells were collected by centrifugation at 8,000xg, 4°C for 20 min, and 
washed twice with MOPS minimal medium. The collected cells were resuspended in 
MOPS minimal medium to a final 00550 of 10. The cell suspension (50 ml) was 
transferred to a 500-ml fermenter in a SixFors multi-fermentation system (Infors HT, 
Bottmingen, Switzerland) with independent control of temperature (37 °C), pH 
(controlled at 7.0 with NAOH 10M), stirrer speed (500 rpm), and dissolved oxygen (not 
controlled) (64). Palmitic acid (C16:o) was added to a final concentration of 0.5% (w/v). 
Additional palmitic acid (0.5% w/v) was added to the medium at indicated time intervals. 
Microaerobic conditions were maintained by sparging the medium with air at 0.05 Llmin. 
2.2.3. Enzyme activities 
The activity of alcohol dehydrogenase (AdhE) was measured following the 
procedure reported by Kessler and coworkers (Kessler et al., 1991 ). E. coli cells from 
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anaerobic or aerobic cultures (OD550 - 0.7) were harvested by centrifugation (2 min, 
10,000 x g), washed twice with a solution of NaCl (9 g/1) and stored as cell pellets at -
20°C. For assays, cell pellets were resuspended in 0.2 ml of 0.1M MOPS-KOH and 
permeabilized by vortex mixing with chloroform. Alcohol dehydrogenase activity was 
assayed by measuring the change in absorbance at 340 nm and 30°C in a 1 ml reaction 
mixture containing 0.1 M MOPS-KOH buffer (pH 7.5), 6 mM DTT, 5 mM MgS04, 0.3 
mM Fe(N~)2(S04)2, 0.4 mM NADH, 10 mM acetaldehyde, and 30 f.ll crude cell extract 
(Kessler et al., 1991). For the anaerobic assay, the above sample preparation and assay 
were carried out in a BACTRON I Anaerobic Chamber (Sheldon Manufacturing Inc., 
Cornelius, OR). Linearity of the reactions (protein concentration and time) was 
established for all preparations. All spectrophotometric measurements were conducted in 
a BioMate 5 spectrophotometer (Thermo Scientific, MA, USA). The nonenzymatic rates 
were subtracted from the observed initial reaction rates. Enzyme activities are reported as 
mmoles of substrate/minute/mg of cell protein and represent averages for at least three 
cell preparations. 
2.2.4. Analytical methods 
Cell growth was monitored by measuring total protein concentration using the 
method of Lowry (Lowry et al., 1951) and a predetermined correlation between cell dry 
weight (CDW) and total protein concentration. The CDW was determined by collecting 5 
ml of a cell suspension on a membrane filter (diameter 47 mm; pore size 0.45 mm) 
(Sartorius, Gottingen, Germany) and applying suction. The filter was washed twice with 
distilled water, dried to constant weight, and desiccated before weighting. 
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The identity of all metabolic products was determined through lD proton NMR 
spectroscopy as previously described (Murarka et al., 2008). Organic acids, ethanol, and 
isopropanol were quantified by HPLC as previously reported (Dharmadi and Gonzalez, 
2005). 
Butanol was quantified in a Varian CP-3800 gas chromatograph (Varian 
Associates, Inc., Palo Alto, CA) equipped with a flame ionization detector (FID) 
following a modification of the method reported by Atsumi and coworkers (Atsumi et al., 
2008a). The separation of alcohol compounds was carried out using a VF-5ht column 
(15m, 0.32 mm internal diameter, 0.10-,um film thickness; Varian Associates, Inc., Palo 
Alto, CA). The oven temperature was initially held at 40 °C for 2 min and raised with a 
gradient of 5 °C/min until 45 oc and held for 4 min. The temperature was then raised 
with a gradient of 15 °C/min until230 oc and held for 4 min. Helium (Matheson Tri-Gas, 
Longmont, CO) was used as the carrier gas with 14 p.s.i inlet pressure. The injector and 
detector were maintained at 225 °C. A 0.5-,ul sample was injected in splitless injection 
mode. 
The analysis of FAs was carried out in a Varian CP-3800 gas chromatograph 
(Varian Associates, Inc., Palo Alto, CA) after hexane/ methyl tertiary butyl ether (MTBE) 
extraction and F As transesterification with methanol (Lewis et al., 2000), according to 
the following method: 50°C held for 1 min, 30°C/min to 160°C, l5°C/min to 200°C, 
200°C held for 1.5 min, 10°C/min to 225°C, 225°C held for 15 min. 
Sample preparation (i.e. MTBE extraction and transesterification) was conducted 
as follows. One ml samples were transferred to 5 ml serum bottles (Supelco, Bellefonte, 
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PA) containing 2 ml of hexane/ MTBE (1:1). Eighty ,ul of 50% H2S04 and 0.05 g NaCl 
were added for pH and ionic strength adjustment, respectively (Lalman and Bagley, 
2004). Triplicate calibration standards for FAs analysis of 1, 2, 5, 10, 20, 30, 40, 50, and 
100 mg/1 were prepared in 1: 1 mixture of chlorophorm/methanol using a 1,500 mg/1 stock 
solution of each FA. The bottles were sealed with Teflon®-lined septa (Fisher Scientific 
Co., Fair Lawn, NJ), secured with caps, and shaken using an orbital shaker at 200 rpm for 
15 min. The samples were then centrifuged for 5 min at 1,750 x g to separate the aqueous 
and organic layers. After centrifugation, the top organic layer was separated from the 
aqueous layer. A 0.5 ml aliquot of the top layer was transferred carefully using glass 
pipettes to 1.0 ml Supelco Reacti-Vials (Sigma-Aldrich, St. Louis, MO) and dried under a 
stream of nitrogen in an N-EVAP evaporator (Organomation Associates, Inc., Berlin, 
MA). 
A fresh solution of the transesterification reaction mix (methanol:hydrochloric 
acid:chlorophorm (10:1:1 v/v/v, 3ml) was added to the dried lipid extract in Reacti-Vials 
(Sigma-Aldrich, St. Louis, MO), which were capped tightly and vortexed. These vials 
were placed in a heater block (AccuBlock Digital Dry Bath, LabNet, Woodbridge, NJ) 
and heated at 90°C for 15 min. 
The transesterification reaction tubes were cooled to room temperature. Water 
(1ml) was added to each tube and the fatty acid methyl esters (FAMEs) were extracted 
with hexane and chloroform (4:1 v/v, 3 x 2 ml). The tubes were vortexed for 30 seconds 
and the upper organic phase collected with a Pasteur pipette. This extraction procedure 
was repeated 3 times. 
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The combined hexane:chloroform solution was evaporated under N2 to dryness, 
and the dry residue redissolved in 60 J..I.L of hexane, transferred to GC vials (Fisher 
Scientific Co., Fair Lawn, NJ) and capped under N2. A 2.0 J..ll aliquot ofF AMEs solution 
was injected (injection temperature 300°C) into the chromatograph. The carrier gas flow-
rate was 2.0 ml/min, with a split ratio of 1:25. 
Stearic (Cis:o), palmitic (CI6:o), myristic (C14:o), lauric (C12:o), capric (C10:o), 
caprylic (Cs:o), and caproic (C6:o) acids (Sigma Chemical Co., St. Louis, MO) were used 
to calibrate the gas chromatograph. The carrier gas used was helium (Matheson Tri-Gas, 
Longmont, CO). Hexane, chloroform, diethyl ether, and MTBE were HPLC grade 
(Sigma Chemical Co., St. Louis, MO). Sodium chloride and concentrated sulfuric acid 
were reagent grade (VWR International, West Chester, PA). 
2.2.5. Calculation of fermentation parameters 
Growth and product yields (gram of product per gram of substrate consumed) 
were calculated as the amount of cell mass or product synthesized per amount of palmitic 
acid (C16:o) consumed. Production of caproic acid (C6:o) and biomass were accounted for 
in product yield calculations. An average molecular weight for an E. coli cell of 24.7 g/C-
mol, which corresponds to an average cell of a molecular formula CH1.90o.sNo.2 (Nielsen 
et al., 2003), was used in the above calculations. 
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2.3. Results 
While proven advantageous, the high degree of reduction of carbon in F As poses 
a metabolic challenge. The conversion of fatty acids to biomass in E. coli results in the 
generation of reducing equivalents (Figure 2-4) as the average degree of reduction per 
carbon in FAs is higher than in biomass (e.g. KPalmitic acid/CI6:0 = 5.8 while Ksiomass = 
4.3)(Nielsen et al., 2003). Under aerobic conditions the respiratory metabolism is active 
and the reducing equivalents are transferred to 0 2, thus facilitating redox balance and 
enabling growth on fatty acids. On the contrary, growth on fatty acids is not possible 
under anaerobic conditions without an electron acceptor (i.e. fermentative conditions), 
because E. coli does not have the ability to ensure redox balance and ATP synthesis in 
the absence of an external electron acceptor (Section 2.1.1 ). 
The balance between cell growth and generation of reduced chemicals and fuels 
can therefore be achieved in two ways: by genetic modifications aimed to reduce the 
efficiency of the respiratory metabolism and thus cell growth or by adjusting the 
availability and/or rate of consumption of terminal electron acceptors (establishing 
microrespiratory conditions). 
The present study has focused on engineering a respiro-fermentative metabolic 
mode that supports the synthesis of fermentative products during respiratory metabolism 
of FAs. To this end, we metabolically engineered native and heterologous pathways for 
the efficient catabolism of F As and the synthesis of fuels and chemicals in E. coli 
(Dellomonaco et al., 2010b). Biofuels, commodity chemicals, and polymer building 
blocks were chosen as model products to illustrate the feasibility of the proposed 
approach (Dellomonaco et al., 201 Ob ) . 
• 
jt-butanol j 
SGdlt l,. Z[H] (,.}! 
-:1 Isopropanol 
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Figure 2-4 Pathways engineered in Escherichia coli for the conversion of fatty acids to fuels 
and chemicals 
Fuels and chemicals are shown in red and green shade, respectively. Also shown are the 
catabolism of fatty acids via the (3-oxidation pathway (orange shade) and glucose through the 
Embden-Meyerhof-Parnas pathway (blue shade). Relevant reactions are represented by the names 
of the genes coding for the enzymes (E. coli genes unless otherwise specified in parenthesis as 
follows : C. acetobutylicum, ca; C. beijerinckii, cb) : aceA, isocitrate lyase; aceB, malate synthase 
A; adc, acetoacetate decarboxylase (ca); ackA , acetate kinase; adh, secondary alcohol 
dehydrogenase (cb); adhE, acetaldehyde/alcohol dehydrogenase; adhE2, secondary alcohol 
dehydrogenase (ca); atoA, atoD, acetyl-CoA:acetoacetyl-CoA transferase; atoB , acetyl-CoA 
acetyltransferase; bed, butyryl-CoA dehydrogenase (ca); crt, crotonase (ca); etfAB , electron 
transfer flavoprotein (ca); fadA, 3-ketoacyl-CoA thiolase; fadB, enoyl-CoA hydratase/3-
hydroxyacyl-CoA dehydrogenase; fadD, acyl-CoA synthetase; fadE, acyl-CoA dehydrogenase; 
hbd, (3-hydroxybutyryl-CoA dehydrogenase (ca); icd, isocitrate dehydrogenase; pta , phosphate 
acetyltransferase; sdhABCD, succinate dehydrogenase; scpA, methylmalonyl-CoA mutase; scpB, 
methylmalonyl-CoA decarboxylase; scpC, propionyl-CoA:succinate CoA transferase; sucA, 2-
oxoglutarate dehydrogenase; sucB, dihydrolipoyltranssuccinylase; sucCD, succinyl-CoA 
synthetase. Maximum theoretical yields of products were calculated as shown in Table 2-2 and 
reported for both glucose (Glue, black) and palmitic acid (C 16:0 , red). Abbreviations: 2[H] = 
NADH = FADH2 = H2 ; P/0 , amount of ATP produced per oxygen consumed in the oxidative 
phosphorylation. 
36 
2.3.1. Engineering fermentative pathways in Escherichia coli for biofuels 
production from fatty acids 
2.3.1.1. Ethanol 
Although ethanol is only a minor product of fermentative metabolism in E. coli 
(Sawers and Clark, 2004), this bacterium has been engineered for the production of 
ethanol from sugars (Jarboe et al., 2007) and glycerol (Durnin et al., 2009; Yazdani and 
Gonzalez, 2008). The maximum theoretical yield for ethanol synthesis from glucose is 
0.51 g ethanol/ g glucose or 0.67 on C-mole basis (Table 2-2). The low ethanol yield on 
glucose is due to the low metabolic efficiency of the pathway that converts this sugar into 
ethanol, which generates two molecules each ethanol and C02 from one molecule of 
glucose (Figure 2-4 and Table 2-2). Given their higher energy content and reduced state, 
the use of F As represents a more efficient alternative, as each P,.oxidation cycle yields 
one molecule of acetyl-CoA, which can be converted to ethanol without any carbon loss 
(Figure 2-4). When accounting for the fact that the last 2-C fragment of a FA molecule 
converted to acetyl-CoA does not generate reducing equivalents, a maximum theoretical 
yield of 1.38 (w/w) is obtained from a 16-C FA molecule (i.e. palmitic acid/CI6:o, the 
most abundant FA in oil-rich feedstocks; see Section 2.1.2.1) (Table 2-2). This value is 
2.71-fold higher than the yield on glucose. On carbon basis, the ethanol yield on C16:0 is 
1.44-fold higher (Table 2-2). The above calculations, however, do not account for the 2 
ATP equivalents required to drive the 13-oxidation pathway, which when accounted for 
would slightly reduce the maximum theoretical (Table 2-2). 
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T.able 2-~ Comparison of .maximum theoretical yields for the production of biofuels and 
biOchemicals from fatty acids and lignocellulosic sugars 
Calculated yields are shown on both weight (w/w) and carbon (C/C) basis. 
Pathway stoichiometry for the synthesis of the specified product 
from glucose (C6Hl206) or palmitic acid (C16H320 2) a 
Biofuels 
Ethanol (C2~0) 
C6Htz06 --+ 2 CzH60 + 2COz 
Ct6H320z--+ 23/3 CzH60 + 2/3 C02 
C1di3202 + 5117 H20--+ 53/7 C2H60 + 6/7 C02 + 8/7 [H); 
8/7 [H] + 2/7 02 --+ 4/7 H20 
Butanol (C4Hto0) 
C6H1206 --+ C4H100 + 2COz +HzO 
C16H3202 + 712 H20--+ 53/14 C¢iw0 + 6/7 C02 + 8/7 [H); 
8/7 [H) + 2/7 02 --+ 4/7 H20 
Biochemicals 
Acetate (C2~02) 
C6Htz06 + 2Hz0 --+ 3 CzH402 
Ct6H3202 + 7 HzO + 7 C02 --+ 23/2 CzH402 
Acetone (CJH60) 
C6H1206 --+ 3/2 C3H60 + 3/2 COz + 3/2 HzO 
Ct6H3202 + 5/4 HzO + 5/4 COz --+ 23/4 C3H60 
Isopropanol (C3Hs0) 
C6H1206 --+ 4/3 C3HsO + 2 COz + 2/3 HzO 
Ct6H3202 + 40/9 HzO --+ 46/9 C3HsO + 2/3 COz 
Succinate (C4H604) 
C6H1206 + 617 COz--+ 12/7 C4H604 + 617 HzO 
C1di3202 + 152/17 C02 + 86/17 H20 --+106/17 C4H604 + 80/17 [H]; 
80/17 [H) + 20/17 02 --+ 40117 H20 
Propionate (C3H602) 
C6Htz06--+ 12/7 C3H602 + 617 COz + 617 HzO 
C16H1202 + 262/83 C02 + 370/83 H20--+ 530183 C1H602 + 216/83 
[H); 
216/83 [H] + 54/83 02 --+ 108/83 H20 
Maximum 
yield 
(w/w)/(C/C) 
0.5110.67 
1.38/0.96 
1.36/0.95 
0.41/0.67 
1.1010.95 
1.00/1.00 
2.70/1.44 
0.48/0.75 
1.30/1.08 
0.44/0.67 
1.20/0.96 
1.12/1.14 
2.8711.56 
0.70/0.86 
1.81/1.20 
• Stoichiometry is based on the pathways shown in Figure 2-4 for the utilization ofF As and glucose, the 
synthesis of products, the TCA cycle, and the oxidative phosphorylation. For the synthesis of biochemicals, 
C02 fixation via the Wood-Ljungdahl pathway (Ragsdale and Pierce, 2008) (2C02 + ATP + 8[H] 7 
AcCoA) or the carboxylation of phosphoenolpyruvate (Sauer and Eikmanns, 2005) (PEP + C02 7 OAA + 
ATP) were also considered (not shown in Figure 2-4). The stoichiometric coefficients were obtained by 
conducting elemental balances on carbon, hydrogen and oxygen. An ATP balance was also included in the 
analysis for the reactions shown in italics. All other reactions represent ATP-generating pathways. Every 
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acetyl-CoA oxidized through the TCA cycle generates 3NADH, 1 F ADH2 and one ATP equivalent. Eleven 
ATPs are generated from the oxidation of the NADH and F ADH2 produced in the TCA cycle (2 and 3 
ATPs per F ~DHz and NADH, respectively) via coupling between electron transfer chain and oxidative 
phosphorylatwn. 
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Figure 2-5 Engineering Escherichia coli for the production of ethanol from fatty acids 
Values represent the means and error bars standard deviations for triplicate cultures. Gene 
overexpressions and deletions are indicated by "+" and "~", respectively , next to the 
corresponding genes or operons. Details about the pathways can be found in Figure 2-4. 
(a) Ethanol concentration (line) and ethanol and caproic acid yields (bars) for 72-hour cultures of 
wild-type MG 1655 and strains containing engineered pathways for ethanol production (oxygen-
tolerant acetaldehyde/alcohol dehydrogenase, adhE*) and efficient catabolism of FAs (jadR 
atoC(c) ). kLa =volumetric oxygen transfer coefficient (h-1). 
(b) Fermentation profile for strain tladhE fadR atoC( c) [adhE*+] in minimal medium with 5 g/L 
palmitic acid (C 16:0) and using a kLa = 6.7 h-'. Additions of palmitic acid (5 g/L each) were made 
every 24 hours . /lCDW, increase in cell dry weight with respect to initial value. 
Despite the aforementioned theoretical advantages ofF As, no ethanol was produced 
by wild-type E. coli strain MG 1655 during the respiratory metabolism of palmitic acid 
(Figure 2-5). Efforts to engineer homoethanol production in E. coli have focused on 
diverting carbon at the pyruvate node by manipulating native (pyruvate dehydrogenase) 
or heterologous (Zymomonas mobilis' pyruvate decarboxylase) pathways (Ohta et al. , 
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1991 ). These strategies, however, are not applicable to the production of ethanol from 
F As because pyruvate is not an intermediate in the (3-oxidation pathway (Figure 2-4). 
Instead, we focus on diverting carbon to ethanol synthesis at the acetyl-CoA node by 
manipulating the enzyme acetaldehyde/alcohol dehydrogenase (AdhE) (Figure 2-4). 
Since AdhE is oxygen sensitive and adhE expression is very low in the presence of 
oxygen (Holland-Staley et al., 2000), we hypothesized that the lack of ethanol production 
in MG 1655 could be related to the low activity/expression of this enzyme under aerobic 
conditions. 
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We then constructed an aerotolerant mutant of AdhE (AdhE*) and overexpressed it 
from the oxygen-independent trc promoter. AdhE* was obtained by site-directed 
mutagenesis of AdhE to substitute the residue at position 568 (Glu568Lys) (Holland-
Staley et al. , 2000). Enzyme assays of cells overexpressing AdhE* confmned its high 
activity under both anaerobic and aerobic conditions (Figure 2-6). Overexpression of 
AdhE* in MG 1655 resulted in the production of ethanol at a yield of 0.48 g /g Ct6:o 
(Figure 2-5a: strain MG 1655 [adhE*+ ]). To investigate a potential competition between 
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the ethanol and biosynthetic and respiratory pathways for reducing equivalents, we 
decreased the respiration rate by lowering the volumetric oxygen transfer coefficient 
(kLa) from 14.5 h- 1 to 6.7 h- 1• This modification led to a 2-fold increase in ethanol yield 
(0.92 g ethanol/g C16:0 : Figure 2-5a). 
While the ethanol yield was very high in strain MG1655 [adhE*+], oxidation of 
palmitic acid was incomplete resulting in the accumulation of caproic acid (C6:o) (Figure 
2-5a). The metabolism of short-chain F As (C4 to C6) in E. coli requires expression of 
both the fad regulon (regulated by FadR) and two degradative enzymes encoded by the 
atoDAEB operon (regulated by AtoC) (Clark and Cronan, 2005) (Figure 2-1 ). Previous 
studies have shown that mutants exhibiting constitutive expression of the fad regulon and 
ato operon (referred to here asfadR and atoC(c), respectively) catabolize both long- and 
short-chain F As (Jenkins and Nunn, 1987b; Nunn, 1986b ). However, such mutants have 
not been tested for their ability to completely oxidize F As without the generation of 
short-chain FAs as by-products, which is the specific problem observed in strain 
MG1655 [adhE*+]. 
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Figure 2-7 Growth comparison of wild-
type Escherichia coli MG1655 and 
derivatives fadR and fadR atoC(c) on 
saturated fatty acids of different chain-
lengths 
Experiments were performed using MOPS 
minimal medium and baffled shake flasks for 
96 hours, as reported in Section 2.2 .2. 
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Therefore, we engineered the fadR atoC( c) phenotype in MG 1655 (Figure 2-7) and 
evaluated its ability to prevent the generation of by-product caproic acid. Overexpression 
of AdhE * in strain fadR atoC( c) resulted in efficient metabolism of palmitic acid without 
the accumulation of caproic acid and also high ethanol yield (Figure 2-5a). It is 
noteworthy that the ethanol yield in this strain is twice the maximum theoretical from 
sugars (w/w basis) and already represents 77% of the maximum achievable from palmitic 
acid (Figure 2-5a). We also performed studies to illustrate the production of ethanol at 
higher titers. For this purpose, experiments were conducted using higher concentration of 
palmitic acid and higher cell density (Figure 2-5b ). Under these conditions, strain fadR 
atoC( c) [ adhE*+] produced ethanol as the only fermentation product at concentrations 
close to 20 g/1, demonstrating that high yield and titers can be achieved. 
2.3.1.2. Butanol 
While microbial production of butanol traditionally utilizes Clostridium 
acetobutylicum (Maddox, 1989; Mermelstein et al., 1994), the limitations of this 
organism has triggered efforts to engineer E. coli, Pseudomonas putida, Bacillus subtilis, 
and Saccharomyces cerevisiae for butanol production, reaching titers and yields of up to 
1.2 g/1 and 6 % (w/w), respectively (Atsumi et al., 2008a; Inui et al., 2008; Nielsen et al. , 
2009; Steen et al., 2008). 
Production of butanol from FAs would provide a 2.7-fold yield advantage over sugars 
(w/w), as can be seen in Table 2-2. Our strategy to produce butanol from F As in E. coli is 
based on the engineering of a synthetic pathway composed of the genes required for 
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butanol synthesis from acetoacetyl-CoA in C. acetobutylicum (crt, bed, etfAB, hbd, 
adhE2) in combination with the E. coli gene responsible for the conversion of acetyl-CoA 
to acetoacetyl-CoA (atoB) (Figure 2-4). 
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Figure 2-8 Engineering Escherichia coli for the production of butanol from fatty acids 
Values represent the means and error bars standard deviations for triplicate cultures. Gene 
overexpressions and deletions are indicated by "+" and "~", respectively, next to the 
corresponding genes or operons. Details about the pathways can be found in Figure 2-4. 
(a) Butanol concentration (line) and butanol, ethanol and caproic acid yields (bars) for 72-hour 
cultures of strains engineered by: i) expression of C. acetobutylicum's pathway for the synthesis 
of butanol from acetoacetyl-CoA (hbd, crt, bed, etfAB, and adhE2), ii) overexpression of E. coli's 
acetyl-CoAacetyltransferase (atoB) for the conversion of acetyl-CoA to acetoacetyl-CoA, iii) 
elimination of E. coli's native ethanol pathway (adhE), and iv) engineering the ,8-oxidation 
pathway for efficient catabolism ofF As (jadR atoC(c)). A kLa = 6.7 h-1 was used. 
(b) Fermentation profile for strain ~adhEfadR atoC(c) [atoB+ hbd+ crt+ bed+ etfAB+ adhE2+] in 
minimal medium with 5 g/L palmitic acid (C 16:0) and a kLa = 6.7 h- 1• Two additions of palmitic 
acid (5 g/L each) were made at 24 and 72 hours. ~CDW, increase in cell dry weight respect to 
initial value. 
When these pathways were expressed in E. coli cells metabolizing palmitic acid, we 
observed significant production of butanol (Figure 2-8a, strain MG1655 [atoB+ hbd+ 
crt+ bed+ etfAB+ adhE2+ ]). We hypothesized that the relatively low yields and titers 
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observed originate in part from the competition between the ethanol and butanol 
pathways for acetyl-CoA and reducing equivalents (Figure 2-4). In agreement with this 
hypothesis, deletion of the native ethanol pathway (!1adhE) resulted in a two-fold 
increase in butanol yield (Figure 2-8a, strain !1adhE [atoB+ hbd+ crt+ bed+ etfAB+ 
adhE2+]). As in ethanol-producing strains (see above), the engineering of the (3-oxidation 
pathway for more efficient utilization of FAs (fadR atoC(c)) also led to an increase in 
product yield (Figure 2-8a, strainfadR atoC(c) [atoB+ hbd+ crt+ bed+ etfAB+ adhE2+]). 
Overall, our approach resulted in butanol yields up to 3-fold higher than those currently 
reported in the literature (Atsumi et al., 2008a; Inui et al., 2008; Nielsen et al., 2009; 
Steen et al., 2008) and represent 16.4% of the maximum achievable from palmitic acid. 
To further ascertain the potential of the engineered strains for butanol production, we 
performed experiments with strain lladhE fadR atoC( c) [ atoB+ hbd+ crt+ bed+ etfAB+ 
adhE2+] at higher palmitic acid concentration and higher cell density (Figure 2-8b). 
Butanol was produced as the main fermentation product at a concentration of 2.05 g/1, 
along with very small amounts of ethanol (Figure 2-8b ). The synthesis of ethanol could 
be due to the ability of Clostridial secondary alcohol dehydrogenase to catalyze the 
conversion of acetyl-CoA to ethanol (Petersen et al., 1991; Y oungleson et al., 1988). 
Even when the butanol pathway has yet to be optimized, the butanol yield and titer 
achieved by our strategy are superior to those reported with strains engineered to produce 
butanol from other carbon sources (Atsumi et al., 2008a; Inui et al., 2008; Nielsen et al., 
2009; Steen et al., 2008). 
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2.3.2. Engineered strains for the production of biochemicals from fatty acids 
FA-containing (industrial) by-product streams such as palm fatty acid distillate or 
palm oil mill effluent (Sumathi et al., 2008; Wu et al., 2009) can be exploited for 
biological production of chemicals (refer to Section 2.1.2.1 for details). In the next 
sections we present the engineering of E. coli to enable the respiro-fermentative 
production of commodity chemicals, organic solvents, and polymer building blocks from 
FAs. 
2.3.2.1. Acetic Acid (Acetate) 
Acetate is an important industrial chemical (Agreda and Zoeller, 1993) and a native 
product of sugar fermentation in E. coli, where it is primarily produced through the 
phosphotransacetylase (PTA)-acetate kinase (ACK) pathway (Clark and Cronan, 2005) 
(Figure 2-4). Although the maximum theoretical yield for acetate production from 
glucose is 1.00 (w/w) (Table 2-2), the biological process used in the commercial 
production of acetate from sugars (Cheryan et al., 1997) and that developed by 
engineering E. coli (Causey et al., 2003) are both based on a maximum theoretical yield 
of 0.67 g of acetate/g glucose. The synthesis of acetate from F As contributes in C02 
fixation and can be achieved at a much higher yield: e.g. a yield of 2.70 (w/w) can be 
realized on palmitic acid (Table 2-2). 
Unlike metabolism of sugars, utilization of F As by E. coli does not lead to the 
synthesis of acetate (Figure 2-9a). Since acetyl-CoA is generated in the 13-oxidation of 
FAs, we reasoned that overexpression of the ACK-PTA pathway (Figure 2-4) should lead 
to significant production of acetate. Indeed, strain MG1655 [ackA+ pta+] produced 
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acetate at a yield of 0.65 g acetate/ g C16:o (Figure 2-9a). As in the case of other products 
discussed in previous sections, a strain with constitutive expression of the fad regulon and 
ato operon (i.e. strainfadR atoC(c) [ackA+ pta+]) not only utilized palmitic acid more 
efficiently but improved acetate production as well (Figure 2-9a), exhibiting yields that 
surpassed those reported for E. coli strains engineered to produce acetate from glucose 
(Causey et al., 2003). 
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Figure 2-9 Production of acetate from F As in engineered Escherichia coli strains 
Details about the engineered pathways are shown in Figure 2-4. Gene overexpressions is 
indicated by "+"next to the corresponding gene. A kLa = 14.5 h-1 was used in all experiments. 
Values represent the means and error bars standard deviations for 72-hour triplicate cultures. 
(a) Acetate concentration (line) and acetate and caproic acid yields (bars) in wild-type MG 1655 
and recombinant strains constructed by overexpressing the native phopshoacetyltransferase (pta)-
acetate kinase (ackA) pathway for conversion of acetyl-CoA to acetate and modifying the 13-
oxidation pathway for efficient catabolism ofF As (jadR atoC(c)). 
(b) Fermentation profile for strain fadR atoC(c)[ackA+pta+] in minimal medium with 5 g/L 
palmitic acid (C 16:0). Additions of palmitic acid (5 g/L each) were made every 12 hours . ilCDW, 
increase in cell dry weight respect to initial value. 
An experiment was conducted to assess the production of acetate at higher titers. As 
shown in Figure 2-9b, 35 g/L of acetate were produced at a yield of 1.10 g acetate/ g Ct 6:o 
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( 40.7% of the maximum achievable from palmitic acid), demonstrating the feasibility of 
achieving high yields and titers. It is noteworthy that this yield is in excess of the 
maximum theoretical on glucose (Table 2-2) and about 2-fold higher than the best yield 
reported to date by an E. coli strain engineered to produce acetate (Causey et al., 2003). 
2.3.2.2. Acetone 
Acetone is a product of the acetone-butanol fermentation by Clostridium spp. 
(Maddox, 1989) and an industrially relevant chemical. 
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Figure 2-10 Production of acetone and isopropanol from fatty acids in engineered 
Escherichia coli strains 
Details about the engineered pathways are shown in Figure 2-4. Gene overexpression is indicated 
by a "+" next to the corresponding genes. A kLa = 14.5 h-1 was used in all experiments . Values 
represent the means and error bars standard deviations for 72-hour triplicate cultures . 
(a) Acetone and caproic acid yields in strains constructed by overexpressing E. coli acetyl-CoA 
and acetoacetyl-CoA transferases (atoDAB) and C. acetobutylicum acetoacetate decarboxylase 
(adc) along with amplification of the native acetate pathway (ackApta). These modifications were 
implemented in wild-type MG1655 and thefadR atoC(c) derivative. 
(b) Isopropanol and caproic acid yields in strains engineered for acetone production and 
overexpressing a secondary alcohol dehydrogenase from C. butyricum (adh), which converts 
acetone to isopropanol. 
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Low product selectivity and titers are key factors that represent a driver for 
heterologous expression of this solventogenic pathway in industrial organisms such as E. 
coli (Bermejo et al., 1998). The acetone pathway involves the conversion of acetyl-CoA 
to acetone via reactions catalyzed by three different enzymes (Jones and Woods, 1986), 
as shown in Figure 2-4. 
Conversion of sugars to acetone is also inefficient in terms of C-recovery, with a 
maximum theoretical yield on glucose limited to 0.48 (w/w) (Table 2-2). Utilization of 
palmitic acid would support a yield 2.71-fold higher than sugars (Table 2-2). 
Since acetone is not a native product of E. coli metabolism, a synthetic pathway 
containing genes from C. acetobutylicum and E. coli was required to convert the acetyl-
CoA produced by the 13-oxidation of FAs to acetone (Figure 2-4). While significant 
acetone production was achieved with this strategy, the resulting yield was low (0.11 g 
acetone /g C16:o: Figure 2-10a, strain MG1655 [atoDAB+ adc+]). We hypothesized that 
acetone production may be limited by the low levels of acetate, a metabolite required in 
the second step of the acetone pathway (i.e. the conversion of acetoacetyl-CoA to 
acetoacetate, Figure 2-4). In agreement with this hypothesis, supplementation of the 
growth medium with acetate increased the acetone yield by more than 60% (Figure 
2-IOa). Simultaneous overexpression of the acetate-producing ACK-PTA pathway, along 
with the synthetic acetone pathway, enabled the synthesis of acetone in the absence of 
added acetate at a yield of 0.28 g acetone/ g C16:o (Figure 2-lOa, strain MG1655 
[atoDAB+ adc+ ackA+ pta+]). When this strategy was implemented in a strain with 
constitutive expression of the fad regulon and ato operon (i.e. strain fadR atoC(c)), 
efficient utilization of palmitic acid along with further improvement in acetone 
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production was observed (Figure 2-10a). The acetone yield on this strain (0.37 g acetone/ 
g Ct6:o) surpassed the yields previously reported using engineered E. coli (Bermejo et al., 
1998; Hanai et al., 2007) and corresponds to 28.5% of the maximum achievable from 
palmitic acid. 
2.3.2.3. Isopropanol 
Isopropanol is a secondary alcohol with applications as both chemical 
intermediate and solvent (Logsdon and Loke, 2000). Isopropanol is produced in C. 
beijerinckii (Chen and Hiu, 1986; George et al., 1983) from acetyl-CoA via the acetone 
pathway (Figure 2-4), as part of a mixed product fermentation. Limitations in the 
utilization of native strains have increased interest to engineer the pathway in industrially 
relevant hosts (Hanai et al., 2007). Isopropanol production from glucose is limited to a 
yield of 0.44 (w/w) (Table 2-2). When compared to sugars, the use ofF As offers a yield 
2.73-fold higher (Table 2-2). Since isopropanol is a non-native product of E. coli 
metabolism, we introduced the clostridial route, which produces this alcohol from acetyl-
CoA, as shown in Figure 2-4. For this purpose, three different pathways were assembled 
in strain MG1655 (Figure 2-4): i) the C. acetobutylicum acetone pathway that converts 
acetyl-CoA to acetone (see Section 2.3.2.2), ii) a secondary alcohol dehydrogenase from 
C. beijerinckii that converts acetone to isopropanol, and iii) the E. coli pathway that 
converts acetyl-CoA to acetate. The resulting strain, MG1655 [atoDAB+ adc+ ackA+ 
pta+ adh+], produced isopropanol at a yield of0.09 g/ g Ct6:o (Figure 2-10b). When these 
pathways were assembled in the fadR atoC( c) strain, efficient metabolism of F As and 
further increase in isopropanol yield were observed (0.13 g of isopropanol/ g Ct6:o, 10.8% 
of the maximum achievable from palmitic acid) (Figure 2-1 Ob ). 
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2.3.2.4. Succinic Acid (Succinate) 
Succinate is expected to become a future platform chemical (W erpy and Petersen, 
2004) and major efforts in recent years have focused on its production by microbial 
fermentation of sugars (Hong and Lee, 2002; Song and Lee, 2006). 
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Figure 2-11 Production of succinate and propionate from fatty acids in engineered 
Escherichia coli strains. 
Details about the engineered pathways are shown in Figure 2-4. Gene overexpressions and 
deletions are indicated by "+" and "d", respectively, next to the corresponding genes or operons. 
A kLa = 14.5 h-1 was used in all experiments. Values represent the means and error bars standard 
deviations for 72-hour triplicate cultures. 
(a) Effect of fadR atoC(c) genotype and deletions of genes encoding TCA cycle enzymes on 
succinate and caproic acid yields. 
(b) Propionate and caproic acid yields in strains overexpressing a metabolic cycle that catalyzes 
the decarboxylation of succinate to propionate (scpA , scpB, scpC). The effect of amplification of 
this cycle , along with the deletion of succinate dehydrogenase (AsdhB), was evaluated in wild-
type MG 1655 andfadR atoC(c) derivative. 
Succinate is a minor product of sugar fermentation in E. coli (Clark, 1989) but it 
is not produced under aerobic conditions because this metabolite is an intermediate of the 
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TCA cycle (Figure 2-11 ). As in the case of other products discussed above, production of 
succinate from F As would offer a significant yield advantage {Table 2-2). Metabolic 
engineering strategies previously reported for the production of succinate from sugars in 
E. coli (Lin et al., 2005; Song and Lee, 2006) cannot be implemented for its production 
from F As because of the significant differences in the metabolic pathways. For example, 
while the synthesis of succinate from sugars is limited by the availability of both reducing 
equivalents and intermediate phosphoenolpyruvate (Hong and Lee, 2002), its production 
from F As is a redox generating process that relies on the availability of acetyl-CoA (see 
Table 2-2 and Figure 2-4). Since fadR mutants are known to exhibit higher expression of 
the glyoxylate shunt enzymes (Gui et al., 1996), and succinate is generated in this 
pathway (Figure 2-4), we evaluated succinate production in strain fadR atoC( c) and 
observed a significant increase in yield (Figure 2-lla). Succinate production was further 
increased by minimizing its conversion to fumarate (llsdhB mutation) and decreasing the 
oxidation ofacetyl-CoA to C02 via the TCA cycle (llsucC/IlsucD mutations) (Figure 2-4 
and Figure 2-11a). These engineering strategies resulted in up to 2.3-fold increase in 
succinate yield with respect to wild-type (Figure 2-lla), that represents 14.6% of the 
maximum achievable from palmitic acid. 
2.3.2.5. Propionic acid (Propionate) 
There is a high interest in producing propionate from sugars via fermentation with 
Propionibacteria but this process suffers from relatively low product yield and 
concentration (Himmi et al., 2000). While a propionate yield on glucose of 0.70 (w/w) 
can be realized the use of F As would support yields approximately 2.59-fold higher 
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(Table 2-2). Three of the genes located in the E. coli scpAargKscpBscpC operon encode 
the enzymes of a postulated metabolic cycle that can catalyze the decarboxylation of 
succinate to propionate (Figure 2-4) (Haller et al., 2000). However, propionate has not 
been reported as a product of E. coli metabolism. By overexpressing the aforementioned 
genes, we achieved for the first time the production of propionate in this organism 
(Figure 2-11 b). Since succinate is the precursor of propionate in this pathway, the same 
modifications that led to increased production of succinate (Figure 2-lla) also resulted in 
higher propionate yields (Figure 2-11 b), with a maximum yield of 8.8% of the maximum 
achievable from palmitic acid. 
2.4. Discussion 
The use of FA-rich feedstocks for the production of biofuels and biochemicals is a 
promising avenue to establish biorefineries. In addition to their abundance, the 
metabolism of F As is highly efficient as it yields 100% carbon recovery in the key 
intermediate metabolite acetyl-CoA from which most biofuels and biochemicals can be 
derived (Figure 2-2). This high metabolic efficiency, along with the high reduced state of 
carbon in F As, could enable the production of fuels and chemicals at yields superior than 
those obtained with the use of lignocellulosic sugars (Table 2-2). However, metabolism 
ofF As requires the presence of an external electron acceptor, which in tum precluded the 
synthesis of fermentation products (Figure 2-5 and Figure 2-8). To overcome this hurdle, 
we engineered a respiro-fermentative metabolic mode that enables the efficient 
production of the desired fuels and chemicals in combination with adequate catabolism of 
FAs. 
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E. coli was chosen as model organism to illustrate the feasibility of this approach, 
which was demonstrated by engineering the synthesis of ethanol, butanol, acetate, 
acetone, isopropanol, succinate, and propionate (Figures 1-5, 1-8, 1-9, 1-10, and 1-11). 
This work represents the first effort towards engineering microorganisms for the 
conversion of F As to the aforementioned products. The yield of ethanol (Figure 2-5), 
acetate (Figure 2-9), and acetone (Figure 2-10a) in the engineered strains exceeded those 
reported in the literature for their production from sugars (Bermejo et al., 1998; Causey et 
al., 2003; Hanai et al., 2007; Jarboe et al., 2007). In the case of ethanol and acetate the 
yields also surpassed the maximum theoretical values that can be achieved from 
lignocellulosic sugars. Butanol (Figure 2-8), on the other hand, was produced at yields 
and titers between two- and three-fold higher than those reported for its production from 
lignocellulosic sugars in engineered E. coli, P. putida, B. subti/is, and S. cerevisiae strains 
(Atsumi et al., 2008a; Inui et al., 2008; Nielsen et al., 2009; Steen et al., 2008). Our work 
(Dellomonaco et al., 201 Ob) also represents the first report of propionate production in E. 
coli (Figure 2-11 b), a compound previously thought to be synthesized only by 
Propionibacteria. Finally, the synthesis of isopropanol and succinate was also 
demonstrated (Figure 2-10b and Figure 2-11a). 
Taken together, the results reported here represent the foundation to establish a new 
approach for the production ofbiofuels and biochemicals from renewable feedstocks. The 
synthetic respiro-fermentative metabolic mode engineered in this work will also serve as 
the basis for the synthesis of other reduced products in the presence of external electron 
acceptors (e.g. oxygen), thus taking advantage of the most significant attributes of 
respiratory and fermentative metabolism. 
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Chapter 3 
Engineering functional differentiation in 
bacteria by harnessing the pluripotent 
capabilities of native hosts 
3.1. Motivation and background 
The availability of diverse biomass feedstocks provides ample opportunity to employ 
microbial means for the conversion of a wide variety of carbon sources into valuable 
products. Exploitation of diverse carbon sources therefore entails solid knowledge of the 
different metabolic pathways associated with the metabolism of each carbon source in order 
to develop and implement a variety of engineering strategies for the efficient production of 
fuels and chemicals from each available source. 
Many native microorganisms possess biochemical capabilities to utilize biomass 
constituents and convert them into fuels and chemicals (Alper and Stephanopoulos, 2009). 
However, native producers are often slow growers and they synthesize a range of byproducts 
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along with the molecule of interest. Strategies designed to engineer cells and their metabolic 
pathways have been extensively exploited over the past few decades in order to improve 
biosynthesis and process efficiencies (Bailey, 1991; Stephanopoulos, 2002). However, 
genetic manipulation of native organisms to convert them into efficient microbial platforms 
is often hindered by their genetic intractability, making desirable establishing expression of 
their entire biosynthetic gene clusters in a more suitable host. As a consequence, more 
recently, metabolic engineering and the emerging field of synthetic biology (Pleiss, 2006) 
have provided key tools aiding in the design, assembly, and implementation of various 
heterologous pathways in model industrial organisms (Clomburg and Gonzalez, 2010; 
Dellomonaco et al., 2010a; Jarboe et al., 2010), building upon the functional diversity among 
species, as inferred by phylogenetics and taxonomy. 
3.1.1. Microbial functional diversity 
Microbial functional diversity is at present highly investigated (Bernhardsson et al., 
2011; Caetano-Anolles et al., 2009; Dalmolin, 2011; Hemandez-Montalvo et al., 2001; 
Koonin and Wolf, 2010; Moya et al., 2009; Pereto', 2011; Tripathi et al., 2007) given the 
impressive biosynthetic potential and the implausible plasticity of microorganisms to adapt to 
changing environment and nutritional conditions. Modem studies on microbial functional 
evolution seek to determine the underlying processes determining functional diversity and 
investigate the reasons why otherwise phenotypically identical bacterial genotypes result 
instead genetically distinct (Travisano, 2005), suggesting a need for the development of 
metrics to measure diversity that can go beyond phenetic considerations. Early taxonomic 
classification of microorganisms was based solely on phenotype, morphology and nutritional 
requirements of bacteria (Bergey, 1994; den Dooren de Jong, 1926). However, these criteria 
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of categorization failed to provide evolutionary relationships (Koonin, 201 0). The criteria 
(morphological traits and phenotypes) the classification was based on were for example very 
subjective and ambiguous (Palleroni, 1983). For the case of bacterial species, this type of 
classification was very difficult as many of them share similar cell shape, size, arrangement 
of flagella, etc. Important criteria like staining reactions, growth-related properties, 
physiology, and serology were therefore introduced to ease the process of categorization. In 
1990, Carl Woese addressed the shortcomings of the phenetic method by proposing a 
restructured scheme of biological classification based on comparison of ribosomal RNA 
sequences and established a sequence-based phylogenetic tree to relate different organisms 
(W oese et al., 1990). Evolutionary distance in the new system proposed by Woese does not 
account for time but is instead solely estimated by the differences identified when pairs of 
rRNA sequences are aligned (Olsen and Woese, 1993). He classified all the organisms as 
belonging to three domains: Eucarya (Eukaryotes), Bacteria and Archea (Figure 3-1). 
Woese's Tree of Life 
Bacteria Archaea Eukaryota 
Figure 3-1 A schematic of the phylogenetic tree created by Carl W oese sh~ws the three domains 
of life: Bacteria, Eucaria, and Archaea. Eukaryotes, Archeans and Bactena all share a common 
ancestor (Woese et al., 1990). 
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Based on this cladistic classification, i.e. a categorization based on evolutionary 
pathways derived from homology of macromolecules (Priest and Austin, 1993), we expect a 
striking and compelling difference from a molecular and metabolic standpoint between 
Eucarya and Bacteria. However, consistent with the early appearance of bacteria on Earth 
(Rasmussen et al., 2008), prokaryotes (including Bacteria and Archea) and Eukaryotes 
contain some common pathways for the dissimilation of carbohydrates, energy generation 
and reducing power (Moat, 2002). Metabolic modes of energy generation in Eukaryotes 
(Helms, 1997), with energy being produced in the form of ATP, encompass alcohol 
fermentation (e.g. Saccharomyces sp.) (Vandijken and Scheffers, 1986), homolactic 
fermentation (e.g. muscle and red blood cells), aerobic respiration (e.g. molds, protozoa, and 
animals) or anaerobic respiration (parasitic helminths, fresh-water snails, lower marine 
organisms, etc.) (Tielens and Van Hellemond, 1998), and oxygenic photosynthesis (e.g. 
algae, plants, cyanobacteria). The aforementioned metabolic modes for energy generation 
exist also within Prokaryotes, in addition to alternative ways of producing energy that are 
instead typical of microbial metabolism (Herrmann et al., 2008) (Thauer et al., 1977) . 
Q 1!0 41) -
Figure 3-2 Phylogenetic tree of life of fully sequenced organisms 
(Ciccarelli et al., 2006) Green section, Archaea; red , Eukaryota; blue, Bacteria. 
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For instance, while evolutionarily distant from a molecular/genetic standpoint m 
Woese's tree of life (Figure 3-2), bacteria can ferment sugars in the same way that brewing 
yeast (i.e., Saccharomyces cerevesiae) ferments sugars to produce ethanol and carbon 
dioxide. Ethanol is indeed the main product of the fermentative metabolism of both 
Zymomonas and Saccharomyces species, belonging to the phylum of Proteobacteria 
(Bacteria) and Ascomycota (Fungi), respectively. While dissimilation of sugars to pyruvate 
employs distinct metabolic pathways (Smolke, 2009), in both species ethanol is produced via 
a 2-step enzymatic process from pyruvate, the end product of glycolysis (Pronk et al. , 1996; 
Rogers, 2007). The first reaction decarboxylates pyruvate to acetaldehyde and C02 and it is 
58 
mediated by pyruvate decarboxylase, a key-enzyme in the eukaryotic alcohol fermentation. 
In both species acetaldehyde is then reduced to ethanol via an alcohol dehydrogenase (Pronk 
et al., 1996; Rogers, 2007). Lactic acid fermentation is another noteworthy example of 
functional similarities in evolutionary distant species that takes place in several 
microorganisms and higher organisms, including plants and vertebrates (Smolke, 2009). 
Lactic acid fermentation occurs for example in the muscle cell under hypoxic conditions; 
while usually muscle cells in vertebrates get the energy needed for contraction from aerobic 
metabolism, during high activity the circulatory system is unable to meet the cells oxygen 
demand (Smolke, 2009). Hence, the breakdown of glycogen through glycogenolysis releases 
glucose in the form of glucose 6-phosphate that is promptly channeled in the glycolysis to 
produce ATP as energy source and pyruvate, in turn converted to lactic acid. The reaction 
mediating the conversion of pyruvate to lactic acid consumes the reducing equivalents 
generated through the glycolysis and, by regenerating NAD+, is accordingly essential to 
maintain redox balance and glycolytic flux. Although the notable phylogenetic distance with 
animal cells, Lactobacillales perform homolactic fermentation in the same way under 
conditions of excess glucose and limited oxygen (Kandler, 1983). Morphology/anatomy, 
nutritional requirements and genetics of bacteria might at this point appear to be relatively 
easy to ascertain compared to most eukaryotes, probably suggesting more conserved 
metabolic capabilities in the realm of Bacteria. In fact, while eukaryotes exhibit considerable 
structural diversity, no such a drastic distinction is identified among the prokaryotes. 
Prokaryotic cells are, unlike eukaryotic ones, not compartmentalized; therefore, incompatible 
metabolic processes cannot be separated within discrete compartments (Pace, 1997). As a 
consequence, the hurdle posed by the inability of confining cellular processes has hindered 
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structural evolution of prokaryotes, while pushing their metabolism toward the acquisition of 
a more diverse set of functions (Pace, 1997). Prokaryotes tolerate extreme conditions and 
flourish in any habitat suitable for life on earth. Hence, their diversity needs to be accounted 
with regards to the reactions they can mediate or the type of stress they can endure. Dramatic 
differences in metabolism are then readily identified within the domain of Bacteria. 
3.1.2. Bacterial fermentative metabolism 
Three physiological groups of bacteria can be distinguished based on their anaerobic 
metabolism: phototrophs, respirers (e.g. denitrifiers, sulfate reducers, methanogens and 
acetogens), and fermentative organisms (Ljungdahl, 2003). Respiration and fermentation are 
two alternative energy-generating metabolic modes that chemoheterotrophes (i.e. organisms 
that use organic compounds as carbon and energy source) utilize (Ljungdahl, 2003). 
Respiration entails the complete oxidation of carbohydrates (or any other organic compound) 
to C02 and H20; molecular 0 2 and nitrate/fumarate are examples of compounds that serve as 
terminal electron acceptors under aerobic or anaerobic conditions, respectively. Conversely, 
fermentation is an energy-generating process that takes place anaerobically and in absence of 
an external electron acceptor. In fermentative metabolism, ATP is generated via substrate-
level phosphorylation during the catabolic oxidation of the substrate. However, in order for 
this process to be sustained, the electrons generated in the catabolism of the substrate have to 
be consumed by a reductive process: this provides the basis for a coupling, which then 
enables redox balance/regeneration of NAD+ to keep the catabolic pathway (and hence 
substrate-level phosphorylation) functioning. The key issue in fermentative metabolism is 
therefore recycling of reduced equivalents to regenerate the oxidized form so that catabolism 
of the carbon source can proceed. Since the amount of reducing equivalents produced varies 
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according to the carbon and energy source, the composition of the mixture of fermentation 
products must also change accordingly (Ljungdahl, 2003). As an example, the phyla of 
Proteobacteria and Firmicutes, within the common domain of Bacteria, include fermentative 
organisms with remarkable differences in morphology, central metabolism and product 
composition of the fermentation mix. Based on the distinct mix of products synthesized out 
of the dissimilation of sugars, the fermentative metabolism mediated by Enterobacteria and 
Clostridia, belonging to the aforementioned phyla, is referred as mixed-acid and acetone-
butanol-ethanol (ABE) fermentation, respectively (Ljungdahl, 2003) (refer to Section 3.1.2.2 
and 3 .1.2 .3 for details). 
3.1.2.1. Conversion of pyruvate to acetyl CoA under anaerobic conditions 
The final product of the oxidation of any carbohydrate via glycolysis is pyruvate. 
Under anaerobic conditions and in the absence of external electron acceptors, pyruvate is the 
main intermediate metabolite for the synthesis of most fermentative products. Pyruvate is 
dissimilated through different pathways (Kessler, 1996; Lee et al., 2008b; Sawers and Clark, 
2004)(Figure 3-3). 
Lactic acid is produced by reducing pyruvate and occurs in a wide range of organisms 
when they grow under fermentative conditions (Figure 3-3), as aforementioned. In 
Escherichia coli two different enzymes mediate the conversion of pyruvate into acetyl-CoA: 
pyruvate formate lyase (PFL) and the pyruvate dehydrogenase complex (PDHC) (Bock and 
Sawers, 1996; Kessler, 1996) (Figure 3-3). PFL is known to be active under hypoxic or 
anoxic conditions, while it is widely accepted that PDHC mediates the aerobic dissimilation 
of pyruvate (Kessler, 1996). The PDHC role during fermentative glucose metabolism has 
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recently been elucidated as associated to the metabolic requirements of co
2 
(Murarka et al., 
2010). 
Figure 3-3 Metabolic pathways for anaerobic pyruvate dissimilation 
Color shades correspond to different dissimilation routes: Pyruvate Dehydrogenase Complex (PDH, 
light blue); Pyruvate Formate Lyase (PFL, blue); Pyruvate: ferredoxin oxidoreductase (PFOR, 
purple). Abbreviations: TTP, Thiamine pyrophosphate; Fdred• Reduced ferredoxin; Fdox• Oxidized 
ferredoxin. 
A comparison of the PDHC and PFL reactions for the conversion of pyruvate into 
acetyl-CoA also reveals that the reaction catalyzed by PDHC produces NADH as opposed to 
the alternative pathway (catalyzed by PFL), which results in no net generation of reducing 
equivalents. An additional enzyme involved in the dissimilation of pyruvate in Enterobacteria 
is pyruvate oxidase (PoxB) (Kessler, 1996). PoxB catalyzes the decarboxylation of pyruvate 
to acetate and C02 , a reaction that also generates reducing equivalents in the form of flavin 
adenine dinucleotide. The metabolism of pyruvate via PoxB is less efficient than the route 
via the PDH; however, the PoxB route is important for wild-type growth efficiency and 
responsible for a significant portion of pyruvate metabolism under aerobic conditions (Li et 
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al., 2007a). However, its metabolic role (if any) under fermentative conditions remains still 
uncertain. 
An alternative route for anaerobic pyruvate dissimilation, present in several species 
within the Enterobacteriaceae family (Blaschkowski et al., 1982; Pomposiello and Demple, 
2000; Wahl and Ormejohnson, 1987) and in Clostridia is the oxidative decarboxylation by 
pyruvate-ferrodoxin (Fd) oxidoreductase to form acetyl-CoA, C02, and reduced ferrodoxin 
(FdH2) (Thauer et al., 1977) (Furdui and Ragsdale, 2000). Electrons produced from Fd can 
either be used in the reduction of protons to form H2, or can be transferred to NAD(P) and 
thereby utilized for the production of alternative reduced fermentation products. 
3.1.2.2. Mixed acid fermentation 
Under anaerobic conditions and in the absence of alternative electron acceptors, 
members of the Enterobacteriaceae family (Escherichia, Enterobacter, Salmonella, 
Klebsiella, and Shigella) ferment sugars to a mixture of acetic, formic, lactic, and succinic 
acid, ethanol, molecular hydrogen and carbon dioxide, a fermentative metabolic mode known 
as mixed-acid fermentation (Sawers and Clark, 2004). 
Hexoses such as glucose or fructose are dissimilated through the Embden-Meyerhof 
pathway to produce 2 NADH per C6 upon conversion to pyruvate. The fate of pyruvate is 
then either reduction to lactate by the action of lactate dehydrogenase, or cleavage to acetyl-
CoA and formate by pyruvate:formate lyase, a key enzyme of mixed acid fermentation 
(Sawers and Clark, 2004), as described in the previous section. 
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Figure 3-4 Mixed acid fermentation by Escherichia coli 
63 
Broken lines illustrate multiple steps. Products of the mixed-acid fermentation are boxed. 
Abbreviations: PEP, phosphoenolpyruvate; 2[H] = NADH = FADH2 = H2 
Most commonly, part of the acetyl-CoA is cleaved to acetate via acetyl-P with 
generation of ATP. Concomitantly, and in order to attain redox balance, ethanol is produced 
from acetyl-CoA by means of a two-step process catalyzed by the bifunctional enzyme 
acetaldehyde/alcohol dehydrogenase that consumes two reducing equivalents (NADH). 
Another alternative is the conversion of pyruvate or posphoenolpyruvate (PEP) to a C-4 
intermediate of the Krebs cycle via incorporation of the C02 produced by the reaction 
I 
mediated by the formate: hydrogen lyase. The composition of the aforementioned compounds 
is therefore fine-tuned in order to produce energy in the form of ATP while preserving redox-
balance (Sawers and Clark, 2004). 
3.1.2.3. Acetone-butanol-ethanol (ABE) fermentation 
Species such as Clostridium acetobutylicum belonging to the Clostridiaceae within 
the phylum of Firmicutes perform the so-called acetone-butanol-ethanol (ABE) fermentation, 
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a process divided into an acidogenic and a solventogenic phase (Jones and Woods, 1986; Lee 
et al., 2008b). At first butyrate is produced, thus leading to acidification of the medium. The 
low pH activates acetoacetate decarboxylase, which mediates the decarboxylation of 
acetoacetate to acetone while reducing the pool of acetoacetyl-CoA that can be reduced to 
butyryl-CoA. Taking up again the butyrate circumvents this redox imbalance. Butyrate is 
activated by CoA transfer and subsequently reduced to butanol via butyraldehyde, thus 
maintaining the redox balance (Lee et al., 2008b). 
3.1.2.4. Homoethanolic fermentation 
Many microorganisms, including bacteria and yeasts, can produce ethanol as the main 
fermentation product from carbohydrates (Figure 3-5). Glycolysis generates two moles of 
pyruvate per mole of glucose converted, along with two reducing equivalents and a net of 
two moles of ATP. 
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Figure 3-5 Pathway mediating the conversion of pyruvate to ethanol 
The reaction reported in red is common to yeasts, plants, and bacteria (i.e., Zymomonas mobilis). 
Abbreviations: 2[H] = NADH = FADH2 = H2 
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The production of compounds more reduced than pyruvate (ethanol, lactate, etc.) 
serves as a mechanism to re-oxidize the reducing equivalents produced and it is therefore 
essential for glycolysis. In the only known homoethanol pathway that evolved in yeast, 
plants, and bacteria (i.e., Z. mobilis), pyruvate is decarboxylated to yield carbon dioxide and 
acetaldehyde by the nonoxidative pyruvate decarboxylase (Figure 3-5). The resulting 
acetaldehyde serves as the electron acceptor for NADH oxidation by the alcohol 
dehydrogenase during production of ethanol from pyruvate. Although a pyruvate 
decarboxylase-dependent pathway has been elucidated in Zymomonas mobilis (member of 
the Proteobacteria family) (Neale et al., 1987), a completely different ethanol fermentation 
pathway exists in Enterobacteriaceae (i.e. E. coli), in which pyruvate is converted to acetyl-
CoA and formate by pyruvate formate-lyase. Acetyl-CoA is then converted to ethanol via a 
two-step pathway catalyzed by the bifunctional enzyme aldehyde-alcohol dehydrogenase that 
consumes two reducing equivalents (NADH) (Figure 3-5). Due to the requirement of two 
reducing equivalents per ethanol generated, the second acetyl-CoA from glycolysis of 
glucose is converted to acetate and an additional ATP. Thus, the native E. coli pathway for 
ethanol from acetyl-CoA cannot support homoethanol fermentation due to a redox 
imbalance. 
3.1.2.5. Glycerol fermentation 
The different characteristics of the anaerobic fermentative metabolism presented 
above for Escherichia sp. and Clostridium sp. seem to corroborate their significant 
phylogenetic distance as reported by Woese. Somewhat counterintuitively, however, 
substantial divergence in terms of metabolism can also be found within the same phylum. 
Enterobacteria of the genera Klebsiella (Homann et al., 1990) (Biehl et al., 1998), 
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Enterobacter (Barbirato et al., 1996), and Citrobacter (Homann et al., 1990) along with 
Lactobacilli (Schutz and Radler, 1984) and Clostridia (Forsberg, 1987) ferment glycerol to 
1 ,3-propanediol (1 ,3-PDO). Glycerol fermentation branches out in two parallel pathways 
(Figure 3-6): oxidative and reductive (Booth, 2005; Yazdani and Gonzalez, 2007). The first 
steps of the oxidative pathway are glycerol dehydrogenation to dihydroxyacetone and its 
subsequent conversion to dihydroxyacetonephosphate. Succinic acid, acetic acid, lactic acid, 
2,3-BDO and ethanol are then produced through the oxidative branch (Yazdani and 
Gonzalez, 2007)(Figure 3-6). The conversion of glycerol to 1 ,3-PDO is realized instead 
through the reductive branch and consists of a vitamin B 12-mediated dehydration to 3-
hydroxypropionaldehyde and its NADH-dependent reduction to 1,3-PDO (Biebl et al., 1999). 
The capability of fermenting glycerol had for long been thought peculiar of species able to 
synthesize 1 ,3-PDO. However, Gonzalez and coworkers have recently elucidated in E. coli 
an alternative mechanism of glycerol fermentation 1 ,3-PDO-independent (Gonzalez et al., 
2008). Production of 1 ,2-PDO provides in this case an avenue to dispose of the excess 
reducing equivalents produced by the synthesis of biomass, thus facilitating redox balance 
(Gonzalez et al., 2008)(Figure 3-6). Concurrently, ethanol synthesis enables ATP-generation 
via substrate level phosphorylation by consuming the NADH generated in glycolysis, and 
therefore represents the major fermentation product. 
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Figure 3-6 Biochemical pathways of anaerobic fermentative metabolism of glycerol 
Reactions reported in orange and blue are specific to Enterobacteriaceae and Clostridia, respectively. 
Broken lines illustrate multiple steps. Abbreviations: PEP, phosphoenolpyruvate; PYR, pyruvate; 
Fdred• Reduced ferredoxin; Fdox• Oxidized ferredoxin; 2[H] = NADH = FADH2= H2 • 
3.1.3. Functional differentiation of metabolic pathways 
Previous examples underline a substantial divergence between molecular (genetic) 
and functional homology and evolution. Although the sequence-based phylogenetic 
(cladistic) classification proposed by W oese provides a good representation of genomes 
evolution, distribution of functions related to carbon and energy metabolism among different 
microorganisms does not necessarily follow the same classification pattern of rRNA (Pace, 
1997). An intrinsic limitation of the phylogenetic analysis based on the comparison of the 
highly conserved small ssu-rRNA subunits consists, for example, in the fact that the 
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evolutionary history of any single gene may differ from the phylogenetic history of the whole 
organism from which the corresponding molecule was isolated. Furthermore, although 
comparative genomics based on orthologous genes has elucidated phylogenetic relationships 
among the known genomes, the mechanisms underlying their speciation remain elusive 
(Boussau and Daubin, 2010). Particularly, phylogenetics fails to account for the contribution 
of external forces such as horizontal gene transfer and pressure from environmental factors to 
genome evolution (Papp et al., 2009; Ragan and Beiko, 2009). 
The broad variety of metabolic capabilities existent in present-day microorganisms 
can have emerged in several ways (Fani and Fondi, 2009). Enzymes mediating identical, 
parallel or reverse reactions may have for example arisen independently. Hence, the 
realization that molecular similarity is only a partial indicator of evolutionary functional 
relatedness opens the question of whether molecular divergence is ultimately correlated to 
functional divergence. So, the establishment of a metric alternative to sequence-homology 
for assessing functional similarities becomes impelling. The introduction of modem 
technologies of characterization of protein 3D structures like NMR and X-ray 
crystallography has elucidated that structures of protein domains are more conserved than 
their primary sequence (Jones, 2000). Functional homology becomes therefore tightly linked 
to structural domain homology (Loewenstein et al., 2009), with the domains evolving either 
from different ancestral proteins or from an evolutionary common ancestor (Buljan and 
Bateman, 2009). Protein domains can therefore be defined as functional and structural units 
of proteins interactions (Kummerfeld and Teichmann, 2009). Consequently, a number of 
novel trees (Figure 3-7) have been proposed which are based on the occurrence of this 
specific feature throughout the whole genome (Bro et al., 2006; Dagan et al., 2010; Forslund 
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et al., 2008; Fukami-Kobayashi et al., 2007; Gupta, 1998; Yang and Bourne, 2009). 
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Figure 3-7 A network based on the domain organization repertoires. 
The tree includes 17 archaeal, 136 bacterial, and 14 eukaryotic organisms (Fukami-Kobayashi et al., 
2007) . The organisms in the tree are color coded according to the NCBI taxonomy (Benson et al., 
2011; Wheeler et al., 2008). The Pfam (Finn et al., 2010) domain organizations were used for 
constructing the domain organization repertoire of each organism. 
Domains within protein structures are defined as structures spatially distinct that 
could conceivably fold and function independently (autonomously folding units) (Ponting 
and Russell, 2002). It has been fairly established that the number of naturally occurring 
protein folds is approximately of the order of 103-104 (Liu et al., 2004) and that the vast 
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majority of these folds is represented within the Protein Data Bank (Berman et al., 2003). 
The question remains open as to whether proteins functionally differentiated and converged 
toward a finite set of optimal conformations or whether we are depicting a snapshot of a 
protein structural ensemble in continuous evolution. The Class, Architecture, Topology, and 
Homologous (CATH) superfamily protein domain database (Orengo et al., 1997) along with 
the Structural Classification of Proteins (SCOP) database (Murzin et al., 1995) are currently 
available resources for the analysis of protein structures and their hierarchical classification 
families, superfamilies, folds and classes. Based on these available resources, Aguilar and 
coworkers recently proposed a series of trees based on the distribution of metabolic functions 
in the metabolome of microorganisms for which the whole genome sequence is known 
(Aguilar et al., 2004). The concept they propose aims at drawing relationships between 
species living in analogous or different niches; the topology of the trees for several metabolic 
classes represent the functional adaptation of pathways, through either gene mutation or 
horizontal transfer, upon selective pressure exerted by the habitat. In addition, the method 
developed by Aguilar and coworkers analyzes the sequential order of domains within the 
primary structures of proteins along with the domain distribution, thus providing more 
detailed aspects of evolution (Aguilar et al., 2004). Homology of protein domains can 
therefore suggest a functional evolutionary relationship, which remains detectable even when 
sequences have diverged beyond any recognizable similarity (Aguilar et al., 2004). Forslund 
and coworkers (Forslund et al., 2008) have further investigated protein evolution based on 
domain trees, analyzing, in particular, evolution of global protein architectures. This 
methodology, being based on non species-specific comparison of global protein architectures 
(Mulder, 2010), overcomes the limitations posed by previous methods of not being able to 
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account for horizontal gene transfer (HGT) (Forslund et al., 2008). 
An alternative strategy to characterize bacterial functional evolution entails making 
use of current knowledge on prokaryotic genomes to derive phylogenies based on the whole 
genomic information of organisms rather than just a small number of genes (Henz et al., 
2005). Phylogenomics, the science that lays at the intersection of evolution and genomics 
(Eisen and Fraser, 2003), utilizes the vast amount of genomic data available to generate more 
accurate functional predictions that consider the evolution of the ensemble rather than the 
individual genes. Phylogenomic trees have been constructed based on this concept and have 
partially covered the gap between phylogeny and functional evolution (Casci, 2011; Delsuc 
et al., 2005; Eisen and Fraser, 2003). Concomitantly, theoretical models involving networks 
evolution (Hirsh and Sharan, 2007; Yosef et al., 2009) have been developed given the 
availability of large-scale protein interaction (PIN) datasets (Fraser et al., 2002; Robertson 
and Lovell, 2009), with the scope of elucidating protein functions, predicting interactions and 
ultimately providing a more detailed evolutive profiling of metabolic networks. 
3.1.4. Current metabolic engineering and synthetic biology approaches applied to 
the production of fuels and chemicals 
While novel methodologies are developed to fill the knowledge gap between genetic 
and functional taxonomies, metabolic engineering and synthetic biology utilize the wealth of 
information generated in this process to construct optimal microbial cell factories to produce 
products of interests by combining favorable metabolic pathways from diverse genera. Not 
surprisingly, in fact, industrial microbiology has historically developed in demand to develop 
cheap and faster substitutes of chemical reactions and based on information provided by 
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philogenetics. Classical industrial microbiology, for example, has for long time aimed at 
developing industrial processes and synthesizing products of interest by exploiting the native 
refined metabolic capabilities of modem bacterial species, previously characterized by 
phenetics. In the early 201h century, for example, industrial fermentation processes harnessing 
the metabolism of Clostridia, as described in Section 3.1.2.3, were developed for the solvent 
production (acetone and n-butanol) (Awang et al., 1988). Clostridia are spore formers and 
obligate anaerobes that grow at slow rates, have complex nutritional requirements and 
produce a mixture of products, thus considerably decreasing product yields. In the attempt to 
address the limitations posed from an industrial perspective by such a complex metabolism, 
metabolic engineering strategies have been developed in the last few decades, which aimed at 
the improvement of n-butanol yield, titer, and productivity by means of genetic manipulation 
of Clostridial metabolism. However, these efforts were hindered by the lack of efficient 
genetic tools to manipulate Clostridia, along with their complex metabolism. In an effort to 
overcome these issues, the genes that enable the synthesis of n-butanol or acetone in native 
producers like Clostridia have been therefore imported into industrial organisms that are 
genetically and metabolically tractable such as E. coli (Atsumi et al., 2008a; Atsumi and 
Liao, 2008; Bermejo et al., 1998; Dellomonaco et al., 2010b; Inui et al., 2008), 
Saccharomyces cerevisiae (Steen et al., 2008), Pseudomonas putida (Nielsen et al., 2009), 
Bacillus subtilis (Nielsen et al., 2009), Lactococcus lactis (Nielsen et al., 2009), and 
Lactobacillus species (Berezina et al., 2010). 
Similarly, the metabolism of glycerol in Clostridia and Enterobacteriaceae (Section 
3 .1.2.5) has been originally explored for the industrial production of 1 ,3-propanediol (Biehl 
et al., 1999). However, metabolic pathways from Klebsiella, Citrobacter or Clostridia have 
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recently been reconstructed in E. coli (Celinska, 2010; Laffend, 1997; Nakamura and Whited, 
2003; Tong et al., 1991) or S. cerevisiae (Cameron et al., 1998; Celinska, 2010; Rao et al., 
2008) because of their industrial amenability and efficient carbohydrate metabolism. 
The strategies hereby reviewed all consist of importing and recombining specialized 
biosynthetic capabilities evolved in one phyla with other favorable traits of the bacterial host, 
an approach that we refer to as Heterologous Metabolic Engineering (HeME). HeME-based 
approaches have been used to engineer chemical and fuel production in the past and are 
currently viewed as the strategy of choice when, based on phylogenetic considerations, the 
host organism is not predicted to possess the desired metabolic function (Na et al., 2010; 
Alper and Stephanopoulos, 2009). Current metabolic engineering and synthetic biology 
approaches are therefore still based on high metabolic segregation models, therefore lagging 
behind when compared to more recent classification of organisms. As an alternative, the 
Homologous Metabolic Engineering (HoME) methodology that we propose builds on the 
different evolution patterns followed by genomes and functionomes (ensemble of metabolic 
capabilities of an organism) and it aims at exploiting the biosynthetic metabolic potential to 
synthesize non-native products via native pathways. 
3.2. Methods 
3.2.1. In silico analysis 
All data reported are based upon sequence comparisons made by using the freely 
accessible genome data of Escherichia coli K-12 substr. MG1655 (http://ecocyc.org/ 
(Keseler et al., 2005)). Protein sequenced were searched through UniProT (www.uniprot.org 
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(Bairoch et al., 2005)) and subjected to similarity searches (BLAST) at the websites of the 
National Center for Biotechnology Information at the National Institutes of Health, Bethesda, 
Md., at www.ncbi.nlm.nih.gov, and of The Wellcome Trust Sanger Institute, Hinxton, 
Cambridge, United Kingdom, at www.sanger.ac.uk/Projects/S_coelicolor. Default settings 
were used, however, without filtering low-complexity regions. Sequence alignments were 
conducted with CLUSTAL W, applying predefined algorithms at www.ebi.ac.uk/clustalw of 
The European Bioinformatics Institute at The European Molecular Biology Laboratory 
(Thompson and He, 2006). 
The three-dimensional structure and functionality of E. coli genes was predicted using 
homology models generated by I-TASSER, a free online resource available at 
http://zhang.bioinformatics.ku.edu/I-TASSER (Roy et al., 2010). 
Protein family signatures were obtained from the EMBL European Bioinformatics 
Institute (EBI) at http://www.ebi.ac.uk/Tools/pfa/iprscan/ (Quevillon et al., 2005) and from 
the European molecular Biology Laboratory (EMBL) at smart.embl-heidelberg.de (Schultz et 
al., 1998). 
3.2.2. Strains, plasmids and genetic methods 
Strains, plasmids, and primers used in this study are listed in Table 3-1. Wild-type 
Kl2 E. coli strain MG1655 (Kang et al., 2004a) was used as the host to implement metabolic 
engineering strategies. Gene knockouts were introduced in MG1655 and its derivatives by P1 
phage transduction as described elsewhere (Miller, 1992), using as donors single gene knock 
out mutants from the National BioResource Project (NIG, Japan) (Baba et al., 2006). 
Deletion mutants were created using a single-step gene inactivation method developed by 
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Datsenko and Wanner (Baba et al., 2006) which employs a gene disruption strategy. In the 
method a PCR insert is first created from a pHD4 template and primers with flanking regions 
homologous to the start and end sequences of the gene to be inactivated. This results in an 
insert with a kanamycin resistance gene in the center of the two FRT (FLP recognition sites) 
and outer homology regions. Wild type cells expressing f.. Red recombinase were then 
transformed with this PCR insert, with recombination resulting in the gene sequence between 
the homology regions being replaced with the FRT::Km::FRT sequence. Subsequent plating 
on LB with kanamycin plates allowed for selecting of positive mutants. The Keio Collection 
mutants were obtained in this state, with the mutant expressing kanamycin resistance. When 
required, the elimination of the kanamycin resistance gene was accomplished by 
transforming the cells with pCP20, a temperature sensitive plasmid expressing FLP. FLP 
expressed from this plasmid cut the Km region from the FRT::Km::FRT site, leaving behind 
one FRT site. pCP20 was then removed by growing the cells at 42 oC. This simple procedure 
enabled the construction of numerous gene deletion mutants from wild type cells by simply 
varying the homologous regions. 
StrainfadR atoC(c), which exhibits constitutive expression of the fad regulon (due to 
fadR) and ato operon (due to atoC(c)), was obtained as follows. Strain MG1655 fadR was 
isolated as an spontaneous mutant able to grow on MOPS (morpholino-propanesulfonic acid) 
minimal medium (Neidhart et al., 1974) plates containing 0.2% (w/v) decanoic acid (Cw:o) as 
the sole carbon source. Strain fadR atoC(c) was then obtained by transducing fadR with a 
phage lysate from strain LS5218, which is afadR atoC(c) mutant (Jenkins and Nunn, 1987a). 
Successful transduction of the atoC(c) mutation into strainfadR was identified by growth on 
MOPS minimal medium plates containing 0.2% (w/v) hexanoic acid (C6:o). 
Table 3-1 Strains, plasmids, and primers used in this study 
Strain/plasmid 
Primer 
Strains 
MG1655 
t:J.adhE 
Description/Genotype/ Sequence 
F- 1- ilvG- rtb-50 rph-1 
MG1655, t:J.adhE::FRT-kan-FRT 
l'l.adhE l'l.ackA-pta MdhA MG1655, t:J.adhE::FRT l'l.ackA.pta::FRT MdhA-FRT-kan-FRT 
l'l.adhE l'l.ackA-pta MdhA fadR MGI655fadR, l'l.adhE::FRT !lackA.pta::FRT llldhA-FRT-kan-FRT 
fadR atoC( c) lladhE 
Plasmids 
pTH.atoDA 
pTH.pflCD.yia Y 
pTH.pflEF.yia Y 
pTH.eutD.ackA 
pTH.eutD.tdcD 
pTH.atoB 
pTHyqeF 
pZS.fucO 
pZS.yqeF 
pZS.KLM.gldA 
MG1655fadR, atoC(c) !ladhE-FRT-kan-FRT 
E. coli atoD and atoA operons under control of Ptrc (AmpR, oriR pBR322) 
E. coli pjlCD andyiaYoperons under control ofPtrc (AmpR, oriR pBR322) 
E. coli pflEF and yiaY operons under control of Ptrc (AmpR, oriR pBR322) 
E. coli eutD and ackA genes under control of Ptrc (AmpR, oriR pBR322) 
E. coli eutD and tdcD genes under control ofPtrc (AmpR, oriR pBR322) 
E. coli atoB gene under control of Ptrc (AmpR, oriR pBR322) 
E. coli yqeF gene under control ofPtrc (AmpR, oriR pBR322) 
E. colifucO gene under control ofPLtet0-1 (tetR, oriR SClOl *,cat) 
E. coli yqeF gene under control ofPLtet0-1 (tetR, oriR SClOl *,cat) 
E. coli dhaKLM and gldA operons under control of PLtet0-1 (tetR, oriR 
SClOl *,cat) 
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Source 
(Kang et al., 
2004b) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Standard recombinant DNA procedures were used for gene cloning, plasmid 
isolation, and electroporation. Manufacturer protocols and standard methods (Miller, 1992; 
Sambrook and Russell, 2001) were followed for DNA purification (Qiagen, CA, USA), 
restriction endonuclease digestion (New England Biolabs, MA, USA), and DNA 
amplification (Stratagene, CA, USA and Invitrogen, CA, USA). The strains were kept m 
32.5% glycerol stocks at -80o C. 
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Plates were prepared using Luria-Bertani (LB) medium containing 1.5% agar and 
appropriate antibiotics were included at the following concentrations: 100 J..lg/mL ampicillin, 
50 J..lg/mL kanamycin, 34 J..lg/mL chloramphenicol and 12.5 J..lg/mL tetracycline. All strains 
created were confirmed by polymerase chain reaction and appropriate phenotypic tests, if 
suitable. 
3.2.3. Culture medium and cultivation conditions 
All chemicals for culture media were obtained from Fisher Scientific (Pittsburgh, P A) 
and Sigma-Aldrich Co. (St. Louis, MO), unless otherwise stated. MOPS minimal medium 
(Neidhart et al., 1974) supplemented with either glucose or glycerol (Fluka Chemie AG, 
Buchs, Switzerland) was used. When required the medium was supplemented with 100 
J..lg/mL ampicillin, 50 J..lg/mL kanamycin, 34 J..lg/mL chloramphenicol and 12.5 J..lg/mL 
tetracycline. Isopropyl-beta-D-thiogalactopyranoside (IPTG, 0.1 mM) and 
anhydrotetracycline (100 ng/ml) were used to induce gene expression from constructed 
plasmids. Prior to use, cultures (stored as glycerol stocks at -80 oC) were streaked onto LB 
plates (with appropriate antibiotics if required) and incubated overnight at 37 oC. 
In the case of butanol, acetone and butyric acid five single colonies were used to 
inoculate 30 mL of MOPS minimal medium supplemented with 2% of carbon source (w/v) in 
50 ml baffled shake flasks (Coming Glass Works, Coming, NY), which were incubated at 37 
oC until an OD550 of -Q.5 was reached. An appropriate volume of this actively growing pre-
culture was centrifuged and the pellet washed and used to inoculate 30 mL of medium in 50 
ml shake flasks to an initial OD550 of 0.05. Fifty-milliliter shake flasks (Coming Glass 
Works, Coming, NY) with four baffles and plastic foam-stoppers were used for microaerobic 
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cultures. Flasks were incubated for 48 hours at 37 OC in a C24 Rotary Incubator Shaker (New 
Brunswick Scientific Co., New Brunswick, NJ). In the case of acetone, higher cell density in-
flask fermentations were inoculated starting from precultures prepared as described above. 
When required, acetic acid at a concentration of 1 gr1 was added to the medium after 12 
hours of cultivation. 
Experiments for the synthesis of 1,3-propanediol were conducted in 17 ml hungate 
tubes (Bellco Glass, Inc., Vineland, NJ). A single colony was used to inoculate 10 ml of 
MOPS minimal medium supplemented with 1% of glycerol in 17 ml hungate tubes (Bellco 
Glass, Inc., Vineland, NJ), which were incubated at 37 oC for 48 hours. In the case of 
anaerobic fermentations, a single colony was used to inoculate 10 mL of medium in each 
tube, which were then incubated (37°C) for 48 h in an Isotemp Incubator (Fisher Scientific, 
Pittsburgh, PA) and sparged with ultra-high purity argon (Matheson Tri-Gas, Houston, TX). 
To maintain sterile conditions, the inlet gas was passed through a 0.2 mm HEPA filter 
(Millipore, Billerica, CA) and the outlet gas line immersed in a 1 M CuS04 solution. When 
appropriate, the media was supplemented with coenzyme B12 at a concentration of5 mg r 1• 
Samples were centrifuged to pellet cells while the aqueous supernatant was collected 
for metabolite analysis. 
3.2.4. Analytical methods 
Cell growth was monitored by measuring the absorbance at a wavelength of 550 nm. 
The identity of all metabolic products was determined through 1D proton NMR 
spectroscopy as previously described (Murarka et al., 2008). Organic acids, ethanol, acetone 
and 1 ,3-propanediol isopropanol were quantified by HPLC as previously reported (Dharmadi 
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and Gonzalez, 2005). Samples (culture supernatant) were analyzed with ion-exclusion HPLC 
using a Shimadzu Prominence SIL 20 system (Shimadzu Scientific Instruments, Inc., 
Columbia, MD) equipped with an HPX-87H organic acid column (Bio-Rad, Hercules, CA) 
with operating conditions to optimize peak separation (0.3 mL!min flowrate, 30 mM H2S04 
mobile phase, column temperature 42 °C) (Dharmadi and Gonzalez, 2005). 
Quantification of butanol was conducted through gas chromatography (GC) in a 
Varian CP-3800 gas chromatograph (Varian Associates, Inc., Palo Alto, CA) equipped with a 
flame ionization detector (GC-FID). 1ml of supernatant of culture broth was extracted with 
500 ~1 of GC standard grade n-hexane (Fluka, Steinheim, Germany) and 1-heptanol (Sigma-
Aldrich, Lausanne, Switzerland) was used as internal standard. The separation of alcohol 
compounds was carried out using a HP-INNOWax (30 m, 0.32 mm internal diameter, 0.50-
~m film thickness; Agilent Technologies, Palo Alto, CA). The oven temperature was initially 
held at 40°C for 1 min and then raised with a gradient of 30°C/min to 130°C and held for 4 
min. The temperature was then raised with a gradient of 15°C/min to 230°C and held for 4 
min. Helium (1 ml min-1, Matheson Tri-Gas, Longmont, CO) was used as the carrier gas. The 
injector and detector were maintained at 250°C. A 1.0-~1 sample was injected in splitless 
injection mode. 
For butyrate quantification, 5 mL of culture was placed in a 15 mL Coming 
CentriStar centrifuge tube (Coming Inc., Lowell, MA) in an ice bath, and then centrifuged at 
8,000 g for 5 minutes and the appropriate volume of supernatant recovered. 2 ml of 
supernatant were acidified with 200 ~1 of acetic acid, supplemented with 100 mg of octanoic 
acid as an internal standard, and extracted with 2 m1 of n-hexane-chlorophorm (4:1, v/v) 
(Lalman and Bagley, 2004). The organic layer was nitrogen evaporated to near dryness, 
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redissolved in 1 ml of a mixture of cholophorm:methanol:hydrochloric acid [ 10: 1:1, 
vol/vol/vol] (Dellomonaco et al., 2010b) and incubated in a sealed vial at 90°C for 1 h. Fatty 
acid methyl esters were extracted with 1 ml ofn-hexane-chlorophorm (4:1, v/v) after addition 
of 500 !J.l of 0.9% (wt/vol) NaCl in water. Gas chromatography was performed with 1 !J.l of 
the n-hexane:chlorophorm solution on a HP-INNOWax (30 m, 0.32 mm internal diameter, 
0.50-!J.m film thickness; Agilent Technologies, Palo Alto, CA) according to the following 
method: 50°C held for 1 min, 30°C/min to 160°C, 15°C/min to 200°C, 200°C held for 1.5 
min, 10°C/min to 225°C, and 225°C held for 15 min (Dellomonaco et al., 2010b). 
3.3. Results 
3.3.1. Proposed approach and methodology 
The Heterologous Metabolic Engineering (HeME) approach is currently the de facto 
strategy implemented to equip organisms with metabolic capabilities for the synthesis of non-
native products. The HeME methodology builds upon the differences in metabolism among 
bacteria belonging to different phyla, and therefore assumes that evolutionary distant species 
from a genomic standpoint will utilize a different toolset of biosynthetic capabilities. By 
doing so, HeME aims at combining favorable traits of evolutionary distant microbial species 
and thus fails at fully exploiting the biosynthetic capabilities of individual bacteria. 
Moreover, the compatibility of the heterologous pathway with the host metabolism might 
represent a concern. As an alternative approach, the Homologous Metabolic Engineering 
(HoME) strategy hereby proposed overcomes this limitation by investigating and harnessing 
functional relatedness of evolutionary distant species applied in this context to the production 
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of industrially relevant molecules. The homologous functionality of molecular evolutionary 
distant proteins encoded within different microbial genomes identified by the presence of 
common protein domains/folds suggests the existence of a common functional ancestor. 
Hence, adaptation of ancestral microbial metabolism and the consequent bacterial speciation 
to endure specific niches is very likely to have evolved from an un-regulated common 
genome encoding broad-specificity enzymes. These broad biochemical capabilities would 
have provided the metabolic plasticity essential for the successful adaptation to different 
niches. 
Consequently, we hypothesize that along with the differentiation of species-specific 
metabolic pathways, modem bacteria have retained ancestral enzymes and pathways with 
lower affinities for "nonphysiological" substrates, and that these metabolic capabilities are 
effectively masked by the regulatory mechanisms that have evolved (Caetano-Anolles et al., 
2009). Based on this and in analogy with embryonic stem cell differentiation processes in 
higher organisms, we propose the existence of a functionally pluripotent metabolic bacterial 
cell able to differentiate into a variety of specialized metabolic forms upon gene recruitment 
and relief of specific regulations. 
ASSEMBLY OF FUNCTIONAL 
SURROGATE PATHWAY 
PROTEIN-INTERACTION NETWORK 
SEARCH 
NATIVE PRODUCERS 
BIOSYNTHETIC PATHWAYS 
DOMAIN-CENTRIC SEARCH 
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Figure 3-8 Workflow of the Homologous Metabolic _Engineering (HoME) approach 
Enzymes mediating biosynthetic pathways of the product of interest in native producers are identified 
and functional analogues are homed in the host organism by i. sequence-based search; ii. Protein 
domain-centric search; and iii. Protein-interaction network search. A functional surrogate pathway is 
reconstructed in the host strain, that now functions like the native producer. The blue arrow in the 
figure indicates re-tuning of the host metabolism. 
Accordingly, we propose an alternative strategy to overcome the limitations posed by 
HeME that entails the recruitment and functional activation of native genes/proteins and their 
assembly into superior metabolic routes for the biosynthesis of products of interest, e.g. fuels 
and chemicals. Since no exogenous gene is recruited to establish the otherwise foreign 
pathway, we have termed this approach Homologous Metabolic ~ngineering (HoME). 
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3.3.1.1. Methodology 
The proposed strategy aims at reconstructing heterologous pathways by homing and 
assembling native functional surrogates. homing: i. Protein-sequence comparative analysis 
(PSCA) using as query the protein known to efficiently mediate the reaction of interest 
against a library of protein sequences from the bacteria of choice by means of Basic Local 
Alignment Search Tool (pBLAST); ii. Domain-centric homology search of the 
aforementioned query using SMART (Quevillon et al., 2005; Schultz et al., 1998) and 
InterProScan (Quevillon et al., 2005) to identify protein similarities across significant 
evolutionary distances using sensitive protein domain profiles. Potential candidates are 
identified by appropriate homology metrics among the best-scoring alignments obtained via 
i. and ii. analyzing them in the context of primary literature and information from genomic 
and metabolic databases. jUnctional assembly: Enzymes identified via homing will be 
assembled expressed into functional pathways in wild-type bacterial hosts, e.g. E. coli by 
directed gene expression. Since the genes proposed as surrogates might also be subjected to 
several levels of regulation, functional expression could also entail manipulating the 
corresponding regulators and blocking competing pathways for common metabolic 
intermediates. The effect of the expression levels of each enzyme in the pathway is also 
considered by using different promoters and RBSs and by evaluating polycistronic and 
individual overexpression of each gene/operon (i.e. individual promoters and RBSs). 
In an effort to lay the foundations of HoME, we have already demonstrated the 
viability of engineering and redirecting the functional differentiation of bacteria by 
harnessing native biosynthetic capabilities. Clostridial ABE fermentation, glycerol 
fermentation to 1,3-PDO, and the yeast homoethanol fermentation were selected as case 
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studies as they represent metabolic capabilities considered unique to organisms that are 
genetically and metabolically distant from E. coli. For all three cases, HeME approaches 
have already been implemented to equip E. coli with the biosynthetic capability of interest 
(Atsumi et al., 2008a; Celinska, 201 0; J?ellomonaco et al., 201 Ob; Inui et al., 2008; Laffend, 
1997; Nakamura and Whited, 2003; Nielsen et al., 2009; Shen and Liao, 2008; Tong et al., 
1991). 
3.3.2. Reconstruction of Acetone-Butanol-Ethanol (ABE) fermentative metabolism 
in Escherichia coli using native pathways 
Industrial microbial fermentations exploiting the biphasic metabolism of Clostridia 
(as described in Section 3.1.2.3) have been among the first large scale bioprocesses to be 
developed for the production of solvents, i.e. n-butanol and acetone (Jones and Woods, 
1986), and butyric acid. Despite the ability of Clostridial metabolism to utilize a broad range 
of carbon sources (monosaccharides, disaccharides, starches, inulin, pectin, whey, and xylan) 
(Nolling et al., 2001), limitations to their industrial use are posed by the tight coupling of 
solventogenesis to regulation of endospore formation (Durre, 2005) and the low product 
yields due to the inevitable formation of byproducts. Although several metabolic engineering 
efforts have been directed to engineering Clostridial metabolism to overcome these 
shortcomings, poor understanding of Clostridial differentiation processes and 
solventogenesis has ignited interest in the development of strains that would combine genetic 
tractability with efficient synthesis of solvents by means of Heterologous Metabolic 
Engineering (HeME) (Atsumi et al., 2008a; Berezina et al., 2010; Dellomonaco et al., 2010b; 
Fischer et al., 2010; Nielsen et al., 2009). 
Butvraldehyde/ Butanol 
Dehydrogenase 
AdhE, FucO, 
YiaY 
Figure 3-9 Acetone-Butanol-Ethanol (ABE) fermentative metabolism reconstructed with 
Escherichia coli native genes 
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Native Clostridial enzymes are reported in blue; E. coli set of functional surrogate enzymes are 
reported in red. Boxes indicate non-native E. coli products. Abbreviations: 2[H] = NADH = FADH2 = 
Hz. 
We selected Escherichia coli as organism of choice and implemented the 
Homologous Metabolic ~ngineering (HoME) methodology described above to engineer 
functional differentiation in E. coli for the synthesis of products typical of the Clostridial 
acetone-butanol-ethanol (ABE) fermentative metabolism, without recruiting any foreign 
genes. 
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3.3.2.1. n-butanol 
n-butanol biosynthesis takes place in a six-step conversion starting from acetyl-CoA 
(Figure 3-9) (Jones and Woods, 1986; Lee et al., 2008b). A thiolase, encoded by thl, catalyzes 
the condensation of two molecules of acetyl-CoA to acetoacetyl-CoA (Stimhemdon et al., 
1995), which is subsequently converted to butyryl-CoA by three enzymes, products of the 
BCS operon: crt, bed, etfAB and hbd coding respectively for crotonase, butyryl-CoA 
dehydrogenase, electron transfer proteins, and 3-hydroxybutyryl-CoA dehydrogenase. Lastly, 
butyryl-CoA is converted to n-butanol in a two-step process catalyzed by a bi-functional 
aldehyde/alcohol dehydrogenase (adhEJ, adhE2). There is evidence that AdhE1 can also 
mediate the conversion of Acetyl-CoA to ethanol. The conversion of butyraldehyde to n-
butanol is also catalyzed with high affinity and specificity by BdhA and BdhB, two different 
n-butanol dehydrogenases present in C. acetobutylicum (Welch et al., 1989). 
Butanol and butyrate are both synthesized via a two-step reaction from butyryl-CoA, 
as shown in Figure 3-9. A set of E. coli enzymes that can act as surrogates of the Clostridial 
pathway mediating the conversion of acetyl-CoA to the common intermediate butyryl-CoA 
(Figure 3-10b) was identified via sequence (Zhang et al., 2010), structure (Altschul et al., 
1997) (Table 3-2) and domain-centric (Quevillon et al., 2005; Schultz et al., 1998) (Table 
3-3) comparisons between the Clostridial enzymes (reported in blue in 10) and those encoded 
in the E. coli genome, along with an analysis of the primary literature and information from 
genomic and metabolic databases. Five E. coli thiolases (AtoB, YqeF, FadA, Fadl and PaaJ) 
exhibited sequence and structure similarity to the C. acetobutylicum acetyl-CoA 
acetyltransferase (ThlA) (Figure 3-10, Table 3-2, Table 3-3). Among all identified 
surrogates, AtoB and Y qeF exhibited the highest similarity to the C. acetobutylicum acetyl-
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CoA acetyltransferase, are classified as biosynthetic acetoacetyl-CoA thiolases (Haapalainen 
et al., 2006) and have higher specificity for short-chain acyl-CoA molecules (Feigenbaum 
and Schulz, 1975; Jenkins and Nunn, 1987a). It is noteworthy that YqeF is a predicted 
acyl transferase of unknown function. 
a. 
Acetyi-CoA 
Thl 11. 
Acetoacetyi-CoA 
b.-1. 
Hbd ~ 2IHI .:..·~H==a:~w:;:~ ! 2. 
3-Hydroxybutyryi-CoA 
Crt 1 3. ton 
Crotonyi-CoA 
d ~ liHI ! 4. 
~~~ry~~-~A J 
I --
1 3. 
I 
- .. 
----- .. 
Figure 3-10 Identification of E. coli functional surrogates mediating the conversion of acetyl-
CoA to butyryl-CoA. 
a . Clostridial enzymatic steps (1. through 4.) mediating the conversion of acetyl-CoA into butyryl-
CoA. Clostridial enzymes are reported in blue. Abbreviations: 2[H] = NADH = FADH2 = H2 • 
b. E. coli functional surrogates identified through sequence-, structure-, and domain-centric homology 
search are reported for each step, as indicated in panel a .. The length of the segments is function of 
the degree of homology between the query and the potential functional surrogates identified in E. coli, 
calculated as average of theE-values reported in Table 3-2 and Table 3-3. 
Three E. coli enzymes were identified as potential surrogates of C. acetobutylicum 3-
hydroxybutyryl-CoA dehydrogenase (Hbd) (Figure 3-1 Ob, Table 3-2, Table 3-3): two 
hydroxyacyl-CoA dehydrogenases (FadB and FadJ), which are involved in the (3-oxidation of 
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fatty acids (Campbell et al., 2003; Clark and Cronan, 2005), and a 3-hydroxyadipyl-CoA 
dehydrogenase (PaaH) that participates in the degradation of phenylacetate (Teufel et al., 
2010). While involved in degradative pathways, these three enzymes catalyze reversible 
reactions and hence were considered viable substitutes of the Clostridial enzyme. 
Four members of the enoyl-CoA hydratase family were chosen among the identified 
surrogates for the Clostridial 3-hydroxybutyryl-CoA dehydratase (Crt), given their high 
structural and sequence similarities (Figure 3-10, Table 3-2, Table 3-3): aerobic (FadB) and 
anaerobic (FadJ) enoyl-CoA hydratases that participate in the P-oxidation of fatty acids 
(Clark and Cronan, 2005), a 2,3-dehydroadipyl-CoA hydratase (PaaF) involved in 
pheylacetate degradation (Teufel et al., 2010), and a crotonobetainyl-CoA hydratase (CaiD) 
involved in camitine degradation (Elssner et al., 2001). Along with FadA, FadB forms the 
fatty acid oxidation complex that also exhibits 3-hydroxyacyl-CoA epimerase and 3-
hydroxyacyl-CoA dehydrogenase activities (Dirusso, 1990; Yang et al., 1988). FadJ (YfcX) 
is a paralog of FadB that bears 3-hydroxyacyl-CoA dehydrogenase activity and has been 
found strongly involved in the anaerobic degradation of long and medium-chain fatty acids in 
the presence of nitrate (Snell et al., 2002), and weakly involved in the aerobic degradation of 
long-chain fatty acids (Campbell et al., 2003). Despite the primary role of these enzymes in 
degradative pathways, the reversible nature of this reaction indicates that they can catalyze 
the dehydration of hydroxyacyl-CoAs. 
Four potential surrogates were identified for the enzyme catalyzing the fourth step of 
the n-butanol synthesis ~athway (butyryl-CoA dehydrogenase) (Figure 3-10, Table 3-2, 
Table 3-3): an acyl-CoA dehydrogenase (FadE), which is involved in the catabolism of fatty 
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acids (Campbell and Cronan, 2002; Clark and Cronan, 2005), a crotonobetainyl-CoA 
reductase (CaiA) that mediates camitine degradation (Elssner et al., 2001), an isovaleryl-CoA 
dehydrogenase (AidB) involved in the adaptive DNA-repair response of E. coli to alkylating 
agents (Rohankhedkar et al., 2006), and a predicted acyl-CoA dehydrogenase (Y diO). The 
butyryl-CoA complex of Clostridia is associated to an electron transfer protein consisting of 
two subunits (EtfAB) and responsible for coupling the reduction of ferredoxin (Fd) to the 
reduction of crotonyl-CoA to butyryl-CoA (Bennett and Rudolph, 1995). While the 
sequence-based search did not return any match, the two subunits of the electron transfer 
protein, EtfA and EtfB, share homologous domains (Table 3-3) with Y diR and Y diQ, 
predicted to be subunits of a flavoprotein (Campbell et al., 2003). 
The last two steps in the n-butanol pathway involve the sequential reduction of 
butyryl-CoA to butyraldehyde to n-butanol, which in Clostridia are catalyzed by 
butyraldehyde and butanol dehydrogenases (BdhA, BdhB, Adh1, Adh2) (Figure 3-9) (Lee et 
al., 2008b ). The sequence and structural analysis suggested twelve potential E. coli 
surrogates: one bifunctional aldehyde/alcohol dehydrogenase (AdhE), two aldehyde 
dehydrogenases (MhpF and GapA) and five alcohol dehydrogenases (FucO, YiaY, EutG, 
YqhD, YbdH). (Table 3-2, Table 3-3). Among them, we selected FucO due to its higher 
structure and sequence similarity to the Clostridial enzymes and its kinetic properties 
(Sophos and Vasiliou, 2003), which in tum should favor the synthesis ofn-butanol. 
Many of the enzymes proposed above as E. coli functional surrogates for the first four 
steps of the Clostridial n-butanol pathway are involved in catabolic functions that mediate the 
degradation of fatty acids (FadB, FadJ, FadE, AtoB) (Clark and Cronan, 2005), pheny1acetate 
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(PaaH, PaaF) {Teufel et al., 2010), and carnitine (CaiA, CaiD) (Eichler et al., 1994) at their 
expression is regulated both locally and globally (Figure 3-1 0). 
These reactions can mediate the conversion of acetyl-CoA to butyryl-CoA. Since the 
same set of CoA thioesters intermediates are used in both the Clostridial pathway and the E. 
coli fatty acid degradation pathway, catalyzed by the products of the fad operon, we 
exploited the fatty acid catabolic route to generate butyryl-CoA, which can be acted upon by 
appropriate aldehyde/alcohol dehydrogenases to generate n-butanol. In an attempt to promote 
the conversion of acetyl-CoA ton-butanol exploiting the aforementioned steps we diverted 
carbon to butanol synthesis at the acetyl-CoA node by disrupting the E. coli adhE gene. To 
investigate further competition for the acetyl-CoA we also overexpressed atoB in the strain 
MG 1655 !l.adhE but observed no butanol biosynthesis (Figure 3-11 ). However, expression of 
genes encoded within the fad operon is subjected to local regulation exerted by FadR 
(Section 2.1.1 ). In order to attain constitutive expression of the fatty acid catabolic pathway 
mutations were introduced in the FadR regulator (Dellomonaco et al., 2010b); pathways 
leading to synthesis of byproducts (ethanol, acetate, and lactate) were also blocked in strain 
MG 1655 fadR. Butanol biosynthesis up to 277 mg r1 (Figure 3-11) was observed when the E. 
coli putative acetyl-CoA acetyltransferase Y qeF was overexpressed in combination with the 
predicted alcohol dehydrogenase FucO in strain MG 1655 !l.adhE !l.ackA.pta !l.frdA !l.ldhA 
fadR. However, overexpression of FucO also contributed to ethanol biosynthesis up to 150 
mg r1 (Figure 3-11), which was the main byproduct along with pyruvic acid (210 mg r1) 
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Figure 3-11 Synthesis of n-butanol using Escherichia coli native genes identified via sequence-
based and domain-centric analyses 
Gene overexpressions and deletions are indicated by "+" and "fl.", respectively, next to the 
corresponding genes. Experiments were run at 37 oc for 48 hours in shake flasks using glucose (2% 
w/v) minimal medium. 
3.3.2.2. Butyrate 
Butyrate is produced in Clostridia during the acidogenic phase; a two-step reaction 
catalyzed by the phosphotransbutylase (Ptb) and the butyrate kinase (Buk) mediates the 
conversion of butyryl-CoA to butyrate with the intermediate formation of butyryl-phosphate 
(Figure 3-12). 
Butyryi-CoA 
Phospho:~:sbutvlase J 
Pta, EutD 
Butyryi-P 
Buk ATPi 
Butyrate Kinase 
AckA, TdcD 
c::~~!i~~~~:J 
Acetate 
Cat3 
Butyryl coenzyme A 
(Co A) :acetate-CoA 
transferase 
ScpC 
Acetyi-CoA 
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Figure 3-12 Escherichia coli surrogate pathway for the clost ·dial butyrate biosynthesis. 
Native Clostridial enzymes are reported in blue; E. coli set of functional surrogate enzymes are 
reported in red. 
An avenue alternative to this has however been recently elucidated in Clostridium 
kluyveri, where butyryl CoA is exchanged with acetate to yield acetyl-CoA and butyrate 
(Seedorf et al., 2008) (Figure 3-12). 
Homology search of functional homologues based on protein sequence comparison 
has identified EutD and Pta as possible candidates for the phosphotransbutylase reaction 
(Figure 3-12) (Table 3-2). The EutD and Pta are both E. coli proteins characterized by 
phosphate-acetyltransferase activity (Bologna et al., 2010; Campos-Bermudez et al., 2010) 
and responsible for the conversion of acetyl-CoA to acetyl-phosphate. EutD has higher 
specificity for acetyl-CoA than Pta and it is therefore hypothesized to be a more efficient 
phosphotransacetylase than Pta in catalyzing the reaction to acetyl-phosphate (Bologna et al., 
2010; Campos-Bermudez et al., 2010). 
The second step in the butyrate biosynthesis consists in the conversion of butyryl-
phosphate to butyrate, which in Clostridia is catalyzed by the butyrate kinase (Buk) (Figure 
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3-12) (Lee et al., 2008b). The sequence and structural analysis suggested two potential E. coli 
surrogates: TdcD and AckA. The E. coli enzymes TdcD (YhaA) and AckA are characterized 
by both propionate and acetate kinase activity (Hesslinger et al., 1998), although a higher 
specificity for propionyl-phosphate has been measured for TdcD (Hesslinger et al., 1998), 
suggesting a longer-chain specificity. 
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Figure 3-13 Butyrate biosynthesis using Escherichia coli functional surrogates identified via 
sequence-based and domain-centric analyses. Gene overexpressions and deletions are indicated by 
"+" and"!;,.", respectively, next to the corresponding genes. 
Since butyryl-CoA is a common intermediate of both n-butanol and butyrate, 
accumulation of this intermediate was achieved by implementing a metabolic engineering 
strategy analogous to what was reported in Section 3.3 .2.1. Constitutive expression of the fad 
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regulon was achieved b . d . . 
y mtro ucmg mutatiOns in the I I 
oca regulator FadR (D II 
al., 201 Ob ). e omonaco et 
The two-step pathway mediating the 
conversion of butyryl-CoA t b 
overexpressed in the engineered E. 
o utyrate was 
coli strain MG1655 L\adhE L\ldh" A k . 
. n LlGC A.pta fadR, Ill 
whtch competing pathways for the acetyl-CoA 
pool had been deleted, along with an 
alternative native E. coli thiolase (YqeF) 0 . 
. verexpresswn of EutD-AckA resulted in the 
production of acetate as the main fermentation product, along with the synthesis of 23 mg r' 
of butyrate (Figure 3-13). However, when TdcD was expressed t"n E c 1· · b" · 
. o 1 m com matwn 
with EutD, butyrate biosynthesis up to 185 mg r' was observed (Figure 3-13), in agreement 
with the higher specificity of TdcD for longer chain acy1-CoA phosphate intermediates 
(Hesslinger et al., 1998). 
3.3.2.3. Acetone 
Clostridial acetone biosynthesis from acetoacetyl-CoA is a two-step pathway 
catalyzed by the enzymes CoA-transferase, and acetoacetate decarboxylase, as reported in 
Figure 3-9. In Clostridium acetobutylicurn the acetate and butyrate produced during the 
acidogenic phase is coupled to the production of acetone via the acetate(butyrate )-
acetoacetate CoA-transferase complex (CoAT) (Andersch et al., 1983) as a detoxification 
mechanism to reduce the inhibitory effects of acids accumulation on cell growth. The Co-A 
transferase acts by converting the carboxylic acids to the respective CoA thioester 
intermediate at the expense of the CoA intermediate of another species of carboxylic acid 
(Figure 3-9). By doing so, the action of the Co-A transferase results energetically favorable 
since it transfers the energy from a thioester to an acid without expenditure of A TP 
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(Hartmanis and Gatenbeck, 1984). The CoA transferase complex appears to be a tetramer 
composed by two subunits, encoded by ctfA and ctjB, respectively (Cary et al., 1990). 
The E. coli enzymes AtoD and AtoA were identified via sequence- and structure-
based search as highly homologous (76% and 72%, respectively) to the Clostridial CoAT 
subunits CtfA and CtfB (Table 3-2). Both enzymes are encoded within the E. coli atoDABE 
operon and are involved in the catabolism of short-chain fatty acids (Jenkins and Nunn, 
1987a). AtoD and AtoA are two subunits of a protein complex characterized by acetyl-
CoA:acetoacetyl-CoA transferase activity that mediates the activation of short chain fatty 
acids to their respective thioesters (Jenkins and Nunn, 1987a). The in silica analysis also 
identified Y diF (Reed et al., 2003) as a potential functional surrogate. The Y diF protein from 
Escherichia coli belongs to a large sequence family of CoA transferases, present in bacteria 
to humans, which utilize oxoacids as acceptors (Rangarajan et al., 2005). Y diF is organized 
into tetramers, with each monomer having an open alpha/beta structure characteristic of 
Family I CoA transferases and it displays enzymatic activity with short-chain acyl-CoAs 
(Rangarajan et al., 2005). 
The last step in the acetone pathway involves the decarboxylation of acetoacetyl-CoA 
to acetone, which in Clostridia is catalyzed by the acetoacetate decarboxylase (Adc). The 
homology search based on protein sequence, structure, and domain organization similarity, 
has in this case not identified any potential candidate (Table 3-2, Table 3-3). This result is 
further supported by a taxonomic analysis of phylogeny conducted to assess the distribution 
of enzymes with acetoacetate decarboxylase activity in the y-Proteobacteria class, according 
to which this activity has not been detected to date in E. coli species, as reported in Figure 
96 
3-14. However, an alternative possibility would be that other known native E. coli 
decarboxylases could act on the acetoacetyl-CoA intermediate. 
(1) 
Figure 3-14 Taxonomic distribution of the acetoacetate decarboxylase in the class of y-
Proteobacteria based on currently annotated protein sequences 
(UniProt, www .uniprot.org (Bairoch et al., 2005) 
Han and coworkers (Han, 2011) have however recently demonstrated the feasibility 
of synthesizing acetone in Clostridial strains in which the adc gene was disrupted. They 
propose a non-enzymatic decarboxylative mechanism based on the hypothesis that the 
carbon-carbon bond breakage in acetoacetate that results in release of C02 would be 
facilitated by conditions that make the ~-carbonyl group a better electron sink, like for 
example, the low pH environment created during acidogenesis (Han, 2011 ). 
In an attempt to promote the conversion of acetoacetyl-CoA to acetone based on the 
considerations stated above, we blocked enzymes involved in the synthesis of by-products 
competing for the acetyl-CoA pool like ethanol (adhE), lactate (ldhA) and acetate (ackA.pta) 
and we overexpressed the E. coli acetyl-CoA:acetoacetyl-CoA transferase complex (AtoDA) 
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along with the thiolase identified above for the n-butanol synthesis (AtoB). However, no 
acetone was produced under these conditions (Figure 3 12a). 
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Figure 3-15 Biosynthesis of acetone using Escherichia coli functional surrogates 
a. Synthesis of acetone using native genes identified via sequence-based and domain-centric analyses. 
Gene overexpressions and deletions are indicated by "+" and "1:1", respectively, next to the 
corresponding genes. 
b. Acetone synthesis in strain MG 1655 !:ladhE !:lldhA !:lackA.pta [atoB+ atoDA+] is reported for 
different pH. An initial OD550 of approximately 2 was used. Cultures were run at 37°C for 24h in 
MOPS minimal medium+ glucose 20 gl" 1 +acetate lgl"1• 
Thus, we reasoned that the synthesis of acetone could have been limited by the low 
levels of acetate, a metabolite required in the second step of the acetone pathway from acetyl-
Co A (Figure 3-9). In agreement with this hypothesis, supplementation of the growth medium 
with acetate resulted in acetone production up to 43 mg 1-1 (Figure 3-15a). Acetone synthesis 
in Clostridia is synthesized, as mentioned above, during solventogenesis, a metabolic phase 
postulated to be induced by the low pH environment. Based on this observation, we 
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hypothesized that pH might influence activity of the acetone biosynthetic pathway and/or 
enhance the non-enzymatic decarboxylation of acetoacetate, as recently demonstrated by 
studies conducted in vitro by Han and coworkers (Han, 2011). A range of different pH was 
therefore explored (Figure 3-15) to simulate the low pH environment created by acidogenesis 
in Clostridia. In agreement with our hypothesis, acetone synthesis was enhanced by low pH 
conditions, returning titers up to 420 mg r1 (Figure 3-15b ). Although acetone production had 
been previously demonstrated in E. coli by heterologous expression of the Clostridial 
pathway (Bermejo et al., 1998; Dellomonaco et al., 2010b), this work represents the first 
report of acetone synthesis in E. coli using solely native genes. 
Table 3-2 Identification of Escherichia coli surrogates for Acetone-Butanol-Ethanol metabolism· via sequence-based 
comparative analysis 
Source of gene sequences used to identify E. coli surrogates Surrogates identified via Surrogates identified via protein pBLAST 1-TASSER(Roy et al., 2010) (Altschul et al., 1997) 
Organism Accession Protein E.C.# Function E.C.# TM- EC- Protein E.C.# Protein E- Identity Similarity # Score" Scorelo value' 
Identification of E. coli s11rrogates for the biosynthesis of ABE intermediates 
Clostridium P45359 ThiA 2.3.1.9 Acetyi-CoA 2.3.1.9 0.9872 3.4125 AtoB 2.3.1.9 YqeF 7E-133 56% 76% 
acetobutylicum C-acetyltransferase 
YqeF 2.3.1.9 AtoB 5E-128 61% 74% 
2.3.1.16 0.9108 2.4499 FadA 2.3.1.174 PaaJ 6E-91 45% 63% 
Fadl 2.3.1.16 FadA 1E-72 40% 60% 
2.3.1.16 Fadl 5E-51 33% 52% 
Clostridium P52041 Hbd 1.1.1.15 3-hydroxybutyryl- 1.1.1.35 0.9424 2.5506 FadB 1.1.1.157 PaaH 4E-67 44% 64% 
acetobutylicum 7 CoA dehydrogenase 
FadJ 1.1.1.35 FadJ 2E-43 37% 57% 
1.1.1.35 FadB 2E-40 36% 55% 
Clostridium P52046 Crt 4.2.1.55 3-hydroxybutyryl- 4.2.1.17 0.9552 2.4493 FadB 4.2. 1.17 PaaF 4E-47 37% 63% 
acetobutylicum CoA dehydratase 
FadJ 4.2.1.- CaiD 7E-39 35% 56% 
PaaF 4.2.1.17 FadB 9E-33 36% 61% 
PaaG 4.1.3.36 MenB 6E-30 31% 50% 
4.2.1.17 FadJ 4E-29 35% 59% 
Clostridium P52042 Bed 1.3.99.2 Butyryl-CoA 1.3.99.10 0.9778 2.4998 AidB 1.3.99- CaiA 9E-43 28% 47% 
acetobutylicum dehydrogenase 
1.3.99.3 0.9724 2.4449 FadE n.d. YdiO 2E-41 30% 48% 
1.3.99- FadE 4E-15 30% 53% 
Clostridium P52039 EtfA 1.5.5.1 Electron transfer d d d d 1.5.5.1 YdiR 7E-31 30% 53% 
acetobutylicum tlavoprotein subunit - - - -
1.5.5.1 FixB 7E-26 31% 49% 
Clostridium P52040 Etffi 1.5.5.1 Electron transfer d d d d 1.5.5.1 YdiQ 2E-21 30% 48% 
acetobutylicum tlavoprotein subunit - - - -
1.5.5.1 FixA IE-18 32% 51% 
- ----- ------------ ------ --------------
Identification of E. coli surrogates for solventogenesis 
BUTANOL 
Clostridium P33744 AdhE 1.1.1.1. Aldehyde-alcohol d d d d I. 1.1.1. AdhE 0.0 56% 75% 
acetobutylicum 1.2. 1.10 dehydrogenase - - - - 1.2. 1.10 
Clostridium NADH-dependent 
saccharobutylicum(Berez Pl3604 Adhl 1.1.1.- butanol 1.1.1.77 0.9404 2.2424 FucO I. 1.1.1. AdhE 2E-91 42% 62% 
ina et al., 2009) dehydrogenase 
1.1.1.1. 0.8679 1.8069 YiaY 1.1.1.77 FucO 5E-66 35% 58% 
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I 
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AdhE 1.1.1.- YiaY 2E-65 37% 56% 
AdhP 1.1.-.- EutG 4E-61 35% 54% 
FrmA 1.1.1.- YqhD 6E-28 25% 46% 
1.1.1.6 0.7979 1.4449 GldA 
Pseudomonas sp. strain Acetaldehyde CF600(Powlowski et al., Q52060 DmpF 1.2.1.10 dehydrogenase 1.2.1.12 0.7439 1.3969 Gap A 1.2.1.10 MhpF 6E-146 79% 92% 1993) 
Clostridium NADH-dependent Q04944 BdhA 1.1.1.- butanol 1.1.1.77 0.9072 1.7913 FucO 1.1.1.- YqhD 3E-68 36% 55% acetobutylicum dehydrogenase 
1.1.1.1 0.8465 1.7242 YiaY 1.1.1.- YiaY IE-32 26% 46% 
AdhE 1.1.-.- EutG 5E-27 27% 42% 
AdhP 1.1.1.77 FucO 7E-27 26% 46% 
FrmA 1.1.1.1. AdhE IOE-24 24% 45% 
1.1.1.6 0.7761 1.4418 GldA ' 
Clostridium 
NADH-dependent 
Q04945 BdhB 1.1.1.- butanol 1.1.1.77 0.9039 1.7305 FucO 1.1.1.- YqhD 4E-69 39% 57% ac:etobutylicum dehydrogenase 
1.1.1.1 0.8443 1.7044 YiaY 1.1.1.- YiaY 9E-30 26% 44% 
AdhE 1.1.1.77 FucO 4E-25 26% 44% 
AdhP 1.1.-.- EutG IE-22 27% 42% 
FrmA 1.1.1.1. AdhE 7E-18 22% 44% 
1.1.1.6 0.7747 1.4652 GldA 
ACETONE 
Clostridium Butyrate-P33752 CtfA 2.8.3.9 acetoacetate Co A- 2.8.3.8 0.9817 2.8995 AtoD 2.8.3.8 AtoD 5E-62 47% 76% ac:etobutylicum transferase subunit 
2.8.3.8 YdiF 4E-09 21% 41% 
Clostridium Butyrate- d d d P23673 Ctffi 2.8.3.9 acetoacetate CoA- -d - - - 2.8.3.8 A to A 2E-63 54% 72% 
ac:etobutylicum transferase subunit 
ldentificution of E. coli surrogates for ucetogenesis 
BUTYRATE 
Clostridium P58255 Ptb 2.3.1.19 Phosphate 2.3.1.8 0.9617 2.0729 Pta 2.3.1.8 EutD 3E-15 26% 45% ac:etobutylicum butyryl transferase 
2.3.1.8 Pta 6E-JI 24% 44% 
Clostridium Q45829 Buk 2.7.2.7 Butyrate kinase 2.7.2.1 0.9628 1.8007 AckA 2.7.2.15 TdcD 2E-09 25% 48% acetobutylic:um 
2.7.2.15 0.9637 1.6866 TdcD 2.7.2.1 AckA 3E-09 28% 50% 
Clostridium Butyryl-
I 
kluyveri( Seedorf et al., A5N390 Cat3 2.8.3.8 CoA:acetate CoA 4.1.3.6 0.7651 1.4438 CitE 2.8.3.- ScpC 4E-17 24% 44% 
2008) transferase 
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• The Template Modeling-score (TM-score) is defined to assess the topological similarity of protein structure pairs. Its value ranges between 0 and I, and a higher score indicates 
better structural match. Statistically, a TM-score < 0.17 means a randomly selected protein pair with the gapless alignment taken from PDB (Roy et al., 2010). 
h An EC-score > 1.1 is a good indicator of the functional similarity between the query and the identified enzyme analogs (Roy et al., 2010). 
c The BLAST E-value measures the statistical significance threshold for reporting protein sequence matches against the organism genome database; the default threshold value is IE-5, 
in which IE-5 matches would be expected to occur by chance, according to the stochastic model of Karlin and Altschul (http://www.ncbi.nlm.nih.gov/BLAST/tutoria!J). 
d Result not significant because ofTM-score<O.l7 and/or EC-score<l.l (Roy et al., 2010) 
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Table 3·3 Identification of Escherichia coli surrogates for Acetone-Butanol-Ethanol metabolism via domain/motif recognition-based 
comparative analysis 
Source of gene sequences used to identify E. coli surrogates Surrogates Identified via domain organization and composition (SMART(Scbultz et al., 1998), lnterProScan (Quevillon et al. 2005)) 
Organism Accession Protein E.C.# 
Pfam(Finn 
# Fundion Domain et al., 2010) Begin End E-value• Protein Aeeession # 
Clostridium P45359 ThlA 2.3.1.9 Acetyl-CoA Thiolase, N-tenninal domain PF00108 1 262 8.20E-116 PaaJ 
acetobutylicum C-acetyltransferase 
FadA 
AtoB 
YqeF 
Thiolase, C-terminal domain PF02803 269 391 6.50E-52 FabH 
FadA 
Fadl 
Clostridium 1.1.1.15 3-hydroxybutyryl-CoA 3-hydroxyacyl-CoA 
acetobutylicum P52041 Hbd 7 dehydrogenase dehydrogenase, NAD binding PF02737 3 182 7.20E-66 PaaC domain 
FadB 
FadJ 
3-hydroxyacyl-CoA PF00725 184 280 4.10E-35 
dehydrogenase, C-terminal PaaC 
domain 
FadB 
FadJ 
Clostridium P52046 Crt 4.2.1.55 3-hydroxybutyryl-CoA Enoyl-CoA PF00378 IS 184 1.40E-54 MmcD 
acetobutylicum dehydratase hydratase/isomerase family 
PaaF 
PaaG 
Clostridium P52042 Bed 1.3.99.2 Butyryl-CoA Acyl-CoA dehydrogenase, N- PF02771 6 118 3.20E-33 CaiA acetubutylicum dehydrogenase terminal domain 
Acyl-CoA dehydrogenase, PF02770 122 173 1.70E-15 CaiA middle domain 
Acyl-CoA dehydrogenase, C- PF00441 229 378 4.10E-46 CaiA terminal domain 
Clostridium P52039 Etti\ 1.5.5.1 Electron transfer Electron transfer flavoprotein PFOIOI2 9 200 9.33E-61 YdiR acetubutylicum flavoprotein subunit domain 
Electron transfer flavoprotein PF00766 210 295 3.90E-35 YdiR FAD-bindin2 domain 
Clostridium P52040 Etffi 1.5.5. Electron transfer Electron transfer flavoprotein PFOI012 22 211 2.89E-66 YdiQ 
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acetobutylicum flavoprotein subunit domain 
Identification of E. coli surrogates for solventogenesis 
BUTANOL 
Clostridium P33744 AdhE 1.1.1.1 Aldehyde-alcohol Aldehyde dehydrogenase PF00171 I 406 
acetobutylicum 1.2.1.1 0 dehydrogenase 6.10E-15 AdhE 
Iron-containing alcohol PF00465 455 850 9.90E-91 AdhE dehydrogenase 
Clostridium NADH-dependent Iron-containing alcohol 
saccharobutylicum(Bere Pl3604 Adhl 1.1.1.- PF00465 7 373 9E-114 Adh2 
zina et al., 2009) butanol dehydrogenase dehydrogenase 
YbdH 
EutG 
YqhD 
Pseudomonas sp. strain Acetaldehyde Semialdehyde CF600(Powlowski et al., Q52060 DmpF 1.2.1.10 dehydrogenase dehydrogenase, NAD binding PFOIII8 6 124 1.32E-10 AdhE 1993) domain 
' 
Prokaryotic acetaldehyde PF09290 132 285 1.50E-63 AdhE dehydrog_enase, dimerisation 
Clostridium NADH-dependent Iron-containing alcohol 
acetobutylicum(Wa!ter Q04944 BdhA 1.1.1.- PF00465 9 381 3.40E-98 Adh2 
et al., 1992) butanol dehydrogenase dehydrogenase 
YbdH 
EutG 
YqhD 
Clostridium Q04945 BdhB 1.1.1.- NADH-dependent Iron-containing alcohol PF00465 9 381 7.40E-95 
acetobutylicum butanol dehydrogenase dehydrogenase Adh2 
YbdH 
EutG 
YqhD 
ACETONE 
Clostridium P33752 CtfA 2.8.3.9 Butyrate-acetoacetate Coenzyme A transferase PF01144 5 216 1.69E-58 YdiF acetobutylicum CoA-transferase subunit 
A toO 
AtoA 
Clostridium P23673 CttB 2.8.3.9 Butyrate-acetoacetate Coenzyme A transferase PF01144 10 205 2.00E-51 YdiF acetobutylicum C oA -transferase subunit 
A toO 
AtoA 
Clostridium P23670 Adc 4.1.1.4 Acetoacetate Acetoacetate decarboxylase PF06314 II 243 8.10E-72 acetobutylicum decarboxylase -
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ldentijicution of E. coli s11rrogutes jor 11cetogenesis 
BUTYRATE 
Clostridium P58255 Ptb 
acetobutylicum 
Clostridium Q45829 Buk 
acetobutvlicum 
Clostridium kluyveri A5N390 Cat3 (Seedorf eta!., 2008) 
2.3.1.19 Phosphate butyryl transferase 
2.7.2.7 Butyrate kinase 
Butyryi-CoA:acetate 2.8.3.8 CoA transferase 
Phosphate acetyllbutaryl PF01515 56 295 3.70E-09 
-transferase 
Acetokinase tamily PF00871 3 354 4.40E-80 TdcD 
Acetyl-CoA 
hydrolase/transferase N- PF02550 6 192 1.40E-23 ScpC 
terminal domain 
a TheE-value measures the statistical significance threshold for reporting protein domain matches against the organism proteome database; the default threshold value is IE-5, in 
which IE-5 matches would be expected to occur by chance 
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3.3.1. Homoethanolic fermentation 
While E. coli has been extensively exploited for bioconversions due to its fast 
growth under both anaerobic and aerobic conditions, and the high glycolytic flux it can 
sustain, it is not regarded as optimal for ethanol production because of the low yield it 
can achieve when compared to yeast strains or Zymomonas spp. Ethanol yield is poor 
because under fermentative conditions E. coli also produces lactic, acetic, formic, and 
succinic acids (Section 3.1.2.2). Homoethanol fermentation in E. coli is hindered by 
redox imbalance. The pathway to ethanol starts from pyruvate, which is cleaved into 
acetyl-CoA and formic acid by pyruvate formate lyase (PFL) (Figure 3-16). Reduction of 
acetyl-CoA to ethanol proceeds in two steps through acetaldehyde as intermediate; the 
multienzyme protein AdhE plays the role of acetaldehyde dehydrogenase and alcohol 
dehydrogenase, each requiring one NADH (Figure 3-16). Thus, on a triose basis the 
pathway from pyruvate to ethanol consumes two NADH, while glycolysis to pyruvate 
only provides one NADH (in conversion of glyceraledehyde-3-P to 1,3-
bisphosphoglycerate ). Therefore, ethanol production is balanced by other more oxidized 
products such as acetic acid (no NADH consumed). To circumvent the redox limitation 
of the endogenous ethanol pathway, pyruvate decarboxylase (PDC) and alcohol 
dehydrogenase (ADH) enzymes from Z. mobilis have been expressed in E. coli, via a 
plasmid bearing an artificial pet (production of ethanol) operon containing the pdc and 
adhB genes (Ingram et al., 1998). The transformation has conferred homoethanol 
pathway, with ethanol accounting for 95% of the fermentation products. Also, redox 
balance is possible in the heterologous pathway because conversion of pyruvate to 
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acetaldehyde and C02 by PDC is non-oxidative, requ1nng only one NADH for the 
reduction of acetaldehyde to ethanol (Figure 3-16). 
Pdcl (S. cerevisiae) 
Pdc (Z. mobilis} 
llvG, llvB, llvl 
Adh (Z. mobilis) 
Pyruvate 
co, • 2(11 .-u-. Format 
Acety -CoA 
rJ(II) 
Ace ardehyde 
Alc;ohol dehvcJroeenase 
YiaY, Fuco 
rz~ 
,------- -- ---, 
: A l : !.,. _______ .., ____ ,! 
-co~ 2[HJ 
Figure 3-16 Homoethanolic fermentation engineered in Escherichia coli 
Reactions engineered are reported in red. Enzymes from native producers (S. cerevisiae, Z. 
mobilis) are reported in blue , while E. coli potential functional surrogates are reported in red. 
Abbreviations: 2[H] = NADH = FADH2 = H2 
The HoME methodology was implemented to identify functional surrogates of the 
non-oxidative pyruvate decarboxylation and hence establish a homoethanologenic 
metabolic mode in E. coli. Sequence-, structure- (Table 3-4), and domain-centric (Table 
3-5) homology search for the S. cerevisiae and Z. mobilis pyruvate decarboxylase 
consistently identified three E. coli functional surrogates, IlvG, IlvB, and Ilvl. The 
products of the genes ilvG, ivlB and ilvl have been identified as distinct isoforms of the 
acetolactate synthase (Vyazmensky et al., 2009) , known to have different catalytic 
properties and used for the biosynthesis of the amino acids isoleucine and valine. 11 vG is 
however not expressed in E. coli K-12 due to a frameshift mutation (Lawther et al. , 
1982). In silica analysis of the dhaB gene product from Zymomonas mobilis has 
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identified the hypothetical proteins Yiay and Y qhD, along with the lactaldehyde 
reductase FucO as E. coli enzymes that could potentially catalyze the conversion of 
acetaldehyde to ethanol with high specificity and efficiency. 
While a metabolic engineering strategy to establish a homoethanologenic 
fermentative metabolism in E. coli has been already devised, we are currently designing 
the experimental framework to support its viability. 
Table 3-4 Identification of Escherichia coli surrogates for homo-ethanologenic metabolism via sequence-based comparative analysis 
Surrogates identified via Surrogates identified via protein pBLAST Source of gene sequences used to identify E. coli surrogates 1-TASSER(Rov et al. 2010) (Altschul et al. 1997) 
Accession TM- EC- E-E.C.I# Protein E.C.I# Protein Identity Similarity 
1 
Organism Protein E.C.I# Fundion Score• Scoreh value' I# 
-~ 
Identijicution of E. coli surrogutes for the biosynthesis of ABE intermediutes 
Saccharomyces Pyruvate d d d P06169 Pdcl 4.1.1.1 decarboxylase 
- - -
d 
- 2.2.1.6 IlvG lE-15 22% 38% cerevisiae isozyme I 
2.2.1.6 IlvB 2E-l5 21% 41% 
2.2.1.6 Ilvl 2E-l4 22% 40% 
Zymvmonas mobilis P06672 Pdc 4.1.1.1 Pyruvate -d -d -d -d 2.2.1.6 PoxB IE-14 21% I decarboxylase 41% 
2.2.1.6 IlvB 3E-l3 25% 41% 
I 2.2.1.6 IlvG 4E-l3 21% 38% 2.2.1.6 Ilvl IE-12 21% 39% 
Zymomonas mobilis P06758 AdhB 1.1.1.1 Alcohol 1.1.1.77 0.9624 2.6598 Fuca YiaY 6E-l44 I dehydrogenase - 63% 77% 
1.1.1.77 Fuca 2E-87 43% 63% 
I 1.1.-.- EutG 4E-63 37% 55% 1.1.1.1 AdhE IE-52 33% 54% 
~ 
The Template Modeling-score (TM-score) is defined to assess the topological similarity of protein structure pairs. Its value ranges between 0 and 1, and a higher score indicates 
better structural match. Statistically, a TM-score < 0.17 means a randomly selected protein pair with the gap less alignment taken from PDB (Roy et al., 201 O). 
h An EC-score > 1.1 is a good indicator of the functional similarity between the query and the identified enzyme analogs (Roy et al., 2010). 
c The BLAST E-va1ue measures the statistical significance threshold for reporting protein sequence matches against the organism genome database; the default threshold value is IE-5 
in which 1E-5 matches would be expected to occur by chance, according to the stochastic model of Karlin and Altschul (http://www.ncbi.nlm.nih.gov/BLAST/tutorialD. ' 
d Result not significant because ofTM-score<0.17 and/or EC-score<l.l (Roy et al., 2010) 
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Table 3-S Identification of Escherichia coli surrogates for homo-ethanologenic metabolism via sequence-based comparative analysis 
Source of gene sequences used to identify E. coli surrogates Surrogates identified via domain organization and composition (SMART (Schultz et al., 1998), 
InterProScan (Quevillon et al. 2005)) 
Organism Accession Protein E.C.# Function 
Pfam(Finn 
# Domain et al., 2010) Begin End E-value• Protein Accession# 
Saccharomyces Pyruvate decarboxylase N-terminal TPP binding P06169 Pdc1 4.1.1.1 domain PF02776 4 180 2.30E-31 llvG cerevisiae isozyme 1 
Ilvl 
PoxB 
llvB 
TPP, central domain PF00205 201 340 1.60E-33 IlvG 
llvl 
PoxB 
llvB 
C-terminal TPP binding 
PF02775 387 527 I.JOE-10 llvG domain 
llvl 
PoxB 
llvB 
N-terminal TPP binding 
Zymomonas mobilis P06672 Pdc 4.1.1.1 Pyruvate decarboxylase domain PF02776 3 179 l.IOE-29 llvG 
llvl 
PoxB 
llvB 
TPP, central domain PF00205 199 360 l.IOE-14 IlvG 
Ilvl 
PoxB 
llvB 
C-terminal TPP binding 
PF02775 387 537 2.10E-17 llvG domain 
llvl 
PoxB 
llvB 
Zymomonas mobilis P06758 AdhB 1.1.1.1 Alcohol dehydrogenase Iron-containing alcohol PF00465 10 375 l.IOE-117 Adh2 dehydrogenase 
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3.3.2. Glycerol fermentation to 1,3-propanediol 
Fermentative metabolism of glycerol has been investigated in great detail in 
several species of the Enterobacteriaceae family, such as Citrobacter .freundii and 
Klebsiella pneumonia as its dissimilation in these organisms is strictly linked to their 
capacity to synthesize the highly reduced product 1,3-propanediol (1,3-PDO) (Bouvet et 
al., 1995). Although it has recently been demonstrated that Escherichia coli is able to 
utilize glycerol fermentatively (Gonzalez et al., 2008), its anaerobic dissimilation has 
been demonstrated associated to the production of two alternative reduced products, 
ethanol and 1,2-propanediol (Gonzalez et al., 2008). 
In this study we have implemented the HoME methodology to the identification 
and functional expression of an E. coli homologous pathway for the synthesis of 1 ,3-PDQ 
from glycerol. The conversion of glycerol to 1,3-PDO consists in the dehydration of 
glycerol dehydratase to form 3-hydroxypropionaldehyde, and its subsequent reduction to 
the major fermentation product 1,3-PDO by the NADH-linked 1,3-PDO dehydrogenase 
(1 ,3-PDO) (Figure 3-17). Glycerol dehydratase is an enzyme consisting of three subunits 
and catalyzes the conversion of glycerol to 3-hydroxypropionaldehyde by a free radical 
mediated reaction involving coenzyme B12 as an essential cofactor (Biebl et al., 1999). 
Glycerol dehydratase is encoded by three structural genes dhaBI, dhaB3 and dhaB4 in 
the case of K. pneumoniae or dhaB, dhaC and dhaE in the case of C..freundii (Homann et 
al., 1990). 
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Figure 3-17 Metabolic pathway of the fermentative metabolism of glycerol 
(a) Reactions reported in black are common to E. coli, C. freundii, K. pneumonia, C. butyricum. 
(b) Enzymes from native producers (C.freundii, K. pneumoniae, blue; C. butyricum, green) and 
E. coli potential functional surrogates (red) mediating the conversion of glycerol to 1,3-
propanediol. Abbreviations: PEP, phosphoenolpyruvate; PYR, pyruvate; 2[H] = NADH = FADH2 
=H2 
The structure and enzymatic mechanism are similar for both Klebsiella and 
Citrobacter spec1es (Homann et al., 1990). The B 12-dependence has important 
implications for the biosynthesis of 1,3-PDO, because the vitamin B12 bound to the 
enzyme is periodically rendered inactive by glycerol during catalysis. Inactivation by 
glycerol involves irreversible cleavage of the Co-C bond of coenzyme B 12, forming 5 '-
deoxyadenosine and an alkylcobalamin-like species (Homann et al., 1990). A reactivation 
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factor catalyzes the exchange of inactive with active vitamin B12 by facilitating the 
dissociation of the inactive vitamin from glycerol dehydratase. A third subunit is finally 
responsible for the reactivation of the inactivated vitamin (Homann et al., 1990). 
Similarity search for sequence and structure homologues of the glycerol dehydratase 
from K. pneumoniae and C. freudii against the E. coli genome have not returned any 
match (Table 3-6). However, the analysis of protein domain composition suggests PduC, 
PduD and PduE as potential candidates in E. coli (Table 3-7). These genes, part of the 
pduABCDE operon, have been characterized in Salmonella enterica in the context of 
propanediol catabolism (Bobik et al., 1997). Specifically, they are shown to be necessary 
and sufficient for propanediol dehydratase activity (Bobik et al., 1997). However, the 
pduABCDE operon has only been identified in pathogenic serological types of E. coli; 
hence, genes belonging to this operon have not been pursued in the context of this study. 
The demand for vitamin B 1z for efficient provision of active glycerol dehydratase 
supersedes generally the natural availability in the host cell and hence requires addition 
of an excessive amount of a high-cost molecule, vitamin B 12, to the culture medium. An 
alternative approach to overcome the vitamin B 1z requirement has been recently provided 
by the Jnstitut National de Ia Recherche in Paris (O'Brien et al., 2004) with the isolation 
of a coenzyme B12-independent glycerol dehydratase from Clostridium butyricum. 
The sequence and structural analysis (Table 3-6), in agreement with the domain 
organization and composition analysis (Table 3-7), suggested PflD and PflF, and PflC 
and PflE as potential surrogates of the Clostridial enzymes DhaB 1 and DhaB2, 
respectively. Both sets of enzymes have recently been predicted based on homology to 
function as pyruvate formate lyases (PFL) (Kim and Reed, 2010). 
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Figure 3-18 Schematic structure showing the domain organization and special sequence 
features of the C. butyricum dhaB2. 
The ferredoxin-like binding domain is reported in red. Uniprot accession numbers: DhaB2 Cb 
(Q8GEZ7), PflA Ec (POA9N4), PflC Ec (P32675), PflE Ec (P75794).The last two characters of 
the abbreviated names refer to the organism: Cb, C. butyricum; Ec, E. coli. 
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Alignment of the dhaBJ gene product with the PflE and PflF returned high 
homology around the presumed active site cysteine (Catalytic domain) and the conserved 
glycine residue (Gly-radical domain), in agreement with what reported by Raynaud and 
coworkers (Raynaud et al., 2003). Sequence comparison of DhaB2 with PflC and PflE 
has detected presence of the first cysteine domain in both PflC and PflE. The ferredoxin-
like binding motif was instead only present in PflE (although switched of few bases, as 
shown in Figure 3-18), making it a better candidate. 
The second step in the conversion of glycerol to 1 ,3-PDO consists in the reduction 
of 3-hydroxypropionaldehyde to 1,3-PDO mediated by the NADH-linked 1,3-PDO 
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dehydrogenase. The products of the dhaT genes from K. pneumonia, C. freudii and C. 
butyricum are 1,3-propanediol dehydrogenases that share very high sequence homology 
and present comparable properties (Biehl et al., 1999; Saxena et al., 2009). Homology 
search based on sequence-, structure- (Table 3-6) and domain composition (Table 3-7) 
comparisons suggest three E. coli oxidoreductases as potential surrogates: Yia Y, FucO 
and YqhD. 
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Figure 3-19 Fermentative dissimilation of glycerol to 1,3-propanediol using Escherichia coli 
native genes 
a. Coenzyme B 12 dependence has been explored for two alternative 1 ,3-PDO dehydratase 
complexes identified through sequence and domain-centric search. 
b. Oxygen sensitivity of the 1 ,3-propanediol biosynthesis pathway is investigated in the E. coli 
strain MG1655 [pflEF+ yiaY+ dhaKLM+ gldA+]. 
Cultures were run in hungate tubes at 37°C for 48h in MOPS minimal medium+ glycerol 10 gl-1• 
115 
Based on the considerations reported above, we engineered E. coli MG 1655 and 
explored the overexpression of the two alternative 1,3-PDO dehydrogenases (pjlCD, 
pjlEF) in combination with the YiaY 1,3-PDO dehydrogenase (Figure 3-19a). The 
glycerol dissimilation pathway was concurrently overexpressed to enhance cell growth 
and generate reducing equivalents needed for the synthesis of 1,3-PDO. While 1,3-PDO 
synthesis was observed for both MG1655 fpjlCD+ yiaY+ dhaKLM+ gldA+] and MG1655 
fpjlEF+ y iaY+ dhaKLM+ gldA+], ethanol and lactic acid were main by-products of the 
fermentation (Figure 3-19a), possibly sustaining redox-balance by acting as alternative 
sinks for reducing power. Also, our results support the hypothesis that both PflCD and 
PflEF function as B12 independent 1,3-PDO dehydratases, as presence of coenzyme B12 
in the medium did not seem to affect 1,3-PDO biosynthesis. Based on the high similarity 
between the E. coli surrogate enzyme complex PjlEF and the native Clostridial 
dehydratase, we also investigated and demonstrated the oxygen sensitivity of the 
assembled pathway in MG1655 fpjlEF+ yiaY+ dhaKLM+ gldA+] (Figure 3-19b). A ten-
fold increase in the 1,3-PDO titer was in fact achieved under conditions of anaerobiosis 
compared to more aerobic ones (Figure 3-19b). 
While the results hereby reported demonstrate for the first time biosynthesis of this 
reduced product in E. coli using solely native genes, they also suggest the existence of an 
alternative latent avenue for the anaerobic glycerol fermentation in E. coli. This study 
proves the presence in E. coli of metabolic capabilities considered peculiar of species 
genetically and metabolically distant, thus corroborating our hypothesis of the existence 
of functionally pluripotent bacterial cells. 
Table 3-6 Identification of Escherichia coli surrogates for glycerol fermentation to 1,3-propanediol via sequence-based comparative 
analysis 
Source of gene sequences nsed to identify E. coli surrogates Surrogates identified via Surrogates identified via protein pBLAST 1-TASSER(Roy eta!. 2010) (Altschul et a!. 1997) 
Organism Accession Protein E.C.# Function E.C.# TM- EC- Protein E.C.# Protein E-value' Identity Similarity # Score• Score• 
B12-independent glycerol dehydratase 
Clostridium butyricum Q8GEZ8 DhaBI 4.2.1.30 Glycerol 2.3.1.54 0.8266 1.8474 PflD 2.3.1.54 PflD 2E-179 41% 62% (Raynaud eta!., 2003) dehydratase 
PflF 2.3.1.54 PflF 3E-153 37% 57% 
2.3.1.- PflB 9E-50 28% 416% 
2.3.1.- TdcE 4E-45 27% 47% 
Clostridium butyricum Glycerol Q8GEZ7 DhaB2 4.2.1.30 dehydratase 1.97.1.4 0.7660 1.4907 PflA 1.97.1.4 PflE 2E-48 39% 57% (Raynaud eta!., 2003) 
activator 
PflC 1.97.1.4 PflC 9E-48 34% 54% 
PflE 1.97.1.4 PflA IE-34 37% 60% 
- YiiW 2E-23 29% 47% 
1,3-propanedio/ oxidoreductases 
Citrobac:ter freundii P45513 DhaT 1.1.1.202 1 ,3-propanediol 1.1.1.77 0.9748 4.2711 FucO 1.1.1.1 YiaY 2E-IOO 48% 64% (Daniel eta!., 1995) oxidoreductase 
1.1.1.1. 0.8643 2.0342 AdhE 1.1.1. 77 FucO 4E-82 43% 61% 
AdhP I. 1.-.- EutG 5E-57 35% 54% 
FrmA 1.1.1.1 AdhE 7E-53 33% 52% 
I. I. 1.6 0.8046 1.6012 GldA 1.1.1.- YqhD 4E-21 25% 43% 
I. I. 1.6 GldA 4E-04 22% 38% 
Klebsiella pneumonia Q59477 DhaT 1.1. 1.202 1,3-propanediol 1.1.1.77 0.9530 2.6543 FucO I. 1.1.1 YiaY 2E-101 49% 63% (Zhuge et al., 20 10) oxidoreductase 
1.1.1.1. 0.8661 2.0322 AdhE 1.1.1.77 FucO IE-82 43% 61% 
AdhP 1.1.-.- EutG 3E-57 35% 54% 
FrmA 1.1.1.1 AdhE IE-53 34% 54% 
1.1.1.6 0.8056 1.5961 GldA I. 1.1.- YqhD 3E-21 26% 43% 
I. 1.1.6 GldA 3E-06 24% 40% 
Clostridium butyric:um Q8GEZ6 DhaT 1.1.1.202 1 ,3-propanediol 1.1.1. 77 0.9603 2.6526 FucO 1.1. 1.1 YiaY 2£-104 49% 66% (Raynaud eta!., 2003) oxidoreductase 
1.1.1.1 0.8693 2.0217 AdhE 1.1.1.77 FucO 6E-78 43% 61% 
AdhP I. 1.-.- EutG 3E-58 35% 52% 
FrmA 1.1. 1.1 AdhE 7E-49 32% 52% 
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1.1.1.6 0.7779 1.6171 GldA 1.1.1.-
1.1.1.6 
YqhD 
GldA 
1E-17 
IE-07 
25% 
24% 
45% 
40% 
• The Template Modeling-score (TM-score) is defined to assess the topological similarity of protein structure pairs. Its value ranges between 0 and I, and a higher score indicates 
better stmcturalmatch. Statistically, a TM-score < 0.17 means a randomly selected protein pair with the gap less alignment taken from PDB (Roy et al., 20 10). 
h An EC-score > 1.1 is a good indicator of the functional similarity between the query and the identified enzyme analogs (Roy et al., 2010). 
'"The BLAST E-value measures the statistical significance threshold for reporting protein sequence matches against the organism genome database; the default threshold value is lE-5, 
in which lE-5 matches would be expected to occur by chance, according to the stochastic model of Karlin and Altschul (http://www.ncbi.nlm.nih.gov/BLAST/tutoriaV). 
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Table 3-7 Identification of Escherichia coli surrogates for glycerol fermentation to 1,3-propanediol via domain/motif recognition-based 
comparative analysis 
Source of gene sequences used to identify E. coli surrogates Surrogates identified via domain organization and composition (SMART(Scbultz et al., 1998), InterProScan (Ouevillon et al. 1005)} 
Organism Accession Protein E.C.# Function 
Pfam(Finn 
# Domain et al., 2010) Begin End E-value• Protein Accession# 
Bl 2-dependent glycerol dehydratiiSe 
Citrobacter freundii P45514 DhaB 4.2.1.30 Glycerol dehydratqe Dehydratase large subunit PF02286 2 555 O.OOE+OO PduC (Seifert et al., 2001) large subunit 
Citrobacter freundii Q59273 DhaC 4.2.1.30 Glycerol dehydratase Dehydratase medium PF02288 15 189 l.lOE-84 PduD (Seifert et al., 2001) 21 kDa subunit subunit 
Citrobacter freundii Q59274 DhaE 4.2.1.30 Glycerol dehydratase Dehydratase small subunit PF02287 2 138 l.OOE-60 PduE (Seifert et al., 2001) 16kDa subunit 
Klebsiella pneumonia Q59476 DhaBI 4.2.1.30 Glycerol dehydrase Dehydratase large subunit PF02286 2 555 O.OOE+OO PduC (Kajiura et al., 2001) alpha subunit 
Klebsiella pneumonia Q59475 Dha83 4.2.1.30 Glycerol dehydratase Dehydratase small subunit PF02287 2 138 7.50E-63 PduE (Kajiura et al., 2001) gamma subunit 
Klebsiella pneumonia Glycerol dehydratase Diol dehydratase Q59474 Dha84 4.2.1.30 reactivase A TPase-like PF08841 276 607 3.30E-158 PduG (Kajiura et al., 200 I) large subunit domain 
Bl 2-independent glycerol dehydramse 
Clostridium butyricum Q8GEZ8 DhaBI 4.2.1.30 Glycerol dehydratase Pyruvate formate lyase PF02901 8 649 4.JOE-260 PflB (Raynaud et al., 2003) 
Glycine radical PFOI228 665 769 2.80E-28 PflD 
TdcE 
PflF 
Clostridium butyricum Q8GEZ7 Dha82 4.2.1.30 Glycerol dehydratase Radical SAM superfamily PF04055 26 238 9.90E-24 AsiB ' (Rayoaud et al., 2003) activator 
ThiH 
HemN 
PflC 
YjeK 
YjjW 
YggW 
PflE 
YdeM 
YgiQ 
Clostridium butyricum Q8GEZ6 DhaT 1.1.1.202 1,3-propaoediol Iron-containing alcohol PF00465 9 377 5.90E-116 Adh2 
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(Raynaud et al., 2003) oxidoreductase dehydrogenase 
1,3-propunediol oxidored11ctuses 
Citrobacter.fi·eundii P45513 DhaT 1.1.1.202 1,3-propanediol Iron-containing alcohol (Daniel et al., 1995) oxidoreductase dehydrogenase 
Klebsiella pneumonia Q59477 DhaT 1.1.1.202 1,3-propanediol Iron-containing alcohol (Zhuge et al., 2010) oxidoreductase dehydrogenase 
Clostridium butyricum Q8GEZ6 DhaT 1.1.1.202 1,3-propanediol Iron-containing alcohol (Raynaud et al., 2003) oxidoreductase dehydrogenase 
PF00465 II 379 4.00E-122 
PF00465 II 379 3.10E-123 
PF00465 9 377 5.90E-116 
·--------
YbdH 
EutG 
YqhD 
Adh2 
YbdH 
EutG 
YqhD 
Adh2 
YbdH 
EutG 
YqhD 
Adh2 
YbdH 
EutG 
YqhD 
• TheE-value measures the statistical significance threshold for reporting protein domain matches against the organism proteome database; the default threshold value is lE-5, in 
which lE-5 matches would be expected to occur by chance (Quevillon et al., 2005; Schultz et al., 1998) 
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3.4. Discussion 
Current employed metabolic engineering methodologies build on phenetic 
observations and on the premise that bacteria that are genetically distant from a 
phylogenetic standpoint are also metabolically distinct. Filling the gap of knowledge 
between functional and molecular differentiation becomes therefore fundamental also to 
the development of novel approaches to design and construct optimal microbial cell 
factories. 
While earlier industrial microbiology efforts aimed at exploiting the metabolic 
capabilities of native producer organisms, synthetic biology and metabolic engineering 
utilize the information generated by structural and functional genomics to identify 
efficient pathways for the biosynthesis of products of interest in native producers and 
reconstruct them in genetically tractable and industrially amenable bacteria, like for 
example the model organisms E. coli and S. cerevisiae. Implementation of this method, 
which we term Heterologous Metabolic Engineering (HeME), thus fails at exploiting the 
full biosynthetic potential of the host. Furthermore, incompatibility of the heterologous 
pathway with the host metabolism is of significant concern, as in many cases it results in 
suboptimal operation of the engineered pathway. As an alternative, we propose 
Homologous Metabolic Engineering (HoME) as a novel methodology that aims at 
exploiting functional relatedness of metabolic pathways in genetically and metabolically 
distant species. The implementation of HoME entails the recruitment and functional 
activation of native genes and/or pathways and their assembly into superior metabolic 
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routes for the biosynthesis of products of interest, e.g. fuels and chemicals. The proposed 
strategy proceeds by identifying functional homologues for the heterologous pathway by 
protein-sequence comparative analysis and domain-centric homology search. Pathways 
identified are assembled and directly expressed in E. coli; functional expression also 
involves manipulating the corresponding regulators and blocking competing pathways for 
common metabolic intermediates. 
In an effort to lay the foundations of this new methodology, we selected the 
Clostridial acetone-butanol-ethanol (ABE) fermentation, the anaerobic glycerol 
fermentation to 1,3-Propanediol and the yeast homoethanolic fermentation as examples 
of metabolic modes peculiar of organisms that are molecularly and metabolically distant 
from E. coli. 
E. coli functional surrogates of the enzymatic steps responsible for mediating 
pathways of the ABE fermentation in Clostridia were identified through sequence-, 
structure-, and domain-centric homology search (Section 3.3.2). Their assembly in E. coli 
strains engineered to block competing pathways for common intermediates, resulted in 
the biosynthesis of butanol, acetone and butyric acid, products peculiar of the Clostridial 
metabolism. Contrarily to what previously assumed, our results demonstrate the existence 
of latent metabolic potential in E. coli that can enable synthesis of non-native products in 
the absence of foreign genes. 
The homoethanologenic metabolism of Saccharomyces cerevisiae and 
Zymomonas mobilis has also been explored (Section 3.3.1). A metabolic engineering 
strategy has been devised based on the indication of the presence of potential E. coli 
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functional surrogates provided by the homology search. However, experimental evidence 
cannot be provided at this moment. 
Proof of concept has also been provided for the case of anaerobic glycerol 
fermentation to 1,3-PDO (Section 3.3.2). While this bioconversion was thought to be 
characteristic of Klebsiella, Citrobacter and Clostridial spp., our results hypothesize the 
existence of a latent similar pathway, therefore corroborating the hypothesis of a common 
metabolic ancestor. 
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Chapter 4 
Engineered reversal of the P-oxidation 
cycle as a metabolic platform for the 
synthesis of advanced fuels and 
chemicals 
4.1. Background and motivation 
Metabolic engineering and synthetic biology strategies have for the most part 
been tailored for the synthesis and optimization of single biofuel or biochemical 
molecules. However, by integrating synthetic competences from diverse metabolic and 
phylogenetic origins within an integrated biological system, it is possible to envisage the 
development of a single technological platform for synthesizing an array ofbiorenewable 
molecules for use in the chemical and energy industry. By analogy with the current non-
renewable petrochemical industry, a successful bio-based chemical industry will 
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therefore build upon the platform-chemical approach, where each chemical intermediate 
is converted to a large number of chemical products. Harnessing the metabolic potential 
of model organisms provides therefore opportunity to produce a broad array of platform 
chemicals, thereby creating a consolidated framework for the production of advanced 
fuels and chemicals. Polyketide and fatty acid biosynthesis are among the biochemical 
pathways presently explored in the context of the combinatorial biosynthesis of fuels and 
chemicals (Hertweck, 2009; Nikolau et al., 2008; Steen et al., 2010). 
4.1.1. Metabolic platforms currently available 
Advanced (long-chain) fuels and chemicals are generated from short-chain 
metabolic intermediates through pathways that require carbon-chain elongation. The 
condensation reactions mediating this carbon-carbon bond formation can be catalyzed by 
enzymes from the thiolase superfamily, including f3-ketoacyl-acyl-carrier protein (ACP) 
synthases, polyketide synthases, 3-hydroxy-3-methylglutaryl-CoA synthases, and 
biosynthetic thiolases (Haapalainen et al., 2006). 
Pathways involving these enzymes have been exploited for fuel and chemical 
production, with fatty acid biosynthesis (f3-ketoacyl-ACP synthases) attracting the most 
attention in recent years (Handke et al., 2010; Lennen et al., 2010; Steen et al., 2010). 
Polyketide biosynthesis takes place through the iterative generation of alkyl chain 
lengths with increasing chain length, ranging from four up to thirty carbon atoms. Fatty 
acids along with a diverse set of fungal and bacterial secondary metabolites belong to this 
class of compounds. Polyketides are synthesized by sequential reactions mediated by a 
---------- ----------------
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set of large protein complexes called polyketide synthases (PKSs ). The biosynthesis 
occurs in a stepwise manner from acyl-CoA intermediates with 2-, 3- or 4- carbons, and 
their activated malonyl derivatives (Hertweck, 2009). Polyketide biosynthesis and fatty 
acid biosynthesis share striking similarities, although they are considered a metabolic 
branch point between primary and secondary metabolism. In both fatty acid synthesis and 
polyketide synthesis, the intermediates are covalently bound to ACP, or Acyl Carrier 
Protein. However, while the 2C donor for fatty acids growth is Acyl-CoA or Malonyl-
CoA, poyketide synthases can use multiple primers including Acetyl-CoA, Propionyl-
CoA, Isobutyrl-CoA, etc .. In both fatty acid synthesis and polyketide synthesis the CoA 
carriers are then exchanged with ACP before being incorporated into the growing 
molecule. Fatty acids and polyketide synthesis are however quite dissimilar in the 
mechanism of chain growth: unlike fatty acid biosynthesis in which each chain 
elongation step is followed by a fixed sequence of ketoreduction, dehydration and enoyl 
reduction, intermediates of polyketide biosynthesis undergo different functional group 
modifications (Hertweck, 2009). Nevertheless, in both pathways, when a defined chain 
length is reached, the thioester-bound substrates are released from the enzyme complex 
and hydrolyzed by thioesterases. The free carboxylic acids can be sequentially reduced to 
the corresponding aldehydes and primary alcohols, and, in turn, the alcohols can be 
acylated to form esters. Based on the thioesterases specificity it is therefore possible to 
generate a variety of products with diverse chain length and functionalities. 
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4.1.2. Functional reversal of the ~-oxidation as a combinatorial platform for the 
production of fuels and chemicals 
Degradative thiolases, which are part of the thiolase superfamily and naturally 
function in the ~-oxidation of fatty acids (Clark and Cronan, 2005; Poirier et al., 2006), 
can also operate in the synthetic direction and thus enable carbon-chain elongation. 
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o o @r.~s······'~ R~~@ 0 AA P.ketoacyi-CoA (Cn+2)-Acyl-toA ~
R P.ketoacids o- 2IHI..JG) 0f R Fatty Acids o-
,....\ 7'2[HI 
0 r u u ····••····~ •• CoA ~ •• CoA, 0 
,;·········" tran~-,8-hydroxyacyl-~~~ r.\ R trans-LV-Enovk~A .................. .. 
1,3-diols @1 trans-~2-Fatty Alcohols 
H20 0 
R~o-R~o-
hydroxyacids trans-~2-Fatty Acids 
Figure 4-1 Proposed metabolic platform for the combinatorial synthesis of advanced fuels 
and chemicals 
The functional reversal of the (3-oxidation cycle engineered in this work (shown in blue) is 
composed of the following enzymes (gene names in parentheses): CD thiolase (yqeF, fadA); ® 
hydroxyacyl-CoA dehydrogenase (jadB); @ enoyl-CoA hydratase (jadB); @ enoyl-CoA 
reductase (ydiO). Intermediates in the engineered pathway can be converted to a functionally 
diverse set of molecules using aldehyde-forming acyl-CoA reductases & alcohol dehydrogenases 
(@)and acyl-CoA thioesterases (@),as indicated. Products whose synthesis was demonstrated in 
this study are shown in boxes. Abbreviations: R, side chain attached to the acyl-CoA group of the 
primer or starter molecule (e.g. R=H for acetyl-CoA and R=CH3 for propionyl-CoA); 2[H], 
NADH/NADPH/Ferredoxin. Dotted lines indicate multiple steps while dashed lines without 
arrowheads connect identical metabolites of different chain length. 
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Here we demonstrate that a functional reversal of the ~-oxidation cycle can be 
used as a metabolic platform for the combinatorial synthesis of alcohols and carboxylic 
acids with various chain lengths and functionalities (Figure 4-1 ). 
This pathway operates with coenzyme-A (CoA) thioester intermediates and 
directly uses acetyl-CoA for acyl-chain elongation (rather than first requiring ATP-
dependent activation to malonyl-CoA), characteristics that enable product synthesis at 
maximum carbon and energy efficiency. The reversal of the ~-oxidation cycle was 
engineered in Escherichia coli and used in combination with endogenous dehydrogenases 
and thioesterases to synthesize n-alcohols, fatty acids and ~-hydroxy-, ~-keto- and trans-
!J. 2 -carboxylic acids. The superior nature of the engineered pathway was demonstrated by 
producing higher-chain linear n-alcohols (C ~ 4) and extracellular long-chain fatty acids 
(C > 10) at higher efficiency than previously reported (Atsumi et al., 2008b; Bond-Watts 
et al., 2011; Lennen et al., 2010; Shen and Liao, 2008; Steen et al., 2010). The ubiquitous 
nature of ~-oxidation, aldehyde/alcohol dehydrogenase, and thioesterase enzymes has the 
potential to enable the efficient synthesis of these products in other industrial organisms. 
4.2. Methods 
4.2.1. Strains, plasmids and genetic methods 
Wild-type Kl2 Escherichia coli strain MG1655 was used as the host to 
implement metabolic engineering strategies. Gene knockouts were introduced in 
MG1655 and its derivatives by Pl phage transduction as previously described (Yazdani 
and Gonzalez, 2008). The native cAMP receptor protein (CRP) was replaced with a 
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cAMP-independent CRP (CRP*) (Cirino et al., 2006) by introducing the crp* gene into 
crp deletion mutants via PI phage transduction using a lysate from strain ET25 (Eppler 
and Boos, 1999), followed by selection on (1%) glycerol minimal media plates with 
tetracycline. All resulting strains are listed in Table 4-1. 
4.2.1.1. Genetic Methods 
Standard recombinant DNA procedures were used for gene cloning, plasmid 
isolation, and electroporation (Sambrook and Russell, 2001 ). Manufacturer protocols and 
standard methods were followed for DNA purification (Qiagen, CA, USA), restriction 
endonuclease digestion (New England Biolabs, MA, USA), and DNA amplification 
(Stratagene, CA, USA and Invitrogen, CA, USA). For plasmid construction, genes were 
amplified from MG1655 genomic DNA using primers designed to create 15 bp of 
homology on each end of the gene insert for subsequent recombination into the desired 
plasmid. 
Plasmids were linearized usmg restriction endonuclease digestion, then 
recombined with the appropriate gene(s) using an In-Fusion Dry-Down PCR Cloning Kit 
(Clontech, Mountain View, CA, USA) and subsequently used to transform chemically 
competent Fusion Blue cells (Clontech, Mountain View, CA, USA). Transformants that 
grew on LB plates containing the appropriate antibiotic were struck for isolation, and 
then subjected to preliminary screening by PCR. Colonies passing preliminary inspection 
were then individually grown for plasmid purification. 
Table 4-1 Strains and plasmids used in this study 
Strain/Plasmid 
Strains 
MGI655 
fadR atoC(c) 
RBOI 
RB02 
RB02!l.yqhD 
RB02 !l.eutE 
!l.yqhD 
RB02 !l.yqeF 
RB02 !:ifadB 
RB02 !l.ydiO 
RB02 !l.focO 
RB03 
!l.adhE !l.pta !l.frdA 
!l.adhE !!.pta !!..frdA 
!l.fadD 
Plasm ids 
pTrcHis2A 
pTHfadBA 
pTHfadBAJadM 
pTHfadM 
pTHyqeF 
pZS blank 
pZS atoB 
pZS betA 
pZS eutG 
pZSfadB 
pZSfadM 
pZSfocO 
pZS tesA 
pZS tesB 
pZSyciA 
pZSydiO 
pZSyiaY 
pZSyqhD 
Description/Genotype 
F-1.- ilvG- rfb-50 rph-1 
MGI655fadR atoC(con) 
MG 1655 fadR atoC(con) !!.areA !l.crp::crp* 
MG 1655 fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !:ifrdA 
MG 1655 fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !l.frdA !l.yqhD 
MG 1655 fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !l.frdA !l.eutE 
!l.yqhD 
MG1655 fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !!.pta !l.frdA !l.yqeF 
M G 165 5 fadR atoC (con) !!.areA !l.crp: :crp* !l.adhE !!.pta !:ifrdA !l.fadB 
MG1655fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !l.frdA !l.ydiO 
MG1655fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !l.frdA !l.focO 
MG 1655 fadR atoC(con) !!.areA !l.crp::crp* !l.adhE !l.pta !l.frdA !l.focO 
!l.yqhD !l.fadD 
MG1655 !l.adhE !l.pta !:ifrdA 
MG1655 !l.adhE !l.pta !:ifrdA !l.fadD 
pTrcHis2A (pBR322-derived), oriR pMB1, lac/1 , bla 
E. coli fadBA genes under trc promoter and lacfl control in pTrcHis2A 
E. coli fadBA, fadM genes under trc promoter and lacfl control in 
pTrcHis2A 
E. coli fadM gene under trc promoter and lacfl control in pTrcHis2A 
E. coli yqeF gene under trc promoter and lacfl control in pTrcHis2A 
oriR pSC101 *, tetR, cat, contains PLtetO-I 
E. coli atoB gene under control ofPLteto.1(tetR, oriR SC101 *,cat) 
E. coli betA gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli eutG gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. colifadB gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. colifadM gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. colifocO gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli tesA gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli tesB gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli yciA gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli ydiO gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
E. coli yiaY gene under control ofPLteto-1(tetR, oriR SC101 *,cat) 
E. coli yqhD gene under control ofPLtetO-I(tetR, oriR SC101 *,cat) 
129 
Source 
(K.ang et al., 
2004a) 
(Dellomonaco 
et al., 2010b) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Invitrogen 
(Carlsbad, CA) 
This study 
This study 
This study 
This study 
(Yazdani and 
Gonzalez, 
2008) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Purified plasmids were confirmed to have the appropriate insert both by PCR as 
well as restriction endonuclease digest verification. Plasmids in each case include the 
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plasmid promoter, a ribosomal binding site for each gene, MG1655 gene(s), and a 
plasmid terminator. Resulting plasmids are listed in Supplementary 
Table 4-2 Comparison of crp,fadR, and atoSC loci of engineered strain RB02 (jadR atoC(c) 
&areA &:rp::crp* &zdhE 4pta 4frdA) and wild-type MG16SS 
Gene Accession # for Mutations/insertions in Comments locus RB02 seguence RB02 seguence 
Mutations collectively reduce 
Banklt144S30S dependence on cAMP for activation 
crp Seql JF781281 I113L, T128I, A14ST of catabolic genes by CRP, as previously described 
(Eppler and Boos, 1999; Khankal et 
al., 2009). 
Inactivation offadR by ISS insertion. 
Banklt1446148 ISS insertion between bp Characteristic phenotype offadR fadR Seq 1 JF793627 inactivation previously confirmed in 39S-396 offadR gene 
strainfadR atoC(c) 
(Dellomonaco et al., 201 Ob) 
atoC tranduced from LSS218 
(constitutive atoC expression( Spratt 
Banklt144S920 et al., 1981a)). Characteristic 
atoSC Seq 1 JF793626 I129S phenotype of constitutive expression 
of ato operon confirmed in strain 
fadR atoC(c) 
{Dellomonaco et al., 2010b}. 
4.2.1.2 Sequencing of regulators 
Chromosomal DNA from strain RB02 served as the template for PCR using 
Phusion High-Fidelity DNA polymerase (Finnzymes, Espoo, Finland). PCR products, 
containing the gene(s) of interest as well as approximately 500 base pairs upstream of 
each gene, were purified using a QIAquick PCR Purification Kit (Qiagen, Valencia, CA) 
and sent to Lone Star Labs (Houston, TX) for sequencing. Sequencing results were 
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analyzed using Sequence Scanner vl.O (Applied Biosystems, Foster City, CA) and Serial 
Cloner v2.1 (Serial Basics, http://serialbasics.free.fr/Home/Home.html). Accession 
numbers for genes sequenced along with the mutations identified are reported in Table 
4-2. 
4.2.2. Culture medium and cultivation conditions 
Chemicals were obtained from Fisher Scientific (Pittsburg, PA) and Sigma-
Aldrich Co. (St. Louis, MO). 
The minimal medium designed by Neidhardt et al. (Neidhart et al., 1974) with 
Na2HP04 in place of K2HP04 and supplemented with 20 giL glucose, 40 giL calcium 
bicarbonate, 100 ~-tM FeS04, 5 mM calcium pantothenate, 3.96 mM Na2HP04, 5 mM 
(N~)2S04, and 30 mM N~Cl was used. Fermentations conducted in the SixFors multi-
fermentation system also included 1 mM betaine. Ampicillin ( 100 ~-tg/mL ), kanamycin 
(50 ~-tg/mL), chloramphenicol (34 ~-tg/mL), anhydrotetracycline (100 ng/mL), and 
isopropyl ~-D-1-thiogalactopyranoside {IPTG; 0.1 mM) were included when appropriate. 
A single colony was used to inoculate 30 mL of medium in 50 mL baffied flasks and 
incubated at 37° C in a rotary shaker (200 rpm) for 24 hours. An appropriate amount of 
pellet from this pre-culture was used to inoculate 30 mL of fresh medium in 50 mL 
baffied flasks to a target initial optical density at 550 nm of 0.05. These cultures were 
then incubated at 30° C in a rotary shaker (200 rpm) for 24 hours, unless otherwise stated. 
The same inoculation procedure was used for additional fermentations conducted in a 
SixFors multi-fermentation system (Infors HT, Bottmingen, Switzerland) with an air 
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flowrate of 1.5 N Llhr and control of dissolved oxygen, pH, and temperature at specified 
values. 
4.2.3. Analytical methods 
4.2.3.1. Metabolite Identification 
The identity of metabolic products was determined through one-dimensional (10) 
proton nuclear magnetic resonance (NMR) spectroscopy. 60 ~-tL of 0 20 and 1 ~-tL of 600 
mM NMR internal standard TSP (3-(trimethylsilyl) propionic acid-04, sodium salt] were 
added to 540 ~-tL of the sample (culture supernatant). The resulting solution was then 
transferred to a 5 mm-NMR tube, and 1D proton NMR spectroscopy was performed at 
25°C in a Varian 500-MHz !nova spectrometer equipped with a Penta probe (Varian, Inc., 
Palo Alto, CA) using the following parameters: 8,000-Hz sweep width, 2.8-s acquisition 
time, 256 acquisitions, 6.3-~-ts pulse width, 1.2-s pulse repetition delay, and presaturation 
for 2 s. The resulting spectrum was analyzed using FELIX 2001 software (Accelrys 
Software Inc., Burlington, MA). Peaks were identified by their chemical shifts and J-
coupling values, which were obtained in separate experiments in which samples were 
spiked with metabolite standards (2 mM final concentration). 
Identification of n-alcohols was conducted through gas chromatography-mass 
spectroscopy (GC-MS) following a modification of the method reported by Atsumi and 
coworkers (Atsumi et al., 2008a). The analysis was performed on an Agilent 6890 
GC/5973 MS (Agilent Technologies, Palo Alto, CA) instrument with a HP-5ms capillary 
column (30m x 0.25 mm x 0.25 ~-tm). 1ml of supernatant of culture broth was extracted 
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with 500 ~-tl ofGC standard grade n-hexane (Fluka, Steinheim, Germany) and 1-heptanol 
(Sigma-Aldrich, Lausanne, Switzerland) was used as internal standard. 0.5 ~-tl of the 
extracted sample was injected using a 20: 1 split at 250 °C. The oven temperature was 
initially held at 75°C for 2 min and then raised with a gradient of 5°C/min to 280°C and 
held for 2 min. Helium (Matheson Tri-Gas, Longmont, CO) was used as the carrier gas 
with a 14-lb/in2 inlet pressure. The injector and detector were maintained at 255°C. 
Identification of fatty acids was performed on a Shimadzu Auto-System GC 2010 
(Shimadzu, Japan) equipped with a DB-5MS capillary column (30 m x 0.25 mm x 0.25 
J.lm) and coupled with a QP-20 10 mass detector. The following method was used: an 
initial temperature of 50°C was held for 2 min and then ramped to 220 °C at 4 °C per min 
and held for 10 min2• Extraction and derivatization procedures are described in Section 
4.2.3.2. 
4.2.3.2. Metabolite Quantification 
The quantification of glucose, organic acids, ethanol, and butanol was conducted 
by high-performance liquid chromatography (HPLC). Samples (culture supernatant) 
were analyzed with ion-exclusion HPLC using a Shimadzu Prominence SIL 20 system 
(Shimadzu Scientific Instruments, Inc., Columbia, MD) equipped with an HPX-87H 
organic acid column (Bio-Rad, Hercules, CA) with operating conditions to optimize peak 
separation (0.3 mL/min flowrate, 30 mM HzS04 mobile phase, column temperature 42 
°C)(Dharmadi and Gonzalez, 2005). 
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Quantification of longer chain (C > 4) n-alcohols was conducted through gas 
chromatography (GC) in a Varian CP-3800 gas chromatograph (Varian Associates, Inc., 
Palo Alto, CA) equipped with a flame ionization detector (GC-FID). Sample extraction 
procedure was as described above in Section 4.3.3.1. The separation of alcohol 
compounds was carried out using a FactorFour™ - VF-5ht column (15 m, 0.32-~-tm 
internal diameter, 0.10-f.lm film thickness; Varian Associates, Inc., Palo Alto, CA). The 
oven temperature was initially held at 40°C for 1 min and then raised with a gradient of 
30°C/min to 130°C and held for 4 min. The temperature was then raised with a gradient 
of 15°C/min to 230°C and held for 4 min. Helium (1 ml min·', Matheson Tri-Gas, 
Longmont, CO) was used as the carrier gas. The injector and detector were maintained at 
250°C. A 0.5-f.ll sample was injected in splitless injection mode. 
For total free fatty acids quantification, 5 mL of culture was placed in a 15 mL 
Coming CentriStar centrifuge tube (Coming Inc., Lowell, MA) in an ice bath and 
sonicated using a Branson Sonifier 450 (Emerson Industrial Automation, Danbury, CT) 
for 5 minutes at a duty cycle of 30% and a power setting of 1. The tubes were then 
centrifuged at 12,000 g for 5 minutes and the appropriate volume of supernatant 
recovered. For extracellular free fatty acid analysis, the supernatant from non-sonicated 
culture samples was used instead. 2 ml of supernatant were acidified with 200 ~-tl of 
acetic acid, supplemented with 100 mg of octanoic acid as an internal standard, and 
extracted with 2 ml ofn-hexane-chlorophorm (4:1, v/v) (Lalman and Bagley, 2004). The 
organic layer was nitrogen evaporated to near dryness, redissolved in 1 ml of a mixture of 
cholophorm:methanol:hydrochloric acid [10:1:1, vollvollvol] (Dellomonaco et al., 2010b) 
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and incubated in a sealed vial at 90°C for 1 h. Fatty acid methyl esters were extracted 
with 1 ml of n-hexane-chlorophorm (4:1, v/v) after addition of 500 ~-tl of 0.9% (wt/vol) 
NaCl in water. Gas-liquid chromatography was performed with 1~-tl of the n-
hexane:chlorophorm solution on a Varian FactorFour™ -VF-5ht capillary column 
(Varian Associates, Inc., Palo Alto, CA, 15m length, 0.32 ~-tm diameter, and 0.1 ~-tm film 
thickness) according to the following method: 50°C held for 1 min, 30°C/min to 160°C, 
15°C/min to 200°C, 200°C held for 1.5 min, 1 0°C/min to 225°C, and 225°C held for 15 
min(Dellomonaco et al., 2010b). 
4.2.3.3. Enzyme Assays 
For measurement of enzymatic activities, cells from 24 hour shake flask cultures 
were washed twice with 9 giL sodium chloride under anaerobic conditions and stored at -
80° C until use. Cell extracts for all assays were prepared as follows under anaerobic 
conditions. 40 units of ODsso nm were re-suspended in 1 mL of 100 mM Tris-HCl buffer 
(pH 7.0) with 1mM DTT. After cellular disruption using a Disruptor Genie (Scientific 
Industries, Inc., Bohemia, NY), cellular debris was removed by centrifugation (13,000 x 
g, 4 °C, 10 min) and the supernatant used as cell extract. Absorbance changes for all 
assays were monitored in a Biomate 5 spectrophotometer (Thermo Scientific, MA, USA). 
The linearity of reactions (protein concentration and time) was established for all assays 
and the non-enzymatic rates were subtracted from the observed initial reaction rates. 
Enzymatic activities are reported as ~-tmol of substrate per minute per mg of cell protein 
and represent averages for at least three cell preparations. Protein concentration was 
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measured using the Bradford Assay Reagent (Thermo Scientific, MA, USA) with BSA as 
a standard. 
Acetyl-CoA acetyltransferase (THL) activity was determined using acetoacetyl-
CoA and CoA as substrates, and the decrease in acetoacetyl-CoA concentration was 
measured at 303 nm (Wiesenbom et al., 1988). 13-Hydroxybutyryl-CoA dehydrogenase 
activity was measured at 340 nm by monitoring the decrease in NADH concentration 
resulting from 13-hydroxybutyryl-CoA formation from acetoacetyl-CoA (Hartmanis and 
Gatenbeck, 1984). Crotonase activity was measured by monitoring the decrease in 
crotonyl-CoA concentration at 263 nm, which results from 13-hydroxybutyryl-CoA 
formation from crotonyl-CoA (Hartmanis and Gatenbeck, 1984). Butyryl-CoA 
dehydrogenase activity was assayed in the direction of crotonyl-CoA reduction by 
monitoring the ferricenium ion at 300 nm, which acts as an electron donor (Lehman et al., 
1990). In addition, assays in which the ferricenium ion was replaced with 0.2 mM 
NAD(P)H and the absorbance measured at 340 nm were also run. Butyraldehyde 
dehydrogenase activity was assayed in the direction of butyraldehyde oxidation by 
monitoring NAD(Pt reduction at 340 nm (Berezina et al., 2010). To measure butanol 
dehydrogenase activity, the decrease in NAD(P)H concentration resulting from butanol 
formation from butyraldehyde is monitored at 340 nm under anaerobic conditions at 30 
oc (Durre et al., 1987). 
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4.3. Results 
Engineering the P-oxidation cycle as a metabolic platform for the combinatorial 
synthesis of advanced fuels and chemicals requires the reverse operation of this pathway 
in the absence of its natural substrate (i.e. fatty acids) and presence of a non-fatty acid 
carbon source (e.g. glucose). Constitutive expression of the fad and ato regulons, which 
encode the P-oxidation system in Escherichia coli (Clark and Cronan, 2005), in the 
absence of fatty acids was achieved by introducing previously reportedfadR and atoC(c) 
mutations (Dellomonaco et al., 2010b). ThefadR and atoC(c) mutations are due to an IS5 
insertion and a point mutation (1129S), respectively (Table 4-2). Several operons 
encoding P-oxidation cycle enzymes are also activated by the cyclic-AMP (cAMP) 
receptor protein (CRP)-cAMP complex and therefore subjected to carbon catabolite 
repression in the presence of glucose (Deutscher, 2008). This regulatory mechanism was 
circumvented by replacing the native crp gene with a cAMP-independent mutant (crp*) 
that contains three point mutations previously reported to confer a catabolite-derepressed 
phenotype (Eppler and Boos, 1999) (Table 4-2). Finally, since anaerobic/microaerobic 
conditions used in the production of fuels and chemicals would lead to AreA-mediated 
repression of most operons encoding the P-oxidation cycle (Cho et al., 2006), the areA 
gene was deleted. 
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Ta~le ~-3 Butanol synthesis, glucose utilization, and cell growth in strain RB02 and its 
derivatives 
Strain 
Butanol produced Glucose utilized Cell growth 
Yield (gig) Concentration (giL) (giL) (giL) 
RB02 [yqeF+ fucO+] 0.182 1.85 10.19 0.72 
Reaction(!): YqeF (predicted acyltransferase) 
RB02 AyqeF lfocO+] 0.019 0.10 5.19 0.32 
RB02 lfocO+] 0.063 0.23 3.66 0.41 
RB02 AyqeF lfocO+ yqeF+] 0.159 1.11 7.00 0.43 
Reactions® and®: FadB (3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase) 
RB02 AfadB [yqeF+ fucO+] NDb NDb 2.96 0.19 
RB02 AfadB [yqeF+ fadB+] 0.157 0.92 5.86 0.52 
RB02 AfadB [yqeF+] NDb NDb 1.84 0.11 
Reaction@: YdiO (predicted acyl-CoA dehydrogenase/enoyl-CoA reductase) 
RB02 AydiO [yqeF+ fucO+] 0.038 0.12 3.14 0.18 
RB02 AydiO [yqeF+ ydiO+] 0.163 0.97 5.94 0.57 
RB02 AydiO [yqeF+] O.ot8 0.103 1.66 0.13 
Reaction®: MhpF (aldehyde-forming acyl-CoA reductase) and FucO (n-butanol dehydrogenase) 
RB02 AfucO [yqeF+] 
RB02 AfucO [yqeF+ fucO+] 
RB02 [yqeF+] 
RB02 AmhpF [yqeF+ fucO+] 
O.ot5 
0.151 
0.088 
NDb 
0.04 
0.85 
0.35 
NDb 
2.75 
5.64 
4.00 
1.16 
0.38 
0.51 
0.68 
0.16 
• THL: thiolase; HBD: hydroxy-acyl-CoA dehydrogenase; CRT: crotonase; BDH: butanol dehydrogenase. 
b ND, not detectable. Minimum detection level for butanol was 5.84 mg l 1• 
c Experiments were run for 24 hours in shake flasks using glucose (1% w/v) minimal medium at 30 °C. 
The genetic manipulations outlined above were implemented in wild-type E. coli 
MG1655 (resulting strain named RBOl: MG1655 fadR atoC(c) crp* &areA) and in a 
strain in which the consumption of acetyl-CoA by other fermentative pathways was 
minimized (resulting strain named RB02: MG1655 fadR atoC(c) crp* &areA &adhE 
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!!..pta !i.frdA). Despite these modifications, none of the products that can be derived from 
the ~-oxidation cycle intermediates (Figure 4-1) were synthesized (Table 4-3). A 
limitation on the expression of 13-oxidation enzymes was ruled out after confirming the 
presence of these activities in strain RB02 (Table 4-4). 
Table 4-4 Activities of p-oxidation and butanol dehydrogenase enzymes in wild-type and 
engineered strains 
Strain 
MG1655 
RB02 (fadR atoC(c) crp* 
tlarcA tlpta tladhE tlfrdA) 
RB02 [yqeF+ fucO+] 
Enzyme activity (~-tmol/mg protein/min)± standard deviation 
THL a HBDa CRTa BDHa 
NDb 0.002±0.000 NDb 0.014±0.001 
0.31 0±0.079 0.304±0.032 0.339±0.049 0.004±0.002 
0.498±0.036 0.292±0.013 0.334±0.017 0.298±0.020 
"THL: thiolase; HBD: hydroxy-acyl-CoA dehydrogenase; CRT: crotonase; BDH: butanol dehydrogenase. 
b ND, not detectable. Minimum detectable activity was 0.001 ~-tmol/mg protein/min. 
The expression of appropriate termination enzymes is also vital to achieve the 
conversion of the CoA-thioester intermediates in the reversal of the 13-oxidation cycle to 
the desired product(s) (Figure 4-1). We first targeted the synthesis of n-butanol, as this 
product can be generated in a one-turn reversal of the 13-oxidation cycle. Unlike the 
significant activity observed for key 13-oxidation enzymes (Table 4-4), the level of n-
butanol dehydrogenase in strain RB02 was very low (Table 4-4), probably limiting n-
butanol synthesis. To address this tssue, two endogenous aldehyde/alcohol 
dehydrogenases with high sequence and structure similarity to the Clostridial 
butyraldehyde/butanol dehydrogenase were expressed in strain RB02: i.e. L-1,2-
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propanediol oxidoreductase (FucO) and an aldehyde/alcohol dehydrogenase (YqhD) 
(Table 4-5). These modifications enabled a functional one-turn reversal of the 13-
oxidation cycle, as evidenced by the synthesis of n-butanol in strains RB02 [yqhD+] and 
RB02 [/UcO+] (Figure 4-2). Despite the potential for YqhD to catalyze the conversion of 
butyraldehyde to n-butanol (Jarboe, 201 0), overexpression of FucO led to higher 
concentration of n-butanol and lower concentration of the major fermentation by-product, 
ethanol (Figure 4-2a). 
Since the initiation of the reversal of the P-oxidation cycle (i.e. conversion of 
acetyl-CoA to acetoacetyl-CoA) is another key step in the engineered pathway, we 
evaluated the effect of overexpressing atoB-encoded acetyl-CoA acetyltransferase, which 
has high specificity for short-chain acyl-CoA molecules (Feigenbaum and Schulz, 1975; 
Jenkins and Nunn, 1987a), and a predicted acyltransferase (YqeF) with high sequence 
similarity to AtoB. These modifications also supported the functioning of a reversal of 
the 13-oxidation cycle, as evidenced by the synthesis ofn-butanol in strains RB02 [atoB+] 
and RB02 [yqeF+] (Figure 4-2a). 
Table 4-5 In silico identification of Escherichia coli surrogates for higher-chain (C i!:: 4) aldehyde-forming acyi-CoA reductases and 
aldehyde/alcohol dehydrogenases (reaction <S> in Figure 4-1). Genes shown in bold were tested in this study. 
Souree of gene sequenees used to Identify E. coli surrogates Surrogates identified via 1-TASSER Surrogates Identified via protein BLAST(Aitsehul et (Rov et al 2010) al. 1997) 
Organism Aeeession Protein E.C.# Fundlon TM- EC- E-# E.C.# Seore• Seoreb Protein E.C.# Protein Identity Similarity value• 
Identification of E. coli surrogates for higher-ch11in (C;:: 4) ffllty aldehyde-forming acyl-CoA reduclllse 
Clostridium NADH-dependent 
saccharobutylicum Pl3604 Adh1 1.1.1.- butyra1dehyde/ 1.1.1.77 0.9404 2.2424 FueO 1.1.1.1. AdhE 2.0E-91 42% 62% (Berezina et al., butanol 
2009) dehydrogenase 
1.1.1.1. 0.8679 1.8069 YiaY 1.1.1.77 FueO 5.0E-66 35% 58% 
AdhE 1.1.1.- YiaY 2.0E-65 37% 56% 
AdhP 1.1.-.- EutG 4.0E-61 35% 54% 
FrmA 1.1.1.- YqhD 6.0E-28 25% 46% 
1.1.1.6 0.7979 1.4449 GldA 
Pseudomonas sp. 
strain CF600 Q52060 DmpF 1.2.1.10 Acetaldehyde 1.2.1.12 0.7439 1.3969 GapA 1.2.1.10 MhpF 6.0E-146 79% 92% (Powlowski et al., dehydrogenase 
1993) 
Acinetobacter sp. Acyl coenzyme A <l.lb 1.-.-.- UcpA 5.0E-20 31% 49% StrainM-1 Q8RR58 AcrM 1.2.1.50 reductase (Liu et al., 2009) 
1.-.-.- YbbO 4.0E-19 30% 50% 
1.1.1.- Ydtu 6.0E-18 27% 47% 
1.1.1.69 ldnO 9.0E-18 29% 49% 
1.1.1.100 FabG 9.0E-17 31% 51% 
Acinetobacter 
calcoaceticus P94129 Acr1 1.2.1.2 Fatty acyi-CoA <l.lb 1.1.1.100 FabG 2.0E-18 31% 53% (Reiser and reductase 
Somerville, 1997) 
1.1.1.69 IdnO J.OE-17 29% 48% 
1.1.1.- Ydtu l.OE-16 27% 47% 
1.-.-.- YbbO l.OE-16 28% 44% 
1.-.-.- UcpA 2.0E-16 31% 52% 
Identification of E. coli surrog11tes for higher-chain ( C;:: 4) llldehydellllcohol dehydrollenues 
Clostridium 
1.1.1.- NADH-dcpendent 1 1.1.1.77 0.9072 1.7913 FueO 1.1.1.- YqhD J.OE-68 36% 55% acetobuty/icum Q04944 BdhA butanol dehydrogenase (Walter et al., 1992) 
1.1.1.1 0.8465 1.7242 YiaY 1.1.1.- YiaY I.OE-32 26% 46% 
AdhE 1.1.-.- EutG S.OE-27 27% 42% 
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AdhP 1.1.1.77 FucO 7.0E-27 26% 46% 
FrmA 1.1.1.1. AdhE I.OE-24 24% 45% 
1.1.1.6 0.7761 1.4418 GldA 
Clostridium NADH-dependent 
acetobutylicum Q04945 BdhB 1.1.1.- butanol dehydrogenase 1.1.1.77 0.9039 1.7305 FucO 1.1.1.- YqbD 4.0E-69 39% 57% (Walter et al., 1992) 
1.1.1.1 0.8443 1.7044 YiaY 1.1.1.- YiaY 9.0E-30 26% 44% 
AdhE 1.1.1.77 FucO 4.0E-25 26% 44% 
AdhP 1.1.-.- EutG l.OE-22 27% 42% 
FrmA 1.1.1.1. AdhE 7.0E-18 22% 44% 
1.1.1.6 0.7747 1.4652 GldA 
Geobacillus GTNG_28 Long-chain alkyl 
thermodenitr!ficans A4IS49 78 1.1.1.- alcohol dehydrogenase 1.1.1.77 0.9106 1.776 FucO 1.1.1.1 YqhD 6.0E-75 41% 59% (Liu et al., 2009) 
1.1.1.1 0.8484 1.7205 YiaY 1.1.1.1 YiaY 7.0E-26 25% 42% 
AdhE 1.1.1.77 FucO 2.0E-24 26% 44% 
AdhP 1.1.1.1. AdhE 2.0E-20 26% 42% 
FrmA 1.1.-.- EutG 5.0E-20 25% 40% 
1.1.1.6 0.7781 1.4072 GldA 
Geobacillus GTNG_I7 Alcohol 
thermodenitrificans A4IP64 54 1.1.1.- Dehydrogenase 1.1.1.202 0.9565 2.5069 YqbD 1.1.-.- EutG 3.0E-57 39% 57% (Liu et al., 2009) 
1.1.1.77 0.9312 2.1532 FucO 1.1.1.1 YiaY 3.0E-54 33% 52% 
1.1.1.1. 0.8512 1.9177 YiaY 1.1.1.77 FucO 2.0E-52 34% 53% 
AdhE 1.1.1.1. AdhE 3.0E-43 34% 52% 
AdhP 1.1.1.1 YqhD l.OE-18 28% 46% 
FrmA 
1.1.1.6 0.7715 1.5259 GldA 
Pseudomonas 
oleovorans Q00593 AlkJ 1.1.99.- Alcohol 1.1.99.1 BetA 2.0E-104 40% 59% (V anbeilen et al., Dehydrogenase 
1992) 
Thermococcus sp. Iron alcohol ES CIIWT4 Adh 1.1.1.1. dehydrogenase 1.1.1.202 0.9301 2.2696 YqhD 1.1.1.1 YiaY 7.0E-40 33% 50% (Ying et al., 2009) 
1.1.1.77 0.9041 1.9642 FucO 1.1.1.1 YqhD 4.0E-30 30% 46% 
1.1.1.1. 0.8352 1.8286 YiaY 1.1.-.- EutG 3.0E-27 30% 46% 
AdhE 1.1.1.1. AdhE 9.0E-27 29% 48% 
AdhP 
FrmA 
1.1.1.6 0.7800 1.3793 GldA 
Thermococcus 
hydrothermalis Yl4015 1.1.1.- Alcohol 1.1.1.1 YiaY 4.0E-37 31% 48% (Antoine et al., Dehydrogenase 
1999) 
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I. 1.-.- EutG 2.0E-34 31% 47% 
1.1.1.1. AdhE l.OE-30 30% 50% 
1.1.1 .77 FucO 4.0E-30 30% 45% 
I. 1.1.1 YQhD 5.0E-19 30% 44% 
Su(folobus tokodaii Q976Y8 ST0053 Hypothetical alcohol 1.1.1.1. 0.9655 1.8286 YiaY 1.1.1.1. AdhP 4.0E-33 31% 50% (Yanai et al., 2009) dehydrogenase 
AdhE 1.-.-.- YydjJ 8.0E-26 30% 50% 
AdhP 1.-.-.- YphC 2.0E-21 31% 47% 
FrmA 1.-.-.- YahK 2.0E-21 29% 45% 
1.1.1.- RspB 6.0E-21 29% 49% 
I. 1.1.103 Tdh 9.0E-20 27% 47% 
1.-.-.- YjjN 3.0E-19 26% 45% 
I. 1.-.- GatD J.OE-18 28% 44% 
" The Template Modeling-score (TM-score) is defined to assess the topological similarity of protein structure pairs. Its value ranges between 0 and I, and a higher score 
indicates better structural match. Statistically, a TM-score < 0.17 means a randomly selected protein pair with the gap less alignment taken from PDB (Roy et a!., 20 10). 
h An EC-score > 1.1 is a good indicator of the functional similarity between the query and the identified enzyme analogs (Roy eta!., 2010). 
c The BLAST E-value measures the statistical significance threshold for reporting protein sequence matches against the organism genome database; the default threshold value 
is 1E-5, in which IE-5 matches would be expected to occur by chance, according to the stochastic model of Karlin and Altschul 
(http://www.ncbi.nlm.nih.gov/BLAST/tutorial/). 
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Figure 4-2 Engineered one-turn reversal of the f3 -oxidation cycle for the synthesis of n-
butanol 
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(a) Effect of gene overexpressions and knockouts (indicated underneath x axis) on the synthesis 
of n-butanol and ethanol in strain RB02 (jadR atoC( c) crp* LlarcA LladhE Llpta ilfrdA). 
Experiments were performed at 30 oc for 24 hours in shake flasks using glucose (1% w/v) 
minimal medium. The n-butanol yield was calculated as g n-butanol/g total glucose consumed. 
(b) Kinetics of n-butanol production by strain RB02 LlyqhD LleutE [yqeF+fucO+]. Cells were 
cultivated in fermentors containing minimal medium supplemented with 5 % (w/v) glucose. The 
dissolved oxygen was controlled at 5% of saturation, temperature at 30 °C, and pH at 7. 
Overexpression of YqeF, whose function in E. coli metabolism is currently 
unknown, gave better results. The simultaneous overexpression of yqeF and fucO in 
strain RB02 yielded high n-butanol titer (1.9 g/L), n-butanol yield (0.19 g n-butanol/g 
total glucose consumed) and n-butanol-to-ethanol ratio (>5:1) (Figure 4-2a). No n-
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butanol synthesis was observed upon overexpression of FucO and YqeF in wild-type 
MG 1655 (Table 4-3), demonstrating the need for an active reversal of the ~-oxidation 
cycle. 
Further reduction in the synthesis of by-product ethanol was realized through 
deletion of eutE (encoding an aldehyde dehydrogenases with high sequence similarity to 
AdhE) and yqhD (YqhD overexpression favored the synthesis of ethanol over n-butanol: 
Figure 4-2a). The resulting strain (RB02 llyqhD lleutE fyqeF+fucO+]) synthesized 2.2 
giL of n-butanol in 24 hours at a yield of 0.28 g n-butanol/ g total glucose consumed 
(Figure 4-2a). When grown in a bioreactor using a higher initial concentration of glucose, 
this strain produced n-butanol at high titer (- 14 giL), yield (0.33 g n-butanol/ g total 
glucose consumed) and rate (- 2 g n-butanol/g cell dry weight/h) (Figure 4-2b). This 
performance, which was achieved in the absence of rich nutrients and without importing 
foreign genes, is several folds better than reported for other organisms engineered for n-
butanol production (Table 4-6) and also surpasses the n-butanol yield and specific 
productivity reported for native producers (Lee et al., 2008b ). The reversal of the 13-
oxidation cycle engineered in this strain operated at a maximum carbon flux of 73.4 
mmol acetyl-CoNg cell dry weightlh (12-18 hours in Fig. 2b), which exceeds the flux 
reported in the literature for native or engineered fermentative pathways (Gonzalez et al., 
2002; Papagianni et al., 2007). 
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Table 4-6 Summary of organisms engineered to produce higher-chain (C ii!: 4) linear n-
alcohols and long-chain (C ii!: 10) fatty acids 
Product Engineered Titer (giL)/ Culture Carbon Medium/ 
Host Yield (% w/w)• Time (hr) Source Cultivation Reference 
Higher-chain (C ~ 4) linear n-alcohols 
n-butanol (C4) E. coli 0.55/2.8 24 Glycerol Rich/Batch (Atsumi et aL, 2008a) 
(Atsumi et aL, 
E. coli 0.82/3.3 100 Glucose Rich/Batch 2008b; Shen and Liao, 
2008) 
E. coli 1.2/6.1 60 Glucose Rich- (Inui etaL, MMIHCDb 2008) 
E. coli 0.58/11.6 48 Glycerol Rich/Batch (Nielsen et aL, 2009) 
S. cerevisiae 0.002/0.0001 72 Galactose Rich/Batch (Steen et aL, 2008) 
B. subtilis 0.024/0.48 72 Glycerol Rich/Batch (Nielsen et aL, 2009) 
P.putida 0.120/2.4 72 Glycerol Rich/Batch (Nielsen et aL, 2009) 
L. /actis 0.028/-- Glucose Rich/Batch (Liuet aL, 2010) 
L. buchneri 0.066/-- Glucose Rich/Batch (Liuet aL, 2010) 
L. brevis 0.3/1.5 60 Glucose Rich/Batch (Berezina et aL, 2010) 
E. coli 2.05/13.4 96 Palmitic MM/Fed- (Dellomonaco Acid Batch et aL, 2010b) 
E. coli 4.65/28 72 Glucose Rich/Batch (Bond-Watts et aL, 2011) 
E. coli 14.5/32.8 36 Glucose MM/Batch This work 
n-hexanol (C6) E. coli 0.04/0.2 40 Glucose Rich/Batch (Zhang et aL, 2008) 
Fatty alcohols 
(Distribution of Cl 0, E. coli 0.06/0.3 Glucose MM/Batch (Steen et aL, 
C12, C14, and C16) 2010) 
Higher-chain n- E. coli 0.42/8.3 48 Glucose MM/Batch (Dellomonaco, 
alcohols (C6 to ClO) 2011b) 
Long-chain (C ~ 10) fatty acids 
Fatty Acids E. coli 1.2/6 Glucose MM/Batch (Steen et aL, (Predominantly C14) 2010)' 
Fatty Acids E. coli 2.51-- 22 Glycerol MM/Fed- (LuetaL, (Wide Distribution) Batch/HCD 2008)' 
Fatty Acids E. coli 0.81116 29 Glycerol Rich/Batch (Lennen et aL, (Predominantly C12) 2010)' 
Fatty Acids (Dellomonaco, (Predominantly C16, E. coli 6.6/28 60 Glucose MM/Batch 2011b) 
C18 
a For products with carbon length distributions, titer represents the sum of products of all chain length produced. 
Yield assumes all the carbon source was consumed when carbon source consumption data not given in reference. 
b Two-phase, high cell density (HCD) culture grown first in rich medium and then incubated in minimal medium 
(MM). 
c Titers reported refer to total (i.e. sum of intracellular and extracellular) free fatty acids. 
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A characterization of the engineered reversal of the f3-oxidation cycle was 
conducted to establish the identity of the enzymes catalyzing each individual step and 
their role on n-butanol synthesis {Table 4-4). Enzyme activity measurements showed high 
level of expression of key enzymes involved in the postulated pathway in strain RB02 
[yqeF +fucO+] and negligible activity in wild type MG 1655 {Table 4-4). Gene knockout 
and gene complementation experiments along with quantification of fermentation 
products {Table 1 b) demonstrated that the primary enzymes involved in the synthesis of 
n-butanol through the engineered reversal of the f3-oxidation pathway are (activities 
shown in parentheses along with reaction numbers, as per Figure 4-1 ): Y qeF (predicted 
acyltransferase: Reaction CD), FadB (3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA 
hydratase: Reactions ® and ®, respectively), Y diO (predicted acyl-CoA 
dehydrogenase/enoyl-CoA reductase: Reaction @), and MhpF and FucO (aldehyde-
forming acyl-CoA reductase and n-butanol dehydrogenase, respectively: Reaction @). 
It is noteworthy that Y diO is proposed here to catalyze the reduction of enoyl-
CoA to acyl-CoA (Reaction @). The reverse of this reaction is catalyzed by FadE and is 
the only irreversible step in the catabolic operation of the f3-oxidation cycle (Clark and 
Cronan, 2005). In agreement with our proposal, deletion of ydiO in strain RB02 
[yqeF+fucO+] completely abolished n-butanol synthesis {Table 4-3) while a fadE 
deletion did not have a significant effect (data not shown). Although ydiO was previously 
proposed to encode an acyl-CoA dehydrogenase that would replace FadE during the 
anaerobic catabolism of fatty acids (Campbell and Cronan, 2002), a sequence comparison 
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between Y diO and proteins encoded in the E. coli genome does not reveal a significant 
similarity to FadE (E-value 0.001 and 81% coverage: Table 4-7). 
I 
Table 4-7 Homology analysis and functional annotation of Escherichia coli ydi genes 
Current annotation" Sequence-based bomologues identified via protein BLAST Functional bomologues identified via I-T ASSER (Altschul et aL 1997) (Roy et al. 2010) 
Enzyme Function Enzyme Function E-valne~ Coverage Similarity Function TM-Seore• EC-Sc:ored 
name 
YdiO Predicted acyl-CoA CaiA Crotonobetainyl-CoA l.OE-102 99% 65% Butyryl-CoA 0.9584 2.2964 dehydrogenase reductase dehydrogenase 
AidB Isovaleryl-CoA 2.0E-14 64% 47% Acyl-CoA 0.9618 2.1730 dehydrogenase dehydrogenase 
FadE Acyl-CoA dehydrogenase 0.001 81% 37% 
Putative electron transfer probable flavoprotein subunit YdiQ flavoprotein subunit FixA required for anaerobic 3.0E-68 99% 71% Adenosine kinase <l.l 
carnitine metabolism 
Putative electron transfer probable flavoprotein subunit YdiR flavoprotein subunit FixB required for anaerobic 6.0E-75 100"/o 64% 
camitine metabolism 
Predicted oxidoreductase with flavoprotein (electron Electron-transferring-YdiS F AD/NAD(P)-binding domain Fixe transport) 5.0E-152 100"/o 78% flavoprotein 0.9404 1.8378 dehydrogenase 
predicted oxidoreductase with 
YgcN FAD/NAD(P)-binding 9.0E-93 99% 62% 
domain 
putative ferredoxin possibly Electron-transferring-
YdiT Ferredoxin-like protein FixX involved in anaerobic 3.0E-33 96% 62% flavoprotein 0.9006 1.5362 
camitioe metabolism dehydrogenase 
YgcO predicted 4Fe-4S cluster- l.OE-18 89% 62% 
containing protein 
" As annotated in Ecocyc(Keseler et al., 2009). Also reported by Campbell, J.W. and coworkers (Campbell et al., 2003). 
b The BLAST E-value measures the statistical significance threshold for reporting protein sequence matches against the organism genome database; the default threshold value is 
1E-5, in which 1E-5 matches would be expected to occur by chance, according to the stochastic model of Karlin and Altschul (http://www.ncbi.nlm.nih.gov/BLAST/tutorial/). 
c The Template Modeling-score (TM-score) is defmed to assess the topological similarity of protein structure pairs. Its value ranges between 0 and 1, and a higher score indicates 
better structural match. Statistically, a TM-score < 0.17 means a randomly selected protein pair with the gapless alignment taken from PDB (Roy et al., 201 0). 
d An EC-score > 1.1 is a good indicator of the functional similarity between the query and the identified enzyme analogs(Roy et al., 2010). 
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In contrast, Y diO shares high homology with crotonobetainyl-CoA reductase 
(CaiA; E-value l.OE-112 and 99% coverage: Table 4-7). CaiA catalyzes the reduction of 
crotonobetainyl-CoA to y-butyrobetainyl-CoA (Eichler et al., 1994), a reaction very 
similar to that catalyzed by Y diO in the engineered reversal of the (3-oxidation cycle. 
Moreover, the operon fzxABCX is required for the transfer of electrons to CaiA (Eichler et 
al., 1995; Walt and Kahn, 2002) and encodes flavoproteins and ferredoxin with high 
sequence similarity to Y diQRST (Table 4-7). 
Table 4-8 Thermodynamic analysis of the engineered reversal of the p-oxidation cycle 
Reaction number and enzyme name (gene) 
CD Thiolase (yqeF,jadA) 
2 Acetyl-CoA 7 Acetoacetyl-CoA + CoA-SH 
® Hydroxyacyl-CoA dehydrogenase (fadB) 
Acetoacetyl-CoA + NADH + H+ 7 3-hydroxybutyryl-CoA + NAD+ 
@ Enoyl-CoA hydratase (fadB) 
3-hydroxybutyryl-CoA 7 Crotonyl-CoA + H20 
@ Acyl-CoA dehydrogenase (coupled to ubiquinone,fadE)b 
Crotonyl-CoA + UQH2 7 Butyryl-CoA + UQ 
@ Enoyl-CoA reductase (coupled to ferredoxin,ydiO-ydiQRS1)b 
Crotonyl-CoA + Fd2- 7 Butyryl-CoA + Fd 
Operation of P-oxidation reversal coupled to ubiquinone 
Operation of P-oxidation reversal coupled to ferredoxin 
Standard A Gr 
(Min AGn Max AGr) [kcallmol] • 
7.1 
(-1.9, 16.1) 
-3.7 
(-12.7, 5.3) 
2.1 
(-2.4, 6.6) 
5.7 
(-3.3, 14.7) 
-16.5 
( -25.5, -7 .5) 
11.2 
-11.0 
• Standard ~G of formation values estimated using the group contribution method( Jankowski et al., 2008) and used to 
calculate the standard ~G of reaction(Feist et al., 2007). Minimum and maximum ~Gr values calculated assuming 
standard conditions (298.15 K, pH 7) with minimum and maximum metabolite concentrations set to 0.00001 M and 
0.02 M, respectively(Feist et al., 2007). Listed ~Gr values are in good agreement with experimentally 
measured/calculated ~Gr values(Seubert and Podack, 1973; Thauer et al., 1977). 
b Calculation of ~Gr for enoyl-CoA reductase used standard reduction potentials from Thauer et a/(Thauer et al., 
1977). 
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This analysis suggests that ferredoxin and flavoproteins encoded by ydiQRST are 
involved in the transfer of electrons to Y diO during the reduction of enoyl-CoA to acyl-
CoA. Indeed, deletion of the ydiQRST operon completely abolished n-butanol production 
(data not shown). Thermodynamic calculations of the engineered reversal of the f)-
oxidation cycle indicate that this pathway can function effectively in the biosynthetic 
direction as long as the reduction of enoyl-CoA to acyl-CoA is mediated by Y diO-
y diQRST (Table 4-8). 
4.3.1. Establishing a platform for the synthesis of advanced fuels and chemicals 
The engineered reversal of the 13-oxidation cycle generates a diverse set of CoA 
thioester intermediates of different chain lengths, which in turn can be converted to the 
corresponding alcohols and carboxylic acids (Figure 4-1 ). The class of alcohol and 
carboxylic acid synthesized can be controlled by choosing a thiolase of appropriate chain-
length specificity (reaction CD, Figure 4-1) and/or a termination enzyme with specificity 
towards the CoA-thioester intermediate of desired chain length and functionality 
(reactions® and®, Figure 4-1). To illustrate product synthesis from intermediates other 
than acyl-CoA, we used thioesterase I (TesA) (Cho and Cronan, 1993) and thioesterase II 
(TesB) (Nie et al., 2008) as termination enzymes. As shown in Figure 4-3 and reported in 
Table 4-9, small amounts of 13-hydroxybutyric, f3-ketobutyric, and trans-2-butenoic acids 
were produced when these thioesterases were overexpressed in strain RB02. 
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Table 4-9 Cell growth, glucose utilization, product synthesis, and carbon recovery for 
derivatives of strain RB02 engineered for the synthesis of 4-C carboxylic acids 
Concentrationb (g/L) 
Strain a Glucose P-keto- P- trans-2- %C-Cells 
utilized C4:0 hydroxy- butenoic recoveryd C4:0 acid 
RB02 0.29 1.76 NDC ND NDC 94.09 
RB02 [tesA+] 0.62 4.25 NDC 0.032 0.010 95.30 
RB02 [tesB+] 0.57 4.30 0.024 NDC NDC 89.88 
RB02 [yqeF+ tesA+] 0.56 4.95 NDC 0.045 0.012 91.08 
RB02 llydiO [yqeF+ tesA+] 0.42 3.34 NDC 0.140 0.171 89.23 
RB03 [yqeF+ tesB+] 0.65 5.16 0.110 NDC NDC 97.17 
RB03 llfadB [yqeF+ tesB+] 0.62 5.03 0.450 NDC NDC 95.53 
a Data represent averages for three samples taken from shake flask cultures grown on 2 % 
(w/v) glucose minimal medium. 
h All genotypes are shown in Table 4-1. 
c ND, not detectable. Minimum detection levels are: p..keto-C4:0, 4.09 mg r 1; p..hydroxy-
C4:0, 3.03 mg r1 trans-2-butenoic acid, 9.40 mg r1• 
d Carbon recovery was calculated as the ratio of total moles of carbon in products per moles of 
carbon in total glucose consumed and expressed on percentage basis. 
The level of these products was significantly increased by simultaneous 
overexpression of thioesterase and yqeF-encoded short-chain acyltransferase (Figure 
4-3). Further increases in titer were realized upon deletion of fadB (~ 500 mg/L (3-
ketobutyric acid) and ydiO (~ 150 mg/L and 200 mg/L of (3-hydroxybutyric and trans-2-
butenoic acids, respectively) (Figure 4-3, Table 4-9). 
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Figure 4-3 Engineered one-turn reversal of the ~-oxidation cycle for the synthesis of short-
chain carboxylic acids 
Synthesis of 13-ketobutyric (left panel), 13-hydroxybutyric (center panel), and trans-2-butenoic 
(right panel) acids upon overexpression of thioesterases I (TesA) and II (TesB) in strains RB02, 
RB02ll.fadB, and RB02 llydiO. Experiments were run at 37 °C for 48 hours in shake flasks using 
glucose (1% w/v) minimal medium. 
The operation of multiple cycles of the engineered reversal of the 13-oxidation pathway, 
and hence the synthesis of CoA-thioester intermediates (and products) of longer chain 
length, can be facilitated by the overexpression of FadA, a 3-ketoacyl-CoA thiolase that 
is part of the 13-oxidation complex (FadBA) and which possesses broad chain length 
specificity (Yang et al., 1990). This modification, in combination with the use of 
appropriate termination enzymes, should support the synthesis of longer chain (C > 4) 
carboxylic acids and alcohols. Indeed, overexpression of the 13-oxidation complex 
(FadBA) in conjuction with thioesterases (TesA, TesB, FadM (Feng and Cronan, 2009) 
or Y ciA (Zhuang et al., 2008)) in strain RB03 (RB02 !J.yqhD !J.fucO !J.fadD) resulted in 
the accumulation of long-chain fatty acids in the extracellular medium (Figure 4-4). The 
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fadD knockout in strain RB03 blocks the catabolic operation of the f3-oxidation cycle, 
thus preventing re-utilization of the synthesized fatty acids. 
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Figure 4-4 The engineered reversal of the f3-oxidation cycle as a platform for the synthesis 
of higher-chain (C > 4) carboxylic acids 
(a) Accumulation of long-chain (C > 10) free fatty acids in the extracellular medium of strain 
RB03 [fadBA+] upon overexpression of different thioesterases (FadM, YciA, TesA, TesB) . The 
yield of each extracellular free fatty acid (g free fatty acid/g total glucose consumed x 100) is 
shown above the bars. Experiments were run at 37 oc for 48 hours in shake flasks using glucose 
(2% w/v) minimal medium. 
(b) Kinetics of fatty acid synthesis by strain RB03 [fadBAjadM+]. Cells were cultivated in 
fermentors containing minimal medium supplemented with 3 % (w/v) glucose. The dissolved 
oxygen was controlled at 2% of saturation, temperature at 37 °C, and pH at 7. 
The choice of thioesterase allowed control over both length and functionality of 
the fatty acid side chain. For example, C16 and C18 saturated fatty acids were the only 
products when FadM was overexpressed while Y ciA and TesA overexpression supported 
the synthesis of f3-hydroxy (C 14:30H) and unsaturated (C 1s: t) fatty acids, respectively 
(Figure 4-4a). When grown in a bioreactor using a higher initial concentration of glucose, 
strain RB03 [fadBAfadM+] produced long-chain extracellular fatty acids at high titer(-
7 g/L) and yield (0.28 g fatty acids/g total glucose consumed) using a mineral salts 
medium without rich nutrients (Figure 4-4b). These results are several folds better than 
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reported previously using an engineered fatty acid biosynthesis pathway (Steen et al., 
2010) (Table 4-6). Unlike previous reports in which a large fraction of the produced fatty 
acids remained inside the cells (Handke et al., 2010; Lennen et al., 2010; Steen et al., 
2010), more than 95% of the fatty acids synthesized by the engineered strains were 
secreted into the medium (Figure 4-4b). 
Table 4-10 Synthesis of long-chain (C > 10) saturated fatty acids by RB03 (RB02 4yqhD 
4fuc0 4/ad.D) derivatives 
Strain a Concentrationb (giL) 
Extracellular FFAs (Free Fatty Acids) 
Glucose Total Total %C-
utilized CIO:O Cl2:0 Cl4:0 Cl6:0 Cl8:0 FFAsd FFAs/ recovery• cow 
MG1655 12.88 NDC ND ND ND ND ND I 93.05 
RB03 4.30 ND ND ND ND ND ND I 90.64 
RB03 [fadBA+] 2.24 ND ND ND ND ND 0.090 0.175 91.55 
RB03 [fadBA+ tesA+] 5.82 ND ND 0.110 ND ND f 92.02 
RB03 [fadBA+ tesB+] 5.16 0.120 ND ND ND ND 94.78 
RB03 [fadBA+ yciA+] 2.87 0.050 ND 0.080 0.450 0.100 91.94 
RB03 [fadBA+ fadM+] 3.07 ND ND ND 0.700 0.180 98.14 
RB03 [fadM+ ]r 3.30 ND ND 0.020 0.150 0.080 0.435 0.790 92.86 
RB03 [fadBAfadM+] 5.91 ND ND ND 0.740 0.500 1.370 2.035 97.19 
MGl655 lladhE llpta ll.frdA 5.04 ND ND ND ND ND ND I 86.44 llfadD 
MGl655 lladhE llpta tifrdA 5.07 ND ND ND ND ND 0.070 0.092 94.15 llfadD [fadM+] 
MGl655 lladhE llpta ll.frdA 
ll{j1dD [fadM+ t 5.23 ND ND ND ND ND 0.261 0.279 96.17 
II Data represent averages for three samples taken from shake flask cultures grown on 2 % (wlv) glucose 
minimal medium. 
b All genotypes are shown in Supplementary Table 7. 
c ND, not detectable. Minimum detection levels are: C10:0, 21.76 mg 1"1; C12:0, 20.45 mg 1"1; C14:0, 27.12 mg 
1"1; C16:0, 20.17 mg 1"1; C18:0, 16.42 mg 1"1• 
d FF As, Free Fatty Acids 
e Carbon recovery was calculated as the ratio of total moles of carbon in products per moles of carbon in total 
glucose consumed and expressed on percentage basis. 
f fadM was overexpressed from medium-copy vector pTrcHis2A (Invitrogen, Carlsbad, CA). 
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No production of extracellular free fatty acids was observed upon overexpression 
of FadM in strain MG1655 !iadhE !!pta !ifrdA !ifadD (Table 4-10), demonstrating the 
requirement of an active reversal of the ~-oxidation cycle. Measurements of total free 
fatty acids in the whole broth (i.e. extracellular + intracellular) in strain RB03 
[fadBAfadM+] and the corresponding controls showed that the engineered reversal 
contributed to the synthesis of 90-95% of the total free fatty acids (Table 4-1 0). 
Table 4-11 Synthesis of higher chain (C > 4) n-alcohols by derivatives of strain RB03 (RB02 
AyqhD AfucO AfadD) derivatives 
Concentrationb (g/L) 
Strain a Glucose %C-Cells 
utilized n-C6-0H n-C8-0H n-ClO-OH recovery d 
MG1655 !).adhE !).pta !).jrdA 0.65 4.16 NDC NDC NDC 91.54 !)./adD [betA+] 
RB03 [fadBA+] 0.71 5.27 NDC NDC NDC 90.38 
RB03 [fadBA+ yia Y+] 0.73 5.06 0.170 0.080 0.170 91.97 
RB03 [fadBA+ eutG+] 0.52 4.00 0.170 0.070 0.010 90.36 
RB03 [fadBA+ betA+] 0.72 3.98 0.210 0.100 0.020 91.16 
a Data represent averages for three samples taken from shake flask cultures grown on 2 % (w/v) glucose 
minimal medium. 
6 All genotypes are shown in Supplementary Table 7. 
c ND, not detectable. Minimum detection levels are: C10:0, 21.76 mg r1; C12:0, 20.45 mg r1; C14:0, 27.12 mg 
r1; C16:0, 20.17 mg r 1; C18:0, 16.42 mg r 1• 
4 FF As, Free Fatty Acids 
e Carbon recovery was calculated as the ratio of total moles of carbon in products per moles of carbon in total 
glucose consumed and expressed on percentage basis. 
f fadM was overexpressed from medium-copy vector pTrcHis2A (Invitrogen, Carlsbad, CA). 
The synthesis of longer-chain (C >4) n-alcohols was also demonstrated by 
overexpressing the appropriate termination enzymes. To this end, we identified native 
enzymes that could serve as potential surrogates for the aldehyde-forming acyl-CoA 
reductases and alcohol dehydrogenases present in organisms that synthesize higher-chain 
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linear n-alcohols (Table 4-5). The product titer (0.33 g/L) and yield (8.3 % w/w) achieved 
upon overexpression of Yia Y (Figure 4-5) were several folds higher than previously 
reported (Steen et al., 2010; Zhang et al., 2008) (Table 4-11). Further improvements in 
the synthesis of these alcohols can be realized by expressing the heterologous aldehyde-
forming acyl-CoA reductases and alcohol dehydrogenases listed in Table 4-5 . 
The ability of the engineered pathway to produce odd-chain alcohols was 
demonstrated by supplementing the medium with propionate as the precursor of 
propionyl-CoA (R = CH3 in Figure 4-1). 
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Figure 4-5 The engineered reversal of the (3-oxidation cycle as a platform for the synthesis 
of higher-chain (C > 4) n-alcohols 
(a) Synthesis of n-alcohols in strain RB03 [fadBA+] upon overexpression of alcohol 
dehydrogenases (Yia Y, BetA, and EutG). The yie~d of each n-alcohol (g ~-alcohol/g total_ glucose 
consumed x 100) is shown above the bars. Expenments were run at 37 C for 48 hours m shake 
flasks using glucose (2% w/v) minimal medium. . 
(b) Effect of alcohol dehydrogenase overexpression (YiaY, BetA , and EutG) on the cham-length 
distribution of n-alcohols synthesized by strain RB03 [fadBA+] in the presence of 0.5 g/L 
propionate. 
158 
A clear shift in the distribution of n-alcohols was observed: odd-chain alcohols 1-
pentanol, 1-heptanol, and 1-nonanol appeared as fermentation products and the synthesis 
of even-chain alcohols significantly decreased (Figure 4-5). BetA overexpression resulted 
in the synthesis of n-pentanol as the only higher-chain alcohol (Figure 4-5d), 
demonstrating the ability to control chain-length distribution. 
4.4. Discussion 
The functional reversal of the ~-oxidation cycle engineered in this work represents a 
novel and efficient platform for the synthesis of advanced fuels and chemicals. 
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Figure 4-6 Comparison of n-alcohols synthesis via the fatty acid biosynthesis pathway and 
the engineered reversal of the p -oxidation cycle 
Reactions CD-® are as indicated in Figure 4-1. (J), acetyl-CoA carboxylase & malonyl-CoA ACP 
transacylase; ®, [3-ketoacyl-acyl-carrier protein synthase; ®, 3-ketoacyl reductase, enoyl 
reductase, and 3-hydroxyacyl dehydratase; ®l & @correspond to acyl-ACP conversion to free 
acids(@)), and acylation(@). 
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Its superior nature is easily illustrated in the following balanced equation for the 
synthesis of n-alcohols from glucose: n/4 Cd{120 6 ~ CnHn+20 + n/2 C02 + (n/2 - 1) 
H20 + n/2 ATP, with n being the chain length of then-alcohol (Figure 4-1). As can be 
seen in this balance, the engineered pathway has the potential to achieve the maximum 
theoretical yield of n-alcohols on glucose (66.7 %, C-mole basis) and generates 1 ATP 
per each two-carbon unit incorporated into the n-alcohol molecule. This ATP yield is 
equivalent to that of efficient homo-fermentative pathways found in nature such as 
ethanol (Osman et al., 1987) and lactic acid (Papagianni et al., 2007) fermentations. The 
high carbon and energy efficiency of the engineered reversal of the 13-oxidation cycle is 
possible because it directly uses acetyl-CoA as the donor of two-carbon units during 
chain elongation (as opposed to first requiring ATP-dependent activation to malonyl-
CoA) and it functions with acyl-CoA intermediates, which are the precursors of n-
alcohols and other important products (Figure 4-1 ). 
The synthesis of n-alcohols through alternative metabolic routes, such as the fatty 
acid biosynthesis (Steen et al., 2010) and keto-acid (Zhang et al., 2008) pathways, is less 
efficient. For example, the use of the fatty acid biosynthesis pathway results in the net 
consumption of 1 ATP per molecule of n-alcohol synthesized (Figure 4-6). 
The fatty acid biosynthesis pathway uses acyl-ACP intermediates and involves a ~­
ketoacyl-acyl-carrier protein synthase along with a 3-ketoacyl reductase, an enoyl 
reductase, and a 3-hydroxyacyl dehydratase (Figure 4-6)(Chan and Vogel, 2010; Cronan 
and Thomas, 2009). Production of n-alcohols from these acyl-ACP intermediates requires 
their conversion to free acids and acylation before their reduction to alcohols can be 
achieved (Steen et al., 2010). The use ofacyl-ACP intermediates and malonyl-ACP as the 
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2-C donor during chain elongation in the fatty acid biosynthesis pathway limits therefore 
its ATP efficiency, making this an ATP-consuming pathway, as shown in the following 
balanced equation for n-alcohol synthesis from glucose: n/4 C6H120 6 + ATP 7 CnHn+lO 
+ n/2 C02 + (n/2 -1) H20, with n being the chain length of then-alcohol. 
The keto-acid pathway (Zhang et al., 2008) is also less efficient than the reversal of 
the 13-oxidation cycle: e.g. the maximum theoretical yield of n-hexanol, the highest-chain 
linear n-alcohol reported with the keto-acid pathway, is only 50% C-mole (2 Glucose 7 
n-hexanol + ATP + 2[H] + 6 C02). 
The results presented here demonstrate that the engineered reversal of the 13-
oxidation cycle is a metabolic platform that can support the combinatorial synthesis of 
advanced fuels and chemicals at high carbon and energy efficiency. While we focused on 
the engineering of E. coli, the ubiquitous nature of 13-oxidation, aldehyde/alcohol 
dehydrogenase, and thioesterase enzymes should enable the use of similar metabolic 
engineering strategies to achieve efficient synthesis of n-alcohols and carboxylic acids in 
other industrial organisms. Although our work (Dellomonaco, 2011 b) only used native 
termination enzymes, further exploiting the potential of the engineered reversal of the 13-
oxidation cycle will likely require the use of heterologous thioesterases, CoA-thioester 
reductases and aldehyde/alcohol dehydrogenases. 
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Conclusions and future directions 
This research study revolved around the development of novel approaches in the 
context of fuel and chemical production in Escherichia coli. Microbial bioconversions are 
a promising avenue for the development of viable processes for the generation of fuels 
and chemicals from sustainable resources. In order to become cost and energy effective, 
these processes must utilize organisms that can be optimized to efficiently produce 
candidate molecules from a variety of feedstocks. While foregoing metabolic engineering 
efforts had targeted the design of cell factories that could efficiently utilize carbohydrate 
feedstocks, this work has demonstrated a novel metabolic platform for the conversion of 
fatty-acid rich feedstocks, previously utilized only for chemical conversions, to fuels and 
chemicals. 
In order to become a viable means for producing biofuels, microbial processes 
must utilize microorganisms that can be readily manipulated to maximize the production 
of candidate chemicals and fuels in large-scale industrial applications. In this regard, 
synthetic biology has provided an avenue to reconstruct de novo pathways in bacteria that 
are not known to possess the metabolic trait of interest by importing foreign pathways. 
The present study proposes a novel methodology in the panorama of the design of 
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microbial factories, alternative to current available platforms that entail either the 
utilization of native organisms or the heterologous expression in model organisms. 
Homologous Metabolic Engineering aims at exploiting innate metabolic potential of 
industrial organisms, and provides an opportunity to re-tune the functional differentiation 
of bacteria. Given the functional plasticity of bacteria, exploiting the native biosynthetic 
potential is the strategy of choice in this work, and is implemented to establish a novel 
platform that utilize a functional reversal of the (3-oxidation cycle to produce a wide array 
of molecules with different chain lengths and functionalities. 
Overall, the study hereby presented has aimed at i. exploring alternative 
renewable feedstocks and developing microbial platform to convert them to valuable 
products; ii. devising and implementing a new methodology to construct efficient 
metabolic platforms: iii. exploring the innate potential of E. coli to establish a platform 
enabling biosynthesis of a diverse array of products. The relevance of this work is 
therefore better realized when considered in the context of the bioindustry workflow 
(Figure 1-1) (Dellomonaco et al., 2010b). 
In Chapter 2 we explored the microbial utilization of fatty-acid rich feedstocks, 
exploited until recently mainly for chemical conversions. The use of FA-rich feedstocks 
for the production of biofuels and biochemicals was established as a promising 
alternative avenue to establish biorefineries. Since metabolism of F As requires the 
presence of an external electron acceptor, that would in tum preclude the synthesis of 
fermentation products, we engineered a respiro-fermentative metabolic mode that could 
integrate the efficient production of the desired products in combination with adequate 
catabolism of FAs. The high metabolic efficiency of the catabolic pathway, along with 
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the high-reduced state of carbon in F As, enabled the production of fuels and chemicals at 
yields superior than those obtained with the use of lignocellulosic sugars. For example, 
the yield of ethanol and acetate in the engineered strains surpassed the maximum 
theoretical values that can be achieved from lignocellulosic sugars (Dellomonaco et al., 
201 Ob ). Butanol, on the other hand, was produced at yields and titers between two- and 
three-fold higher than those reported for its production from lignocellulosic sugars in 
engineered E. coli, P. putida, B. subtilis, and S. cerevisiae strains (Atsumi et al., 2008a; 
Inui et al., 2008; Nielsen et al., 2009; Steen et al., 2008). Our work (Dellomonaco et al., 
20 lOb) also represented the first report of propionate production in E. coli, a compound 
previously thought to be synthesized only by Propionibacteria. 
The results obtained in this study have provided a novel avenue for a more efficient 
and productive use of fatty-acid feedstocks as a source for the generation of reduced 
chemicals and fuels. While Escherichia coli has been the model organism considered in 
this study, several other strains have been identified as possessing characteristics required 
for fatty acids catabolism. Yeasts, such as Saccharomyces cerevisiae and some 
oleaginous species, are able to grow on fatty acids as sole carbon and energy source 
{Trotter, 2001). A strategy similar to the one implemented in this study can therefore be 
extended to other model organisms, like for example S. cerevisiae. However, the design 
of the metabolic engineering strategy will have in this case to account for the 
complication posed by the compartmentalization of biochemical processes in yeasts. 
Chapter 3 provides a novel methodology (Homologous Metabolic Engineering, 
HoME) (Dellomonaco, 2011a) to design optimal biocatalysts for the conversion of 
feedstock constituents to molecules of interest. This new approach builds upon the innate 
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plasticity of bacterial metabolism, and thus aims at awakening and engineering latent 
metabolic potential of functionally pluripotent bacteria to produce fuels and chemicals. 
The differentiation of E. coli function-orne has been engineered and re-tuned from a 
mixed-acid fermentative metabolism to a Clostridial acetone-butanol-ethanol metabolism. 
E. coli metabolism has also been engineered to dissimilate glycerol to 1,3-propanediol 
(Dellomonaco, 2011a), a metabolic capability present in the y-Proteobacteria but never 
demonstrated to date in E. coli using native genes. While these results further 
demonstrate that phylogenie distance of species does not necessarily entail distinct 
biochemical capabilities, they also support our hypothesis of the existence of a functional 
pluripotent bacterial cell (Dellomonaco, 2011a). Furthermore, they provide a proof of 
concept demonstration of HoME as a viable alternative approach to Heterologous 
Metabolic Engineering strategies currently employed in biocatalyst development. 
In Chapter 4 a metabolic platform for the synthesis of a wide variety of 
molecules was demonstrated in E. coli by engineering a functional reversal of the 
fatty acids catabolic pathway (f3-oxidation) (Dellomonaco, 2011b). The reversal ofthe 13-
oxidation cycle was engineered in E. coli and used in combination with endogenous 
dehydrogenases and thioesterases to synthesize n-alcohols, fatty acids and carboxylic 
acids. The superior nature of the engineered pathway was demonstrated by producing 
higher-chain linear n-alcohols (C 2: 4) and extracellular long-chain fatty acids (C> 10) at 
higher efficiency than previously reported. 
The ubiquitous nature of 13-oxidation, aldehyde/alcohol dehydrogenase, and thioesterase 
enzymes has the potential to enable the efficient synthesis of these products in other 
industrial organisms. Furthermore, the flexibility of the pathway allows its 
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implementation for the production of a wide array of products. Acyl-CoA intermediates 
generated by the engineered reversal of the /)-oxidation can be converted to fuels and 
chemicals of different chain length by selecting and overexpressing termination enzymes 
(aldehyde/dehydrogenase, thioesterase, etc.) with appropriate specificity. 
Since our results have demonstrated that a functional reversal of the /)-oxidation cycle 
can be used as an efficient platform to produce acyl-CoA-derived products, synthesis of 
products derived from these intermediates can be envisioned. As an example, acetone 
production has already been demonstrated in Chapter 3 using native E. coli genes, and 
production of long chain fatty acids in Chapter 4 has proved the efficiency of this 
platform in generating longer chain Co-A derivatives. It is therefore possible, in 
principle, to produce methylketones with higher chain length by integrating both 
strategies. 
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